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Myelin is a multilayered lipid-rich structure that surrounds selected axonal segments 
in the central and peripheral nervous systems (CNS and PNS, respectively). Myelin 
insulates axons, which increases nerve conduction velocity by up to two orders of 
magnitude. The correct formation and stability of myelin are crucial for the function 
of the nervous system, as demonstrated in the case of demyelinating diseases. The 
disruption of myelin and its compact structure can result from an autoimmune 
response, such as in the case of multiple sclerosis (MS), which affects the CNS. 
Another mechanism arises from mutations, which compromise myelin protein 
function and lead to disease. Such disorders include PNS neuropathies. 
Demyelinating conditions are generally chronic, incurable diseases. Remedies for 
these remain to be developed due to insufficient understanding of the formation and 
stability of healthy myelin. 
The insulative nature of myelin arises from a specialized plasma membrane that is 
wrapped dozens of times around the axon, before myelin undergoes compaction that 
excludes most water content. Stacked lipid membranes are adhered together by 
myelin-specific proteins with unique structural and functional properties. Such 
proteins include the intrinsically disordered myelin basic protein (MBP) and the 
integral membrane protein, myelin protein zero (P0), in the CNS and PNS, 
respectively. These proteins are only abundantly expressed in myelin and they are 
highly conserved within vertebrates. Both MBP and P0 have been linked to 
demyelinating disorders, with the structural details remaining to be elucidated. 
In this thesis, a cross-complementary biophysical method ensemble was established 
and used to characterize the folding, lipid binding, and membrane stacking properties 
of MBP, uncovering a putative mechanism for MBP-induced formation of compact 
myelin. The same workflow was used to characterize the cytoplasmic domain of P0 
(P0ct), which has been suggested to adhere membranes together in the PNS similarly 





environments. The results provide a model for P0-induced membrane stacking in the 
PNS. 
The effect of ions on the function of MBP and P0ct was studied, unveiling that Ca2+, 
the most abundant divalent cation in myelin, modulates their activity. The study was 
expanded to peripheral neuropathy-related mutant variants of P0ct, and a specific 
gain-of-function mutation may explain the aberrant myelin phenotype in patients. 
The biophysical approach described in this thesis enables the characterization of 
myelin proteins and their disease variants. While well-behaving model lipid 
conditions were employed here, more physiologically relevant conditions should be 
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1.1. MYELIN, A NERVE INSULATOR 
1.1.1. THE NERVOUS SYSTEM 
Humans and all vertebrates alike enjoy the luxury of a nervous system – the 
immensely complicated, yet organized biological network that specializes in 
transmitting, storing, and processing information as nervous impulses originating 
from internal or external stimuli, or commands from the organism itself. The nervous 
system is classically divided into two interconnected parts: the central and the 
peripheral nervous systems (CNS and PNS, respectively). The CNS is comprised of 
the brain and spinal cord, and functions as a mainframe to process and compile 
information needed for maintaining normal bodily functions, making decisions, 
learning and memory. The PNS connects to the CNS, and consists of sensory 
(afferent) and motor (efferent) nerves that encompass all other nerves in the body. 
The PNS is subdivided into autonomic and somatic, or voluntary and involuntary 
nervous systems, respectively, which control information relay between the CNS and 
peripheral organs, muscles, the skin, and sensory organs. Together with the CNS, the 
PNS forms a tremendously efficient system that allows the vertebrate to maintain 
normal everyday existence and respond to stimuli1. 
The most important cell type in both the CNS and the PNS is the neuron. This 
specialized cell is composed of (1) a soma, where the nucleus resides and the majority 
of cell respiration and protein synthesis occurs, (2) the axon, the only process used to 
relay nervous impulses towards synapses, and (3) dendrites, which are processes 
connecting to other neurons through synapses and act in nerve impulse reception2. 






impulses, also known as action potentials. In these events, voltage-gated ion channels 
open on the axonal plasma membrane (axolemma) and cause a rapid influx of Na+ 
ions from the extracellular space to the Na+-deficient axonal cytoplasm (axoplasm), 
which results in membrane depolarization and a flow of ions traveling along the axon 
towards the synapse due to the rapidly formed concentration gradient. The flow of 
Na+ consecutively triggers opening of more Na+-channels on the way, increasing the 
amount of cytosolic Na+, thus allowing the action potential to propagate. The 
membrane is repolarized through a flux of intracellular K+ to the extracellular milieu, 
followed by active Na+/K+ exchange through the membrane, returning the resting 
potential3. 
In addition to neurons, both the CNS and PNS consist of several other cell types, 
collectively referred to as glial cells. In the CNS, this group includes microglia and 
astrocytes. Microglia act as immune response cells in the brain and spinal cord, where 
macrophages and other immune cells cannot normally enter due to the presence of the 
blood-brain barrier. Astrocytes carry out a myriad of roles in the CNS, including 
structural and metabolic support to other cell types, such as neurons. Glial cells found 
in the PNS include satellite cells and enteric glia. Satellite cells carry out supportive 
roles in sensory, sympathetic and parasympathetic neuronal clusters, whereas enteric 
glia have similar roles in the digestive system2. 
Very abundant cell types in both the CNS and PNS are myelinating glia. These cell 
types have several supportive roles, but most importantly they are responsible for the 
generation of myelin, which will be introduced in the forthcoming chapter. 
 
1.1.2. THE STRUCTURE AND FUNCTION OF MYELIN 
In the nervous system, myelinating glia produce a periodic structure called myelin, 
which forms a sheath by wrapping around short, adjacent segments of selected axonal 
regions with the main purpose of insulating them. After the initial discovery of 
myelin over 160 years ago4, the structure and function of myelin has been extensively 





that is wrapped around an axonal length in the order of 20-200 µm, but can be as long 
as 1500 µm. Several dozens or even hundreds of membrane layers are formed, which 
undergo protein-mediated compaction through the tight adhesion of adjacent, 
apposing membranes. This excludes nearly all solvent content from the cytoplasmic 
and extracellular compartments of myelin, and makes myelin into an incredibly lipid-
rich structure, forming the basis of its insulative function7. 
Insulation of axons results in an enhancement in action potential velocity. The 
underlying mechanism is relatively simple: the insulative nature of myelin blocks 
most of direct ionic contact with the axolemma, which prevents ionic entry and 
leakage to and from the axeplasm. Between evenly spaced, individual myelin units, 
short segments of axolemma remains unmyelinated and thus accessible to 
extracellular ionic content. It is at these segments, called nodes of Ranvier, where 
massive concentrations of voltage-gated ion channels are present, waiting for an 
action potential to occur. Upon channel activation, a tremendous ionic influx occurs 
almost instantaneously towards the axoplasm, generating membrane depolarization 
and a high, sudden local concentration of Na+, which will rapidly dissipate along the 
axon, until reaching the next node of Ranvier, where the effect re-occurs8. This fast 
mode of nerve impulse conduction, with a velocity of up to two orders of magnitude 
compared to unmyelinated axons, is called saltatory conduction. It is the product of 
the combined effect of myelin-mediated insulation, regularly spaced nodes of 
Ranvier, as well as the local concentration of voltage-gated ion channel at these 
nodes5. 
Historically, myelin was thought to be merely involved in axonal insulation, but in 
more recent times, novel roles for myelin have been suggested and unveiled9-11. 
Axons by themselves vary between 0.1 - 20 µm in diameter, and can be even a meter 
in length1, 12. This makes them inherently fragile, and myelin has been shown to have 
a supportive role in providing mechanical strength to axons and brain matter itself13. 
Additionally, since membrane polarization in axons is actively maintained by Na+/K+ 
exchangers, axons require substantial amounts of energy in the form of adenosine 5′-





Recently, a supportive role of myelin by supplying substrates that can be fed to 
axonal metabolic pathways has been suggested, allowing axons to gain a more 
constant stock of chemical energy in their otherwise insulated environment9, 10. This 
trophic support is not limited to the transfer of small molecules from myelin to the 
axon, but the transfer of entire proteins and even ribosomes has been documented14, 
15. 
Myelin in the CNS and PNS carries out the same function(s), and while they 
structurally resemble each other, there are some notable morphological differences in 
myelinating glia and myelin itself. These differences will be described in more detail 
in the forthcoming sections, finally followed by the description of the molecular 
ultrastructure of myelin. 
 
1.1.2.1. Central nervous system myelin 
The myelinating cell of the CNS is the oligodendrocyte – a type of glial cell that 
develops and matures during embryogenesis and early post-natal life from 
oligodendrocytic progenitor cells16. From the oligodendrocytic cell body, several long 
outgrowths make contacts with axonal segments, which become enclosed in myelin. 
A single oligodendrocyte often myelinates axons of several neurons and can also 
produce multiple adjacent or separate myelin units on a single axon (Fig. 1)17. Most 
CNS axons that have a diameter of 0.2 µm or more are myelinated by 
oligodendrocytes, and the myelination is controlled through cell signaling18. Most 
axons in the CNS are myelinated, but those few unmyelinated axons that remain are 












Fig. 1. Oligodendrocytic myelin sheath. (A) Schematic of a CNS neuron with its axon 
decorated with oligodendrocytic myelin. (B) Unrolled myelin sheath with various 
compartments indicated. (C) Cross section of an oligodendrocytic myelin-axon unit, with 
compartments and features indicated. Legend: Ab, abaxonal collar; Ad, adaxonal collar; CM, 
compact myelin; IM, inner mesaxon; LIs, longitudinal incisures; OM, outer mesaxon; PAS, 
periaxonal space; PNC, paranodal collar; RCs, radial components. Light blue and gray 






Even though myelin clearly has its benefits, one might still ask if myelin is absolutely 
necessary. In practical terms, insulation is the only feasible method to increase nerve 
impulse conduction in vertebrates, as the amount of axons and neurons that build up 
nerves can be immensely high. In the absence of myelin, however, it is known that 
nerve impulse conduction velocity does correlate with axonal diameter20, and a 
notable example is the squid axon, which lacks a myelin sheath, but ensures efficient 
nerve impulse conduction by having a diameter of up to 1 mm21. The sheer 
complexity of the vertebrate nervous system seems to have favored the emergence of 
myelin in evolution so much that it has occurred twice: in the CNS and in the PNS22. 
 
1.1.2.2. Peripheral nervous system myelin 
PNS myelin is formed by Schwann cells, named in the honor of Theodor Schwann, 
who discovered peripheral myelin. The fundamental difference to oligodendrocytic 
myelin is that each individual Schwann cell forms a single myelin unit and as such is 
situated very close to the axon itself, with the Schwann cell nucleus residing on the 
outer edge of the myelin unit. Hundreds of Schwann cells may decorate a single axon, 
each separated by a node of Ranvier (Fig. 2)23. Schwann cells are surrounded by a 
basal lamina – a carbohydrate-rich sheath that smoothly transitions from one myelin 
unit to another. This basal lamina is a specific structure of unknown function and is 
not found around oligodendrocytic myelin24. The myelination of PNS axons seems to 
correlate with axonal diameter, with axons having a diameter below 2 µm being 
unmyelinated. The fate and amount of ensheathment is governed by the axon through 
signaling pathways25. Unmyelinated PNS axons are still wrapped by Schwann cells, 
but as opposed to forming multiple layers of tight water-deficient membrane stacks, 
the axons only become surrounded by a non-compacted structure called amyelin, 
where a single Schwann cell can ensheath multiple nearby axons26. However, the 
general consensus of axonal diameter being the regulator of myelination in the 
scientific community has been challenged, as axonal signaling with Schwann cells 
has been shown to be an important regulatory mechanism in the formation of myelin, 









Fig. 2. Schwann cell myelin sheath. (A) Schematic of a peripheral neuron with its axon 
decorated by Schwann cells. (B) Unrolled Schwann cell with various compartments 
indicated. (C) Cross section of a Schwann cell-axon unit, with compartments and features 
indicated. Legend: Ab, abaxonal collar; Ad, adaxonal collar; BL, basal lamina; CM, compact 
myelin; IM, inner mesaxon; OM, outer mesaxon; PAS, periaxonal space; PNC, paranodal 
collar; SLIs, Schmidt-Lanterman incisures. Light blue and gray denote compact and non-







In addition to oligodendrocytes and Schwann cells, it is worth mentioning that these 
two cell types are often mistakenly considered the only myelinating glia of the 
nervous system. In fact, Schwann cell-like olfactory ensheathing cells are present 
both in the CNS and PNS in small numbers, specifically involved in myelinating 
axons of the olfactory bulb and the olfactory nerve, respectively28. Additionally, a 
relatively new discovery of myelinating cells termed motor exit point glia seems to 
also extend over the boundaries of CNS and PNS29. In this thesis, we will focus only 
on myelin originating from Schwann cells and oligodendrocytes, as those cells types 
are generally responsible of producing the major fraction of all endogenous myelin. 
 
1.1.2.3. The ultrastructure of myelin 
While myelination in the CNS and PNS is organized rather differently in terms of 
how the myelinating glia actually form myelin, the ultrastructure of a single myelin 
sheath is quite similar between the two nervous systems in terms of the overall 
structure and molecular organization. Of the total mass of myelin, less than half is 
water on average30, and on the molecular level, myelin is mostly composed of lipids, 
around 70 – 85% of the dry mass, with proteins representing the remaining 15 – 
30%31. This equals an average protein-to-lipid (P/L) ratio of 0.25, by mass, and is 
significantly less than in other biological membranes. For comparison, most plasma 
membranes have a P/L ratio of 0.7 – 1.5 by mass32, and in the mitochondrial inner 
membrane the P/L ratio can be as high as 3 – 4 by mass32, 33. Additionally, several 
ionic species are present, most notably the divalent cations Ca2+ and Zn2+, at 
concentrations of 1 mM and 50 µM, respectively34, 35. 
As illustrated in Fig. 3, a myelin unit can be longitudinally divided into three 
principal segments: the internode spans most of the myelin unit, and at the distal ends 
of the internode, the myelin membrane curves in towards the axon. This curved 
segment is called the juxtanode, which then transitions into the paranode, mostly 
consisting of the paranodal loops. The paranodes form the ends of the myelin sheath, 






Fig. 3. Myelin ultrastructure. Schematic view of a longitudinal section of myelin in the 
CNS and PNS with the internode, juxtanodes and paranodes indicated. The cytoplasmic 
(MDL, major dense line) and extracellular/intramyelinic (IPL, intraperiod line) 
compartments form the periodicity of compact myelin (CM), as shown in the zoom-in (red 
inset). Adjacent myelin units cover the nodes of Ranvier (NOR) with microvilli in the PNS. 
Schwann cells are additionally shrouded by a basal lamina (BL). In the CNS, the nodes of 
Ranvier are covered with astrocyte processes (ASP). Non-compact myelin is shown in gray. 
The axoplasm is colored yellow. Most of the indicated morphological features are shared 
between the CNS and PNS myelin. Legend: Ab, abaxonal layer; Ad, adaxonal layer; PAS, 




The two major morphological structures in myelin are compact and non-compact 
myelin, which differ from each other in appearance, function, solvent content, protein 
content, and subdivisions36. The general architecture of a myelin sheath is fairly 
simple and has been illustrated in various ways in Fig. 1-3. Starting from inside, after 
the axolemma resides the periaxonal space – the extracellular compartment between 
the axon and the innermost myelin membrane known as the adaxonal membrane. 
Cellular communication between the axon and the myelinating glia takes place 
through the periaxonal space37. Additionally, the myelin sheath supplies the 
periaxonal space with lactate and pyruvate, which can be transported to the axon for 





The adaxonal membrane encompasses the adaxonal collar, a single aqueous cytosolic 
compartment of non-compact myelin, where also the leading edge of the myelinating 
plasma membrane, the inner mesaxon, resides. This is followed by dozens of tightly 
stacked myelin membranes that form the bulk content of compact myelin. Moving 
outwards, compact myelin is followed by the abaxonal collar, another non-compact 
compartment of high cytosolic content36. Finally, the abaxonal membrane, the 
outermost plasma membrane, separates the myelin sheath from the extracellular 
milieu. Here, the non-leading end of the plasma membrane, the outer mesaxon, is 
present. Additionally, the abaxonal layers in the PNS form villi that shroud the nodes 
of Ranvier. In the CNS, such villi are not present. Instead, the nodes are covered by 
astrocyte processes39. 
While the overall myelin architecture in the CNS and PNS is similar, the two myelin 
systems are not identical. There are noteworthy differences present, including the 
radial component and longitudinal incisures in CNS myelin, and Cajal bands and 
Schmidt-Lanterman incisures (SLIs) in PNS myelin. Further details about these 
structures, as well as compact and non-compact myelin in general, will be covered in 
the next chapters. 
 
1.1.2.4. Compact myelin 
Compact myelin forms the major fraction of the entire myelin sheath. As the name 
implies, this is the main structure containing stacked adhered membranes, which 
substantially decreases solvent content and provides myelin with its insulative 
character. Alternating between the stacked membranes of compact myelin is the 
cytoplasm of the myelinating cell and the enclosed extracellular compartment, also 
known as the intramyelinic compartment (Fig. 3). These two compartments have 
differences in protein content as well as their volume. Early electron micrographs 
already provided evidence of this periodic structure in the myelin sheath, where 
alternating electron-dense features and separating spaces between them could be 
resolved40-42. The electron-dense feature, the major dense line (MDL), turned out to 





membrane bilayers are nearly fused together (Fig. 3), with a mere 3-nm spacing 
between them. For comparison, a single myelin lipid bilayer is typically around 4.5 
nm in thickness. The space between the separate MDLs, the intraperiod line (IPL), 
was in fact the less compacted extracellular compartment, with a spacing of ~5 nm43. 
The high periodicity of these alternating structures was discovered many decades ago, 
with a level of organization capable of producing a diffraction pattern, when exposed 
to X-rays44, 45. In CNS, a unique structure is present in compact myelin, known as the 
radial component, which is a network of tight junctions between the myelin 
membranes. The radial component lacks cytosolic content, and is thought to 
contribute to the stabilization of the multilamellar structure of compact myelin46, 47. 
 
1.1.2.5. Non-compact myelin 
Despite being the lesser myelin compartment in terms of volume and dry mass, non-
compact myelin carries an essential role in myelin maintenance. In addition to 
encompassing various cell organelles and metabolic pathways that maintain the 
homeostasis of the myelin sheath, translation of all compact myelin proteins required 
for the stability and formation of myelin occur in non-compact myelin. 
Within the abaxonal collar, vast amounts of respiration and other cellular metabolism 
occurs in addition to the transport of extracellular nutrients and exchange of other 
factors with the cytoplasm38. Various cellular interactions and processes are present in 
the abaxonal collar and in the extracellular milieu, such as metabolic exchange with 
astrocytes, linking the metabolic flux towards myelinating glia to the blood stream48. 
An interesting difference can be noted for the abaxonal layer between the CNS and 
PNS: whereas the abaxonal collar in the CNS is uniformly non-compacted, the 
abaxonal collar in the PNS contains membrane appositions that exclude substantial 
amounts of cytosolic volume. Whilst similar to compact myelin, albeit not as tight, 
these appositions form the morphologically distinct boundaries for non-compact 





The adaxonal collar acts as a reservoir of cargo that crosses the adaxonal membrane 
to and from the periaxonal space, as well as factors relevant for compact myelin 
maintenance9, 38. The paranodal collars connect the abaxonal and adaxonal collars 
with each other at the ends of the myelin unit. At the end of the myelin unit, the collar 
arranges in a longitudinal fashion around the axon and forms structures called 
paranodal loops. These are attached to the axon through tight paranodal junctions, 
separating the periaxonal space from the extracellular space50. 
In addition to the paranodal collars, cytoplasmic channels that span through compact 
myelin are present in myelin. Longitudinal incisures in CNS myelin are arranged 
along the length of the myeli unit, whereas the equivalent channels found in PNS 
myelin, the SLIs, are arranged transversely. These channels are filled with cytosolic 
content, and in wrapped myelin, these channels will stack on each other, creating a 
gap junction-mediated shortcut through compact myelin from the abaxonal collar to 
the adaxonal collar50, 51. 
 
1.2. THE MOLECULAR CHARACTERISTICS OF MYELIN 
1.2.1. THE LIPID COMPOSITION OF MYELIN 
Since myelin is notably rich in lipids, it is necessary to consider the lipid species 
present. Despite being quite different from other biological membrane arrangements 
in terms of morphology and total lipid fraction, the lipid species present are, 
surprisingly, not specific to myelin, but only enriched in certain aspects. 
Around 700 different individual lipid species have been identified in myelin, which 
differ in terms of headgroup and fatty acid complexity52. In humans, the CNS myelin 
lipid content consists of 27.7% cholesterol, 27.5% galactosphingolipids and 43.1% 
phospholipids by mass. The major fraction of galactosphingolipids exists as 
cerebrosides at 22.7% of total myelin lipid content, accompanied by sulfatides, 
present at around 3%. The phospholipid pool consists of the neutral phospholipids 
phosphatidylcholine (PC), phosphatidylethanolamine (PE) and sphingomyelin (SM), 





Marginal amounts of cardiolipin, phosphatidic acid (PA), phosphatidylinositols (PI), 
and phosphatidylglycerol (PG) are also present53. Additionally, a rather large fraction 
of total myelin lipids is formed of plasmalogens, at around 12.3%, mostly 
ethanolamineplasmalogens54. The length and saturation degree of fatty acids in 
myelin vary: virtually all fatty acid chains are between 16 and 22 carbons long, with 
46% being fully saturated (lacking double bonds; major species are 16, 18, and 20 
carbon units in length) and 54% unsaturated (major species are 18 and 22 carbons 
long with 1 and 3 double bonds present, respectively). The fraction of 
polyunsaturated fatty acids, with two or more double bonds present, is around 30%, 
from which around half consists of fatty acids with 22 carbons and 3 double bonds55. 
The myelin membrane is asymmetric, meaning that the two monolayers that form the 
bilayer have different lipid profiles. Whilst cholesterol is rather uniformly distributed 
in the bilayer, the outer membrane monolayer is mostly composed of galactolipids, 
whereas the inner monolayer is enriched in phospholipids56. This essentially makes 
the outer monolayer surface covered in sugar moieties on the extracellular side, 
whereas the inner monolayer surface, which faces the cytoplasm, becomes net 
negatively charged due to the presence of PS, PI, PG, and PA. Past lipid 
quantifications of marmoset white matter allow us to elaborate further on the 
composition of the inner myelin monolayer: in healthy marmoset CNS myelin, the 
dominant lipid species are cholesterol at 31.6%, and the zwitterionic PC and PE at 
25.9% and 29.0%, respectively. SM makes up 6.2%, whereas PS, the major 
negatively charged lipid, is present at 7%57, 58. Given that around 12.3% of total 
myelin lipids are (ethanolamine)plasmalogens, one can also calculate that as much as 
70% of all PE content is in fact present as plasmalogens54 Additionally, one should 
note that the headgroups of phospholipids are significantly larger and more polar 
compared to the single hydroxyl group of cholesterol. Due to this, as well as its 
highly hydrophobic tail, cholesterol tends to embed deep into the membrane, causing 
the membrane surface on the cytoplasmic side to be almost entirely covered by 
phospholipid headgroups59. Therefore, the headgroup fractions can be further 
calculated to be 38%, 42%, 10%, and 9% for PC, PE, PS, and SM, respectively, with 





cytoplasmic monolayer. Marmoset lipid compositions are described here, instead of 
human, due to the fact that demyelinating models in marmosets, more specifically 
experimental autoimmune encephalitis (EAE) models, have been characterized and 
will be further discussed in Chapter 1.3.2. Very notably, the cholesterol fraction in 
EAE lipid compositions is increased from 31.6% to 37.4%57, 58, which is an almost 
20% increase in total cholesterol amount, and in this disease model, myelin 
compaction is aberrant. Cholesterol is generally very abundant in myelin. In fact, 
endogenous free cholesterol is mostly present in myelin membranes, and only minor 
changes in its abundance can be tolerated, especially when its total lipid fraction is 
lowered; its availability is considered a rate-limiting step in myelin formation60, 61. 
The differences between CNS and PNS myelin in terms of lipid species are rather 
small. Compared to CNS myelin, the amount of galactolipids is lower in PNS myelin, 
and SM is present in higher amounts53. This is rather important to note, since SM is 
known to influence the behaviour of the membrane and its lipid rafts, together with 
cholesterol62. SM has also been shown to interact with some myelin proteins63. In 
PNS myelin, the distribution of fatty acid lengths and saturation degrees is rather 
similar to CNS myelin, with the single most abundant type of fatty acid being oleoyl, 
consisting of 18 carbon units and a single cis-double bond in carbon position 9. This 
type of fatty acid makes up over 30 mol-% of total fatty acid content in PNS myelin64. 
 
1.2.2. MYELIN PROTEINS 
As opposed to lipids, the myelin proteome is significantly different from any other 
biological system. Both CNS and PNS myelin harbor only a handful of very abundant 
and specific proteins that are strictly localized to either non-compact or compact 
myelin in a manner that is at least partially driven by size exclusion65. The proteins in 
these two compartments carry out various structural and functional roles, which will 
be only generally outlined in this chapter before focusing more on specific proteins. It 
is noteworthy that a general trait of myelin proteins is that their functions are rather 
poorly characterized, if known at all. An overview of myelin proteins and their major 












































































































































































































































































































































































1.2.2.1. Compact myelin proteins 
As compact myelin needs to remain stable, it is enriched with structural proteins that 
promote membrane adhesion in both the MDL and IPL. Despite the apparent 
similarity of CNS and PNS myelin, they in fact contain a different assortment of 
proteins with little overlap. 
In the CNS, the major compact myelin proteins are proteolipid protein (PLP), myelin 
basic protein (MBP), myelin-associated oligodendrocytic basic protein (MOBP), and 
myelin/oligodendrocyte glycoprotein (MOG). Of the total myelin protein mass, PLP 
and MBP solely make up around 50% and 30%, respectively66. The function of the 
highly hydrophobic tetraspan proteins PLP and its minor splice variant ‘DM20’ are 
not entirely understood. Both are thought to be involved in oligodendrocyte 
maturation, and PLP is a required component for the structural integrity of myelin, 
likely to be involved in the formation of stacked bilayers67-69. MBP is rich in Arg and 
Lys, making it strongly positively charged and capable of interacting with negatively 
charged phospholipids. MBP has a key role in the formation and stability of compact 
myelin as a membrane stacker, and MBP is a key factor involved in multiple sclerosis 
(MS)70. MBP is one of the principal proteins for this thesis, and will be discussed in 
closer detail in Chapters 1.2.2.3. and 1.3.2.1. MOBP is the third most abundant 
protein in CNS myelin, and like MBP, is notably abundant in cationic amino acids. Its 
function, however, is most likely involved in the formation of the radial component 
rather than MBP-like membrane stacking71-73. MOBP, like MBP, is an antigenic 
protein in MS74, 75, and sequence analyses have revealed a potential zinc-finger 
domain76, which might have functional implications, given that Zn2+ is rather 
abundant in myelin34, 35. MOG is an exclusively mammalian protein, present only on 
the outermost surface of oligodendrocytic myelin77, 78. It is further a member of the 
immunoglobulin (Ig) superfamily, and contains an extracellular, glycosylated Ig-like 
domain, followed by a transmembrane domain and a membrane-associated 
cytoplasmic segment79. While MOG is known to be involved in MS80, its 





In PNS myelin, the most abundant compact myelin proteins are myelin protein zero 
(P0), peripheral myelin protein 2 (P2), peripheral myelin protein 22 (PMP22), and 
MBP. A striking difference to CNS compact myelin is that the abundance of MBP is 
merely 5 – 18%, while the other three are present at over 50%, 15% and 2 – 5%, 
respectively82.   
P0 is a 30-kDa single-pass transmembrane protein and the most abundant protein in 
PNS compact myelin. It is involved in membrane stacking in the IPL through 
homophilic interactions involving its Ig-like domain83, and the molecular aspects of 
P0 will be explained deeper in Chapter 1.2.2.4., as well as its role in peripheral 
neuropathies in Chapter 1.3.2.2. PMP22 is a 22-kDa transmembrane protein with four 
membrane-spanning helices and is involved in the formation of cholesterol-rich lipid 
patches and linking the actin cytoskeleton to the membrane84. Whilst none of the 
tetraspanning membrane proteins of myelin have been characterized structurally, a 
recent structure of claudin-15 and the subsequent construction of a PMP22 homology 
model have provided insights into the PMP22 conformation and potential 
arrangement in the myelin membrane85, 86. Both P0 and PMP22 are glycosylated on 
the extracellular side of the membrane, and while both are integral membrane 
proteins confined to the lipid membrane environment, P2 is a folded, soluble protein 
in the cytoplasm. Discovered already in the early 1970s, P2 carries out a function in 
MDL membrane stacking, similarly to and in synergy with MBP, although the 
interesting feature remains that P2 is not ubiquitously expressed between separate 
PNS myelin units87-90. P2 is structurally well-characterized; crystal structures have 
been solved numerous times of the wild-type protein as well as mutants91-97, and 
shown to belong to the superfamily of fatty acid-binding proteins. P2 is a 14.5-kDa 
protein with a β-barrel fold, topped with a helical lid segment, which is known to be 
involved in membrane binding in the cytoplasm. Crystal structures have supported the 
function of P2 as a lipid carrier in myelin maintenance. The transportation of 






1.2.2.2. Non-compact myelin proteins 
Sequestered from compact myelin are the proteins present in non-compact myelin. 
Much different from other glia, there are factors that specifically express in these 
distinct compartments and co-exist with the more canonical cellular elements, often in 
very high levels. Non-compact myelin is involved in the maintenance of compact 
myelin and the axon, and includes metabolic functions as well as nutrient transport, 
and therefore carries a different proteome than compact myelin9, 99. Additionally, 
some non-compact myelin proteins define the boundaries of major cytoplasmic 
content and tight membrane adhesions100-102.   
In the CNS, one of the most abundant proteins by far is 2′,3′-cylic nucleotide 3′-
phosphodiesterase (CNPase), a member of the 2H phosphodiesterase superfamily and 
makes up 4% of all myelin proteins66, 103. Part of the pool of CNPase is membrane-
associated via a fatty acylated cysteine104, 105, and since it interacts with filamentous 
actin and tubulin, it has been proposed to link the cytoskeleton to the myelin 
membrane106, 107. This function is important in myelin, as a recent study revealed that 
it is this specific function that together with MBP regulates the balance between 
compact and non-compact myelin, which has a fundamental importance not only in 
insulation, but in establishing cytoplasmic channels essential for myelin 
maintenance102. Perhaps the most important function of CNPase is its enzymatic 
activity in depleting 2′,3′-cyclic nucleotides from the cytosol108-113, many of which are 
thought to be transported into myelin from the axon114. These compounds damage 
mitochondria, potentially to an apoptotic degree110, 115, and CNPase therefore has 
been suggested to be essential in ensuring the long-term survival of the myelinated 
axon114. Additionally, CNPase has been shown to interact with calmodulin, much like 
many other myelin proteins, and potentially be involved in ribonucleic acid (RNA) 
metabolism and trafficking116-119. 
Non-compact CNS myelin includes several other specific proteins, the most abundant 
ones including myelin-associated glycoprotein (MAG), sirtuin-2 (S2), and 
oligodendrocyte-specific protein (OSP, also known as claudin 11)66, 103, 120, 121. MAG 





long (L-MAG) and a short (S-MAG) isoform103. L-MAG has a function in 
establishing physical contact with the axon through the periaxonal space, by the use 
of its multiple Ig-like domains122, and L-MAG and S-MAG both are capable of 
interacting with several cytosolic factors with distinct selectivity between the two 
isoforms, as reviewed earlier76, 122. S2 is a nicotinamide adenine dinucleotide-
dependent deacetylase, which is involved in the deacetylation of microtubules, for 
instance120. S2 has been shown to be present in myelin, and its transport to myelin is 
governed by the presence of PLP123. OSP is an integral membrane protein that forms 
local tight junctions between apposed myelin membranes in the radial component121. 
PNS myelin is rather different from the CNS regarding its proteome. Both MAG and 
CNPase are present at reduced amounts, at a mere 0.3% and 0.5%, respectively82. 
Unlike in CNS myelin, MAG is present in SLIs, both mesaxons and paranodal loops, 
in addition to the adaxonal membrane122. The most abundant protein in PNS non-
compact myelin is periaxin (PRX), present as a short (S-PRX, 16 kDa) and long (L-
PRX, 155 kDa) isoform, the latter harboring a nuclear localization signal (NLS) 
sequence and predicted to be mostly disordered124, 125. S- and L-PRX, which form 
cytosolic homo- and heterodimers through their N-terminal PDZ domains126-128, are 
abundant at the abaxonal layer, where L-PRX scaffolds dystrophin-related protein 2 
and integrin β4, forming membrane appositions through a protein meshwork 
underneath the myelin membrane itself100, 129, 130. The function of S-PRX is unclear to 
date, although it might have relevance in sequestering the aforementioned meshwork 
or blocking the nuclear export of L-PRX128, 131. The exact significance of these 
appositions that line Cajal bands is not understood, let alone them specifically being 
present in PNS myelin, but the absence of PRX or dystrophin-related protein 2 
abolishes the morphology49, 100, 101. 
One noteworthy, less abundant protein is connexin 32 (Cx32), which like other 
connexins is not exactly specific for myelin, but is important for its development132-
134. This transmembrane protein is present in paranodal loops and SLIs, where it has 
been hypothesized to form gap junctions with the axonal membrane, contributing to 





flux through compact myelin, as well as between the Schwann cell and the axon134, 
135. Finally, epithelial cadherin (EC) is another low-abundance protein, which is 
involved in the formation of Ca2+-dependent homophilic adherens junctions between 
myelin membranes in SLIs, at the paranode, and at the outer mesaxon136-138. 
One might consider myelin as a relatively simple system in terms of the proteins 
present and the functions they perform, given the overwhelming abundance of a 
relatively small collection of proteins compared to the entire myelin proteome. 
However, especially recent research has made it obvious that the few abundant 
proteins in myelin are not meant for a single task, but rather carry out multifunctional 
roles. These proteins include, but are not limited to, MBP, CNPase, and P2, which are 
very abundant in myelin66, 70, 76, 82, 125, 139. Be it membrane adhesion/interaction with 
the myelin membrane, protein-protein interactions, fatty acid transport, or enzyme 
activity, it is enticing to speculate that myelin has evolved to accommodate proteins 
that are capable of simultaneous but functionally different tasks, or at least adapt to 
carry out such tasks upon need. Due to the spatial confinement of myelin, as well as 
its requirement to remain under stable equilibrium for prolonged times, the high 
expression levels of extremely long-lived140, multifunctional proteins might be 
advantageous, as opposed to multiple proteins carrying out solely distinct tasks. 
In the chapters that follow, we will focus deeper on MBP and P0, two of the most 
abundant compact myelin proteins in the CNS and PNS, respectively. Most of what is 
discussed in the current study from now on will particularly involve these two 
proteins and their variants. 
 
1.2.2.3. Myelin basic protein 
MBP is one of the most important and abundant multifunctional proteins in CNS 
compact myelin. Originally, MBP was named A1 protein after its discovery as an 
elongated myelin-specific protein141-145. The name ‘myelin basic protein’ is more 
descriptive in the sense that the protein resides in myelin and has an alkaline nature, 





cannot consider MBP to be a single protein, but rather a heterogeneous ensemble of 
different splice variants that are subject to numerous post-translational modifications 
(PTM), although a predominant form exists endogenously146. 
In humans, the Mbp gene is located in chromosome 18 after the gene in the 
oligodendrocyte lineage (Golli), which are transcribed together into a long 179-kb 
RNA transcript that gets spliced into several messenger RNAs (mRNAs) encoding for 
a total of six known MBP protein isoforms (UniProt P02686)147. Two of them consist 
of translated content encoded by Golli exons, in addition to Mbp exons. The 
remaining four are solely encoded by Mbp – these four are often referred to as the 
‘classical isoforms’148. All four undergo N-terminal processing in the form of initial 
Met removal and subsequent N-terminal acetylation, which are thought to occur co- 
or post-translationally149. The Golli-MBP isoforms are less characterized non-
classical MBPs, which undergo nuclear localization and bind nuclear factors that 
regulate gene expression150. They also have been shown to regulate Ca2+ entry in 
different cell types151, 152. It is probable that more classical isoforms exist in humans, 
based on studies on other organisms: especially mouse and rat MBPs have been 
extensively characterized and found to undergo similar splicing and N-terminal 
processing as the human protein (UniProt P04370; P02688)153-159. The major classical 
mouse MBP isoforms are listed in Table I. 
 
Table. I. Details of the major classical mouse MBP isoforms. All data is based on the 
sequences from UniProt P04370 (MBP_MOUSE). Isoelectric points (pI) were calculated 
using ProtParam160. 
Isoform # Residues* Mass (kDa)* pI** Localization161, 162 
4 194 21.5 11.24 Nucleus, cytosol 
5 168 18.5 11.14 Cytosol 
6 153 17.2 11.75 Nucleus, cytosol 
8 127 14.2 11.75 Cytosol 
*Post-translational initial Met removal and subsequent N-terminal acetylation. 






The predominant isoform of all endogenous MBP in myelin, the ‘18.5-kDa 
isoform’146, will be a major focus in this thesis. MBP is not homologous to any other 
known proteins, yet it is conserved among vertebrates, especially in mammals163. As 
selected examples, the human and chimpanzee 18.5-kDa MBP isoforms are almost 
100% identical, mouse and rat proteins both have sequence identities of 94% 
compared to the human protein, whereas for bovine MBP the same identity is 91%. 
More distantly related vertebrates, the chicken and the African clawed frog, have 
sequence identities of only 69% and 59%, respectively. The discussed sequences are 
aligned in Fig. 5. The most distantly related MBPs have been identified in 
cartilaginous fish163, 164. 
 
Fig. 5. Sequence alignment of selected vertebrate MBP 18.5-kDa isoforms. Selected 
sequences have been aligned to highlight the conservation of MBP among vertebrates165, 166. 
Residue numbering is based on the human protein. The secondary structure labels denote the 
known α-helical segments of lipid-bound MBP167. ‘Xenopus’ denotes the African clawed 
frog (Xenopus laevis). All sequences were retrieved from UniProt (P02686, P06906, P04370, 
P02688, P02687, P15720, P87346). Double Phe-motifs (**), the Src homology 3-binding 
motif (PXXP), the predicted calmodulin-interaction site (green) and the immunogenic 





Fig. 5 displays that MBPs are abundant in Arg and Lys, which increase their 
isoelectric points (pI; see Table I) and give them an unusually high net charge at 
physiological pH. Based on the amino acid sequence of N-terminally acetylated 
mouse 18.5-kDa isoform, this charge is +19, and has a significant impact on the 
structure and functions of MBP. Free in solution, MBP has been shown to be an 
intrinsically disordered protein (IDP), lacking substantial secondary and tertiary 
structure content168-171. MBP is often considered an archetypal IDP, which exists as 
an ensemble of flexible, dynamically interchanging conformers in solution172, rather 
than having defined molecular boundaries like folded proteins do173, 174. The unfolded 
nature of MBP was already realized quite early142, 143 and finally accepted as a 
consensus when rigorous crystallization attempts for structure determination had 
failed175. MBP is present in the stacked membranes of compact myelin (Fig. 6). Upon 
lipid biding, MBP gains significant amounts of folding as shown by circular 
dichroism (CD) spectroscopy171. Attempts to determine the detergent- and lipid-
bound structures of MBP have been carried out using electron microscopy and 
modeling techniques176-178, and to this date, the best experimental structure of lipid-
bound MBP is a low resolution C-shaped, folded molecule with a diameter of 5 
nm177, which has also been supported by small-angle X-ray scattering (SAXS) 
experiments on lipid-bound MBP169. Modeling studies suggest that the core of this C-
shaped conformation is rich in β-sheets (Protein Data Bank (PDB) ID: 1QCL)178. 
More recently, some more elaborate experiments on MBP-derived peptides using 
nuclear magnetic resonance (NMR) and electron paramagnetic resonance 
spectroscopy been conducted to uncover helical segments and solvent exposed areas 
of lipid-bound MBP170, 179-182. Three transient α-helical segments within MBP have 
been discovered in the presence of 30% 2,2,2-trifluoroethanol (TFE), a compound 
that decreases the dielectric nature of water, favoring spontaneous protein folding. 
These helices have been shown to be amphipathic when folding in the presence of 
lipids and detergents167, 183, 184. In the computationally predicted model of MBP, none 
of these segments adopt a helical fold, but are specifically part of the β-sheet core, 
indicating that more structural studies are required to understand the conformation of 







Fig. 6. The structure, functions, and modifications of MBP. MBP is multifunctional, and 
in its soluble disordered state takes upon many tasks. MBP and cations are drawn in red, 
whereas other proteins and the oligodendrocyte are drawn in gray. In modifications, Arg is 
colored red due to its positive charge, whereas the phosphoresidues pSer and pThr are 
colored blue to denote negative charge. Black arrows represent the functions of MBP, 
whereas gray dashed arrows represent modulation effects. Legend: PI, phosphatidylinositols. 
The structures of calmodulin and Fyn Src homology 3 domain are based on PDB IDs 
1CLL185 and 4EIK186, respectively. The C-shaped model for MBP is based on PDB ID 





In addition to membrane stacking, which is the most important function regarding this 
thesis, MBP is multifunctional. These various functions of MBP have been illustrated 
in Fig. 6. Amongst many protein-protein interactions, MBP interacts with actin- and 
tubulin-based cytoskeletal elements, calmodulin, and Fyn kinase171, 187-191. The 
cytoskeletal interactions affect oligodendrocyte process formation191, 192, and the 
occurrence of certain MBP isoforms in the nucleus has been linked to 
oligodendrocyte differentiation, although the nuclear interaction partners of MBP are 
not known162, 193. Additionally, MBP contains a PXXP polyproline motif (Fig. 5–6), 
which binds the Src homology 3 domain of Fyn kinase, an important signaling 
molecule in neuronal differentiation and development194, 195. These functions link 
MBP to oligodendrocytic myelination that is clearly separate from membrane 
stacking. The calmodulin interaction has been shown to be Ca2+ dependent187, having 
an impact on the membrane-stacking function and cytoskeletal interactions of 
MBP171, 183. A major calmodulin binding site has been identified in the C-terminus of 
MBP188, 189, 196, but also other sites have been proposed to be present190. 
More recent findings around the membrane-stacking function of MBP has been 
studied and reviewed extensively. The membrane stacking and involved folding of 
MBP are spontaneous; however, they are affected by the individual lipid types as 
demonstrated in several biophysical studies: the essential requirement for the 
association of MBP with membranes is the presence of net negatively charged lipids, 
namely PS and PI171, 197, 198. Additionally, cholesterol and PE have been shown to 
enhance the binding of MBP to lipid vesicles, especially in conditions that disfavor 
electrostatic binding, indicating either specific molecular interactions between the 
lipids and the protein, or the involvement of the general biophysical properties of the 
membrane itself197, 198. Ions, especially divalent cations, have an effect on MBP 
binding and membrane stack organization, likely impacting myelin formation and 
pathology199, 200. Indeed, MBP has been shown to sequester PIs in the membrane, PI-
phosphates specifically, as well as divalent cations201, 202. 
At the molecular level, membranes stacked by MBP in in vitro model systems 





have shed light on the molecular details of MBP-mediated membrane stacking: cell 
culture models expressing MBP have shown that plasma membranes can collapse into 
a myelin-like stack65, and atomic force microscopy (AFM) studies have revealed that 
MBP adsorbs into net negatively charged membranes in vitro and eventually stacks 
them in a cholesterol-dependent manner89, 203. Characterization of MBP bound to lipid 
vesicles has also been performed using X-ray and neutron scattering methods. The 
membrane repeat distance of MBP-adhered vesicles was determined using small-
angle X-ray diffraction (SAXD) to be around 80-82 Å, depending on P/L ratio, where 
an increased amount of protein tightened the membrane stack94. Recent studies have 
allowed a more detailed picture on this, showing that the interlamellar space between 
the membranes is around 35 Å204, which is expected considering the repeat distances 
observed for the MDL in endogenous myelin205. Additionally, the impact of 
temperature and the presence of P2 alter the repeat distance90. 
The arrangement of MBP within a membrane stack is thought to be very dense, 
existing as a protein meshwork, which is phase-separated from the surrounding 
solvent, as was shown though a combined approach of fluorescence microscopy, 
visible light microscopy, and AFM. More importantly, the arrangement seems to be 
governed by specific amino acids: two pairs of Phe residues were identified to be 
essential for the phase separation to occur in MBP charge-neutralizing conditions, as 
mutagenesis of these amino acids abolished the behaviour206. Still, some key aspects 
of myelination are open: how does MBP associate with a membrane at the molecular 
level? What is the conformation of MBP on a single membrane prior to stacking? 
Finally, a notable aspect of MBP that separates it from many other proteins is the vast 
assortment of PTMs it undergoes, especially in higher vertebrates164. In addition to 
co-translational N-terminal processing, including N-terminal acetylation, MBP has 
been found to undergo N-terminal butylation, hexylation, octylation, and 
decylation149, 207. Other PTMs include adenosine diphosphate ribosylation208, 209, Arg 
deimination (citrullination)210-213, Arg Nω-methylation and dimethylation214, 215, Gln 
deamidation212, 216, 217, Lys acetylation164, Met oxidation218 and Ser/Thr/Tyr 





targeted amino acid, and the most abundant ones are the deimination of Arg to 
citrulline (Cit) and the phosphorylation of Ser and Thr (Fig. 6)210, 212. These 
modifications are thought to modulate all functions MBP harbours. As an example, 
Thr98 phosphorylation in the PXXP motif weakens MBP binding to Fyn kinase194, 222. 
The effect of citrullination is the most studied aspect of MBP modifications due to the 
fact that deamination of Arg, which MBP is very abundant in, irreversibly decreases 
the net charge of the protein. This affects the binding of MBP to phospholipids225, 226, 
and has been suggested to potentially alter its cation-binding properties, resulting in 
stacked myelin membrane destabilization146. The citrullination of MBP is carried out 
in the myelin cytosol and nucleus by peptidylarginine deiminases 2 and 4213, resulting 
in eight charge isomers, denoted C1 – C8 with varying amounts of Cit. The C1 charge 
variant is completely uncitrullinated, and thus the most cationic species of MBP. C8 
on the other hand is the most citrullinated and least cationic variant, containing 6 – 7 
Cit residues per protein146. All 18 highly conserved Arg residues of 18.5-kDa MBP 
(Fig. 5), have been identified as (potential) targets of deimination210-212. 
 
1.2.2.4. Myelin protein zero 
P0, along with MBP and P2, was one of the first myelin-specific proteins 
discovered87. P0 is a 30-kDa transmembrane protein of the PNS, localized into the 
compact myelin of Schwann cells. It has an extracellular, N-terminal Ig-like domain, 
a single-span transmembrane helix, and a C-terminal cytosolic extension of 69 
residues (P0ct). This domain structure, and the domains themselves, are highly 
conserved in vertebrates (Fig. 7A). The structure of the rat P0 Ig-like domain was 
solved in 1996 from a soluble, truncated construct227. In 2012, the human P0 Ig-like 
domain was solved228, and both proteins present a typical Ig-like stacked β-sheet fold 
with high structural conservation. A conserved disulphide between β-strands 2 and 6 
was observed and is required for the correct function of the protein in myelin (Fig. 
7B)227-229. In humans, only one P0 isoform is considered predominant, although a stop 
codon readthrough has been described in mice and rats, producing an L-MPZ isoform 








Fig. 7. Sequence alignment of selected vertebrate P0s. (A) Selected sequences have been 
aligned to highlight the conservation of P0 among vertebrates165, 166. Residue numbering and 
secondary structure labels are based on the mature human protein. ‘Xenopus’ denotes the 
African clawed frog (Xenopus laevis). All sequences were retrieved from UniProt (P25189, 
A0A2J8JAV0, P27573, P06907, P10522, P37301, A2VD98). The conserved disulphide-
forming Cys residues (*) and the palmitoylation site (P) have been indicated. The colored 
lines below the alignment mark the boundaries of the Ig-like domain, transmembrane helix 
and P0ct. The blue box indicates the known neuritogenic segment. (B) Superposition of rat 
(green; PDB ID 1NEU227) and human (magenta; PDB ID 3OAI228) P0 Ig-like domains with 
N- and C-termini highlighted. The conserved disulphide is indicated with an arrow. 
 
 
When translated, P0 harbours an N-terminal 29-residue signal sequence that targets 
the protein to the endoplasmic reticulum (ER)232. In this thesis, the numbering of P0 
will correspond to the precursor sequence, ergo, the first amino acid of mature P0 is 
residue number 30 (Fig. 7). After membrane insertion and translation, the signal 
peptide is cleaved off, which results in mature P0. In the ER, the disulphide bond 
between β-strands 2 and 6 is formed, and Asn122 in the Ig-like domain is 





P0 is a membrane stacking protein involved in the compaction of the IPL. The Ig-like 
domains carry out this function by forming homophilic oligomers83, and the reported 
PTMs in the Ig-like domain are crucial for its role as a membrane stacker229, 234, 235. 
The oligomeric state of P0 has puzzled the field for years. Detergent-solubilized P0 
has been observed to form dimers and tetramers, but the oligomeric distribution has 
been noted to be different between P0 from different organisms236-238. The crystal 
packing of the rat Ig-like domain provided insights into the potential mechanism of 
membrane stacking in the IPL, again, hinting a dimeric or tetrameric assembly, 
resulting in several different suggested arrangements227. However, the tetramerization 
of the Ig-like domain in solution was only observed at very high protein 
concentrations227. Additionally, the transmembrane domain of P0 has been described 
as a dimerizing Gly-zipper, which would contribute to the formation of tetrameric P0 
assemblies239, but in the absence of further studies the true oligomerization mode of 
the apposing Ig-like domains remains obscure. In addition to homophilic adhesion, P0 
has been shown to interact with PMP22 in the IPL. This interaction might have 
additional structural relevance in myelin stability240, 241. 
P0ct resides in the cytoplasmic compartment of myelin and is known to be essential 
for the stacking function of the extracellular domain in the IPL242. Despite lack of 
homology, P0ct greatly resembles MBP in the sense that it is highly basic, with a pI 
value of 11.11, due to high abundance of Arg and Lys residues. Similarly to MBP, 
P0ct is an IDP and binds negatively charged lipids, folding in the process. P0ct has 
been suggested to function as an MBP-like membrane stacker in the MDL243-246. 
Especially the presence of cholesterol has been shown to influence the folding of 
P0ct, and the protein has been suggested to adopt a β-sheet-rich fold in myelin244. 
Regarding PTMs, P0ct contains a Cys residue close to the end of the transmembrane 
helix, which is known to be fatty acylated, most often palmitoylated247, 248. The fatty 
acylation has been shown to be required for the proper membrane stacking function 
of P0249. P0ct also undergoes phosphorylation at Ser210, Tyr220, Ser226, Ser228, 
Ser233, Ser237, and Ser243250-253. Mutation of Ser228 and Ser243 blocks 
phosphorylation and reduces P0-mediated membrane adhesion254. A neuritogenic 





which can be used to induce EAE in rodents255. Within the neuritogenic segment, a 
conserved YAML-motif, which is required for the trafficking of P0, is present256. 
 
1.3. THE BIOCHEMISTRY OF (DE)MYELINATION 
Myelination is the process of myelin formation and is rather poorly understood at the 
molecular level. The formation of the intricate periodic structure is a carefully 
regulated event, which requires the coordinated translation and interplay of correctly 
functioning proteins, as well as the presence of the correct lipids, ions, and other 
factors61, 102, 257, 258. Successful myelination results in a mature myelin sheath, which 
needs to be actively maintained. The characterization of myelin at the molecular level 
is important, as it is the only way to understand demyelination and dysmyelination – 
the states of myelin destruction and abnormal formation, respectively, both of which 
lead to incurable diseases. In this chapter, the function of selected myelin proteins in 




The cell signaling involved in myelination has been reviewed earlier17, 36, 51, 259-261, but 
what induces myelin maturation at the biochemical level is still slightly obscure. 
Nevertheless, progress in this aspect has been made, as a recent study unveiled the 
central role of actin disassembly in myelin compaction257. This is a logical 
mechanism, as the MDL is obviously too narrow to accommodate major cytoskeletal 
structures, but changes in oligodendrocyte process growth requires actin filaments in 
myelin wrapping262. The regulation of myelin protein expression is carried out by 
factors like Unc-51-like kinase 4. Hypomorphic mice of this putative kinase 
developed hypomyelination in the CNS and 40 – 60% lowered transcription and 
expression levels of the normally very abundant myelin proteins, including CNPase, 





The membrane-stacking function of MBP and its regulation in the CNS are pivotal in 
the formation of compact myelin, as MBP is one of the first proteins to be translated 
during myelin compaction, even before the most abundant CNS compact myelin 
protein, PLP264. Clearly MBP orchestrates CNS myelination, but how does MBP 
exactly stack membranes in vivo? It is known that the mRNA of MBP is transported 
along microtubules to the peripheral processes of oligodendrocytes, and translated in 
the vicinity of the membrane when compaction occurs265-270, which is presumed to be 
enabled by stimulation by axonal electrical signals271. The molecular mechanisms by 
which MBP actually induce stacking are unclear, although several theories and final 
stacked arrangements have been proposed based on studies reviewed above70, 182, 272, 
273. 
The importance of MBP is well demonstrated by its absence, which has an effect on 
CNS myelination. This is evident from autosomal recessive mouse models, harboring 
spontaneous MBP-deficiency, termed shiverer mice based on their phenotype to 
‘shake’ involuntarily. On the cellular level, the phenotype manifests as 
dysmyelination – the abnormal formation and reduced amounts of myelin – in the 
CNS, while PNS myelin remains unaffected274. The effect is related to the formation 
of the MDL, which in MBP-deficient mice does not properly compact275, 276. 
The role of P0 in PNS myelination is rather different from MBP. P0 is basally 
expressed in Schwann cells already before myelination occurs, regardless of whether 
a Schwann cell is destined to form myelin or amyelin277. Upon myelination, the 
expression levels of P0 have to be carefully regulated, as overexpression of P0 has 
been shown to end myelination prematurely278. Nevertheless, the absence of P0 does 
result in an aberrant myelin phenotype, which cannot be rescued by overexpression of 
PLP, the most abundant CNS compact myelin protein279, 280. 
 
1.3.2. DEMYELINATION 
Loss of myelin mass and/or function can occur through demyelination or 





formation, whereas dysmyelination is the abnormal formation of myelin. Both 
demyelination and dysmyelination can arise from genetic reasons281, 282, but 
especially demyelination can involve several other factors as well, such as 
autoimmunogenic events283, abnormalities in mitochondrial function284, 285, and 
mechanical disruption such as traumatic brain injury286. Demyelination and 
dysmyelination not only disturb myelin and its function, but can also contribute to 
axonal degeneration287. In this chapter, two of the most abundant demyelinating 
disorders are presented on a general level, followed by discussing the proteins 
involved in these diseases. 
 
1.3.2.1. Myelin basic protein and multiple sclerosis 
MS is a chronic autoinflammatory disease of the CNS, in which nerve impulse 
conduction velocities decrease substantially due to demyelination, manifesting as a 
spectrum of neurological problems: numbness, weakness and pain of the limbs, 
double vision, loss of vision, fatigue, dizziness, tremors, lack of coordination, and 
speech issues288. Patients suffering from MS might experience several of these 
symptoms together in a progressive manner, with symptoms becoming worse over 
time, or a relapsing-remitting manner, with symptoms re-occurring as attacks and 
disappearing for periods of unpredictable length. At the histological level, 
demyelination causes lesions, scarring of nerve tissue. MS is the most common 
neurological disease within the age group of 20 – 40 years, where the disease usually 
onsets289. 
While the possible causes of MS are largely debated, MS patients often display only 
some of all known symptoms, making the treatment of MS difficult and often 
personalized. There is no known cure for MS, and patients remain affected for life. 
The demyelination in MS is at least partially considered to be of autoimmunogenic 
origin, either caused by T-cells that manage to cross the blood-brain barrier, or by 
CNS microglia. These immune cells destroy myelin due to myelin factors mistakenly 
being recognized as threats, decreasing axonal insulation and saltatory conduction290, 





histocompatibility molecules that can bind specific myelin proteins and/or peptide 
segments292. 
Numerous myelin-specific proteins have been identified as autoantigens in MS, 
including CNPase, MAG, MBP, MOBP, MOG and PLP74, 75, 211, 293-300. Several 
peptide segments of these proteins have been shown to be autoantigenic when 
injected to animals, causing EAE301, 302, and many EAE animal models have 
subsequently been used as MS disease models to study the molecular basis of the 
disease57, 302, 303. 
The involvement of MBP in MS has been studied for decades, and multiple aspects of 
MBP-mediated autoantigenicity have been suggested. In its physiological state, MBP 
should remain lipid-bound between the myelin membranes, but several factors can 
cause MBP to ‘escape’ and become recognized by the immune system292, 304. Indeed, 
an immunogenic segment within MBP and the critical residues required for 
antigenicity have been identified and structurally characterized, in which the segment 
assumes an extended conformation (Fig. 8)305-309. These residues are Glu85 – Arg99 
in human MBP, and the segment is highly conserved (Fig. 5). Residues 82 – 91 in 
mouse MBP are likely to be folded as an α-helix when MBP is membrane-bound184. 
The roles of citrullination and phosphorylation are rather central, as heavy 
citrullination reduces the cationic nature of MBP and thus its membrane-binding 
tendency, potentially allowing dissociation and interaction with the immune 
system226. In mouse MBP, Thr92 and Thr95 within the immunodominant segment are 
known phosphorylation sites that influence membrane binding when 








Fig. 8. Molecular recognition of the immunogenic segment of MBP. Crystal structure of 
major histocompatibility complex class 2 crystallized with the autoantigenic segment of 
MBP (PDB ID 1FV1308). Residues Pro85 – Gln103 of human MBP have been indicated in 
the figure from left to right. 
 
 
Another autoimmunogenic aspect to consider is the proteolytic degradation of myelin 
proteins, including MBP, resulting in immunogenic peptides. MBP in its unbound 
state is disordered, and hence an attractive target for proteolysis311, and MBP has 
even been reported to undergo autoproteolysis312. On the other hand, modified MBP-
derived peptides have been explored as potential treatment candidates for MS, due to 
their antagonistic properties in EAE313-319. The inflammatory peptide recognition of 
MBP could arise from molecular mimicry, as several immunogenic MBP peptides 
share sequence and folding similarities to peptides of pathogenic origin, like the 
human immunodeficiency virus (HIV)320-324. Recognition of such MBP peptides 
could therefore trigger inflammation, which normally would occur in the event of a 
viral infection. This has also been observed in the opposite direction, where HIV 
patients display MS-like symptoms and produce antibodies against MBP325.  
In EAE/MS models involving MBP, aspects surrounding lipid composition and 
cellular environment have also been studied: the cytoplasmic lipid composition in 





reported55, 57, 204. Such phase behaviour can be modulated by ionic strength200, and 
these two factors together could be speculated to drive the progression of MBP 
release and/or degradation. Understanding how MBP and the other factors mentioned 
above are involved in MS etiology at the molecular level is necessary for designing 
novel treatments and remedies. 
 
1.3.2.2. Myelin protein zero and peripheral neuropathies 
Charcot-Marie-Tooth disease (CMT) is a peripheral neuropathy and the most 
common inherited neurological condition, with a prevalence peaking at 1 in 2500. 
CMT exhibits a broad spectrum of symptoms, including numbness and tingling 
sensations in limbs, fatigue, weakness, pain, muscle spasms, loss of muscle mass and 
very commonly arched feet, which is considered a hallmark for the disease. The 
disease onset varies broadly. Some experience their first symptoms in early 
childhood, while others reach an age of 40 years before any symptoms surface326. 
CMT occurs due to PNS demyelination and sometimes due to related axonal 
degeneration. Unlike MS, CMT has a strong genetic component associated to it, and 
is not an autoimmune disease affecting oligodendrocytes, but a demyelinating 
condition in which the integrity of Schwann cell myelin decreases and axonal 
function slows down or fails due to lack of insulation and trophic support327. 
Several subtypes of CMT exist, denoted CMT1, CMT2, CMT4, CMTX, and 
dominant intermediate CMT, which are further subcategorized with letters (CMT1A, 
CMT1B, etc.). The various categories enclose differences in the affected proteins, 
specific mutations (including deletions, duplications and point mutations), and in 
dominant, recessive or X-linked heritability. These include, but are not limited to, the 
myelin proteins Cx32, P0, P2, PMP22, PRX, DRP2 and several mitochondrial 
proteins, implying that mitochondrial dysfunction can also result in CMT in addition 
to common factors from compact and non-compact myelin328, 329. Mitochondrial 
dysfunction is also evident in the case of two Pt-containing anti-cancer drugs, 





DNA and as such could cause a CMT-like peripheral neuropathy as a side effect331. 
CMT can therefore be induced by defects in structural proteins relevant for myelin 
structure and by the disruption of myelin and/or axonal maintenance through 
mitochondrial dysfunction. 
One subtype of CMT, Dejerine-Sottas syndrome (DSS; historically CMT3), is 
characterized as a severely disabling form of CMT that onsets very early in life and 
causes major muscle degeneration due to lowered nerve conduction velocity. 
Treatments for CMT and DSS are symptomatic, and the diseases are currently 
deemed incurable326. 
Specific mutations in P0 account for demyelinating autosomal dominant CMT1B, 
axonal dominant CMT2I, DSS, and other CMT-like peripheral neuropathies332, 333. 
Most individual mutations, and the most common ones, occur in CMT1B. These 
mutations in P0 are mostly localized in the Ig-like domain, but several also exist in 
P0ct251, 332, 334: T216ER335, D224Y334, 336, R227S332, and the deletion of Lys236 
(K236del)337 are connected to CMT1B, K236E338 occurs in CMT2I, and A221T339 
occurs in DSS together with V42del, which resides in the Ig-like domain. The P0ct 
mutations have been illustrated in Fig. 9. 
   
 
Fig. 9. P0ct mutations. P0 has 
been drawn in its membrane-bound 
state with P0ct shown as individual 
residues. Color coding signifies 
residue characteristics: red, basic; 
blue, acidic; gray, non-polar; white, 
polar; green, Gly and Pro; yellow, 
Cys. The fatty acyl PTM has been 
drawn on Cys182. The YAML 
motif is indicated with white letters 
and the neuritogenic segment is 
indicated with a red line color. The 
Ig-like domain, transmembrane 
helix and P0ct are not drawn in 





The effects of many of the mutations in the Ig-like domain or P0ct are not known. 
The mutations could disturb membrane stacking by affecting the folding of P0, its 
homophilic adhesion, or its other interactions. Additionally, some mutations have 
been proposed to induce ER stress and the unfolded protein response (UPR)340. 
Interestingly, one specific mutation in the Ig-like domain has been shown to introduce 
a new glycosylation site341. Most of the mutations mentioned above are involved in 
demyelinating phenotypes, but D224Y is a clear outlier as it has been connected to a 
hypermyelinating CMT1B phenotype, with unusually thick compact myelin336. The 
molecular details of mutation-induced myelin malformation are not understood, 






















































2 AIMS OF THE STUDY 
 
The study of myelin-related proteins in solution and in native-like environments can 
be challenging due to the involved physical attributes: hydrophobicity, highly 
positively charged proteins, low water content, high content of certain ionic species, 
and intrinsic protein disorder76. As MBP and P0 are highly abundant CM proteins in 
CNS and PNS myelin, respectively, their thorough characterization in lipid-rich 
conditions is necessary. While numerous past studies have amassed data for MBP 
regarding its various functions70, 342, the same cannot be stated for P0ct, for which 
only a few studies have been published243-245. To understand the biochemical 
foundation of myelin in health and disease, further studies are required for both 
proteins. 
The primary object of this project was to establish a collection of biophysical, cross-
complementary methods, suitable for the study of recombinantly produced MBP, 
P0ct, and other proteins alike. The reasoning behind the chosen methods was to 
obtain quantitative data for several sample aspects, which allow the description of 
protein interaction mechanisms, affinities and rates with lipid structures of various 
compositions, as well as the involved effects on protein folding, dispersity, and 
potential membrane stacking. A key component of the study was to involve methods 
that remain independent of using tags, antibodies, or other modifications on the 
studied proteins and lipids, but rather follow intrinsic biophysical attributes of the 
analytes. MBP, a protein already characterized earlier, was to be used as a reference 
protein to test and optimize the methods at hand, and P0ct was chosen as a novel 






The secondary object of this project was to subsequently use the established method 
workflow to study the role of MBP and P0ct in myelin stability, formation, and 
disease. Both proteins were to be characterized in different lipid compositions and 
ionic contents, to gain an insight into which molecular determinants can affect their 
functions, and to what extent. Additionally, since P0ct is known to be a fundamental 
player in the disease etiology of peripheral neuropathies, mutant variants of P0ct were 
to be studied using the same workflow, once one had been established for the wild-
type protein. 
The expected outcome of the project was to efficiently take advantage of strong 
cross-complementation of various methods, with the possibility to apply the obtained 
characterization strategy in future studies involving the same proteins, or 
physically/functionally similar ones. The application would require only minimal 
working habit adjustments in screening through different conditions, for instance. 
Additionally, the project was expected to provide novel information on the molecular 
structures and functions MBP and P0ct, thereby providing novel structural aspects of 
















3 MATERIALS AND METHODS 
 
In this chapter, experimental procedures used to obtain all relevant data for this thesis 
are presented, with a focus on background principle, usage, sample requirements, and 
data analysis. Protein, peptide and lipid preparations are also outlined briefly – more 
detailed information on all experiments can be found in Articles I – IV. Only the 
relevant experiments that were performed by the author of this thesis are presented in 
high detail, together with some relevant collaborative studies, which were crucial for 
the outcome of the study (Chapter 3.7).  
 
3.1. RECOMBINANT PROTEIN PREPARATION 
The proteins used in the study were produced using recombinant methods. Bacterial 
expression plasmids prepared in Gateway vectors (Invitrogen) were available prior to 
the start of this study. These plasmids encoded for an MBP construct corresponding 
to the mouse 18.5-kDa isoform (UniProt ID: P04370-5) with a cleavable N-terminal 
hexahistidine-tag from the pTH27 vector343 (His-MBP) used in Articles I and III, 
and a P0ct construct corresponding to the 69 C-terminal amino acids of human P0 
(UniProt ID: P25189-1) with a cleavable N-terminal His-tagged maltose-binding 
protein (pHMGWA vector343, 344), used in Articles II, III and IV. Additionally, a 
plasmid from earlier studies171, 345, encoding for an MBP construct with an 
uncleavable C-terminal Leu-Glu linker and His-tag (MBP-His) in a pET22b(+) vector 
(Novagen) was used in Article I for nanogold labeling of transmission electron 






Detailed expression and purification procedures are described in Article I for His-
MBP and MBP-His, and in Article II for P0ct. In short, the expression of all proteins 
was carried out in LB medium at 37 °C using 0.4 – 1.0 mM isopropyl β-D-1-
thiogalactopyranoside induction for 2-3 h with constant shaking. After expression, the 
cells were collected by centrifugation and re-suspended in suitable lysis buffers, 
followed by purification or storage by freezing. The purification of His-MBP was 
carried out using immobilized metal ion affinity chromatography (IMAC) in 
denaturing conditions, followed by His-tag removal using selective proteolysis346 and 
a second IMAC step, and finally by a size-exclusion chromatography (SEC) step in a 
non-denaturing buffer to ensure monodispersity and removal of soluble aggregates. 
MBP-His was expressed and purified in a similar manner using IMAC, with the 
exception of omitting subsequent His-tag removal, and instead dialyzing the protein 
into a non-denaturing buffer prior to SEC. The reasoning behind the initial denaturing 
purification steps was the fact that both His-MBP and MBP-His were expressed in an 
insoluble state. The denaturing buffer allowed solubilization of the proteins and the 
final purity of the proteins was enhanced due to the lower presence of degradation 
products and contaminating proteins. 
In the case of P0ct, all purification steps were performed in non-denaturing 
conditions. After the initial IMAC step and proteolytic affinity tag cleavage, the 
protein mixture was either subjected to sequential SEC runs, or the His-tagged 
maltose-binding protein was removed using an amylose resin affinity step, prior to 
SEC. A second IMAC step was deemed impossible since cleaved P0ct was found to 
have strong affinity for the resin even without an affinity tag (data not shown). 
After purification, the obtained cleaved recombinant MBP composed of 170 amino 
acids (ProtParam160: 18544.7 Da; pI = 11.14), corresponding to the full 169-amino 
acid sequence of mouse 18.5-kDa MBP isoform, with an additional N-terminal Gly 
residue remaining from the tag cleavage. The obtained MBP-His behaved similarly to 
His-MBP in IMAC purification and SEC, and as such would be composed of 177 





initial Met removal345, which resulted in a 176-residue protein with an experimentally 
determined molecular weight of 19421.6 Da. 
The obtained P0ct, on the other hand, contained 70 amino acids (ProtParam160: 
7990.3 Da; pI = 11.11), corresponding to residues 180-248 of the human P0 
precursor, again with an additional N-terminal Gly. P0 is known to undergo 
palmitoylation at Cys182247, 248, which would be unlikely to occur in bacteria during 
expression. Therefore, this residue in P0ct had been deliberately mutated into a Leu, 
which is a bulky hydrophobic residue that partially mimics a fatty acid moiety and 
increases the local hydrophobicity in the protein chain. Additionally, the mutation 
deletes a chemically reactive residue, which could otherwise result in unwanted 
disulphide-mediated dimers or other oxidized molecular species, as IDPs are known 
to easily form dimer artifacts that can influence downstream experiments347.  
Related to the neuritogenic segment within P0ct255, a synthetic peptide corresponding 
to the sequence (P0ctpept; NH2-ASKRGRQTPVLYAMLDHSRS-COOH) was ordered 
from GenScript and used in Article II for folding studies. 
In Article IV, a total of six CMT and DSS mutations332, 334-339 were generated directly 
in the P0ct expression construct using site-directed mutagenesis, and the six mutant 
protein variants were expressed and purified in an identical manner to wild-type P0ct. 
The introduced mutations resulted in the following single amino acid changes: 
T216ER, A221T, D224Y, R227S, K236E and K236del. 
 
3.2. LIPIDS AND DETERGENTS 
The experiments presented later in this study involved the use of various lipids and 
detergents. Synthetic chemicals were used as opposed to natural extracts whenever 
possible to gain strict molecular control over different experimental conditions. This 
allowed testing of specific molecular attributes when determining the functional 





To study protein binding to lipids, membrane stacking and protein folding, several 
chemical aspects were compared: lipid headgroup charge, lipid tail saturation, and the 
presence of selected lipid species known to be present in myelin. Mixtures of mostly 
PC, PG and PS headgroups were used to assess the effect of electrostatic forces on the 
studied proteins and their functions, and additionally, two different lipid tail settings 
were chosen for checking the effect of fatty acid saturation: 1,2-dimyristoyls (DM) 
and 1,2-dioleoyls (DO). The following lipids formed the basis of the experimental 
material: 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-
glycero-3-phospho-(1′-rac-glycerol) (DMPG), 1,2-dimyristoyl-sn-glycero-3-phospho-
L-serine (DMPS), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-
sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG), 1,2-dioleoyl-sn-glycero-3-phospho-
L-serine (DOPS) (Fig. 10A). To compare lipid tail saturation, the DM- and DO-based 
lipids were chosen for two reasons. Firstly, DO-based lipids, which are abundant in 
myelin, have their gel-fluid transition temperature (Tm) below 0 °C, and they will 
always remain in the liquid disordered phase at ambient temperatures. The chosen 
DM lipid mixtures in most cases can also be brought to the same phase at reasonable 
temperatures around 25–30 °C, as opposed to 1,2-dipalmitoyl- or 1,2-distearoyl-based 
lipids that have very high Tm values. Secondly, since DO-based lipids have a cis-
double bond in carbon position 9, they will be kinked in the middle, essentially 
reducing the thickness of the bilayer. Bilayers of DOPC and DMPC are roughly the 
same thickness in the liquid disordered phase at 30 °C, which rules out artifacts in 
protein function arising from bilayer thickness itself348, 349. In addition to these 
general lipids and their mixtures, we chose to include other lipids as well, most 
notably 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), a mixture of 
SMs, and cholesterol (Fig. 10A-B). PEs, SMs, and cholesterol are all abundant lipids 
in myelin, and the two latter are known interaction partners of one another and of 
myelin proteins62, 63. They are also known modulators of membrane phase 






Fig. 10. Detergents and lipids. (A) The phospholipids used in this study varied with respect 
to their headgroup complexity and charge (PC, PS, PG and PE), as well as lipid tail 
saturation (DM and DO). The structure of SM is representative with regard to its fatty acyl 
chain (here drawn as an oleoyl group), as the used SM was a natural extract containing a 
mixture of several molecular species. (B) Cholesterol was the only sterol used in this study, 
being the major sterol compound present in myelin membranes. (C) The used detergents 
were mostly different in headgroup complexity, although OG also had a shorter hydrocarbon 
tail compared to SDS, DPC and LDAO. For simplicity and when applicable, all lipids and 





With the intention of eventually expanding into more physiologically relevant 
materials, well-behaving model lipid mixtures were initially used. DOPC:DOPS (1:1) 
was chosen as a base lipid composition, as DO-based lipids are abundant in myelin, 
and an equimolar amount of PC and PS typically can be used to form small and large 
vesicle structures that repel each other and do not fuse into larger structures rapidly. 
To compare the saturation degree, we chose DMPC:DMPG (1:1) for three reasons: 
(1) this lipid mixture, whilst PG is not as physiologically relevant as PS, is net 
negatively charged, and forms small vesicles that remain stable in size. (2) DMPC 
and DMPG both have a Tm around 23 – 24 °C, as opposed to DMPS (Tm = 35 °C)
352, 
meaning that their phase behaviour is similar and the transition between the gel phase 
and fluid phase can be performed at near-ambient temperatures, ensuring protein 
stability over long periods of time. Finally, (3) as mentioned above, DMPC and 
DOPC in their fluid phases have very similar lipid bilayer thicknesses348, 349. In this 
case, the fluid phase has to be considered rather than the gel phase, as DOs remained 
always in the fluid phase due to all experiments being performed above their Tm. With 
these points at hand, protein activity in the two lipid mixtures would be mostly 
governed by fatty acid saturation degree, although the chemical difference between 
PS vs. PG headgroups could influence binding as well. For the latter, given the 
equimolar ratio in the mixtures, the specific headgroup complexity was expected to 
play a minor role in contrast to the total net charge of the chosen lipids. In vesicle 
aggregation studies, DOPG was initially used instead of DOPS, to gain a better 
comparison. 
It is noteworthy that myelin contains more PE than PC53, both of which have a net 
neutral charge. Again, PCs were chosen as the major lipid species instead of PEs for 
two reasons: (1) PEs are mostly present as plasmalogens54, and the tail complexity 
adds another variable to the lipid mixture. We simplified the system to contain only 
one type of hydrocarbon tail per lipid mixture, with the exception of SM, which could 
only be obtained as a natural extract, being of heterogeneous composition. (2) In the 
case of DMPC vs. DMPE, if we consider the Tm values of PC, PE and PS, PE has a 
significantly higher Tm value (~50 °C) 





to ambient temperature. With these arguments at hand, PCs were chosen as the net 
neutral lipid species. 
In the current study, both vesicles and supported lipid bilayers (SLB) were used as 
model systems. Vesicles can essentially be divided into multilamellar vesicles (MLV) 
and unilamellar vesicles, of which the latter can be further divided into small 
(diameter <100 nm; SUV), large (diameter 100 – 200 nm, LUV), and giant 
unilamellar vesicles (diameter >1 µm; GUV)353, based on their average size. In this 
study, GUVs were avoided as they are complicated to prepare in large scale for 
biophysical studies. The true power of GUVs lies more in methods capable of 
observing them directly, such as fluorescence and light microscopy354. 
To ensure proper lipid mixing, and a subsequent homogeneous lipid composition in 
the generated vesicles, lipids are typically dissolved and mixed in chosen molar or 
mass ratios using organic solvents, such as chloroform, methanol, or mixtures thereof. 
After a desired lipid composition has been obtained, the organic solvent is evaporated 
using a nitrogen stream, followed by freeze-drying for several hours under vacuum. 
In the current study, lipid mixing was always performed in glass vessels to avoid 
plastic contamination in the obtained dry lipid films. After drying, vesicle formation 
can be induced by swelling the dry lipid film in water or in a chosen buffer, by gentle 
inversion over time at a temperature above the Tm. Vortex mixing the suspensions 
breaks down large structures, which can be further subjected to freeze-thaw cycles by 
immersing to a liquid N2 bath and a warm water bath, with a temperature above the 
Tm. Here, the largest lipid structures burst, but the suspension remains heterogeneous 
in terms of vesicle size and the amount of enclosed lamellae355. MLVs, however, can 
be useful in some methods: if a method like differential scanning calorimetry (DSC) 
is used to probe for changes in the behaviour of lipids, due to the fact that MLVs are 
multilamellar, and thus not completely accessible to the used proteins, they can 
contain an ‘internal standard’ of intact bilayers for comparative reasons. On the other 
hand, in such cases, it is imperative to assess several independently prepared lipid 
batches in the chosen experiment to avoid artifacts that arise from batch 





Unilamellar vesicles can be prepared in several manners, all of which have their 
advantages and drawbacks. In this study, we generated LUVs of an average 100-nm 
diameter using syringe extrusion through polycarbonate filter membranes. SUVs, on 
the other hand, were formed using either strong water bath sonication or tip 
sonication, while avoiding excessive heating, forming vesicles with a diameter below 
100 nm on average356. 
SUVs were used in most experiments due to their easy preparation procedure, also 
maximizing total accessible surface area for proteins and retaining accurate sample 
lipid concentration. LUVs, on the other hand, were only used in surface plasmon 
resonance (SPR) measurements, since extrusion through the membrane filters any 
solid particles out from the suspension. The drawback of extrusion is a decrease in the 
lipid concentration in the suspension. This is not a major issue in SPR, as the accurate 
concentration of immobilized lipids on the sensor chip is not very important, as long 
as surface saturation is reached. Regarding SUVs, their concentration remains known 
after the procedure, assuming that the lipids do not undergo degradation due to 
elevated temperature, and that the lipids do not oxidize due to introduction of 
dissolved O2 in the solvent. Additionally, when using SUVs, it is important that the 
method of interest does not suffer from a slightly wider vesicle size distribution, as 
opposed to using LUVs.  
After vesicle formation, the vesicles were stored unfrozen for a maximum of 1 week 
for DO-based lipids and 2 weeks for DM-based lipids, to avoid any artifacts induced 
by lipid oxidation or degradation. In practice, vesicles were used as fresh as possible 
in each experiment, and ‘base level’ samples were measured in most cases, especially 
during CD measurements, to ensure that the lipids and proteins work as intended. 
These base level samples, in all cases, were MBP and P0ct in the presence and 
absence of DMPC:DMPG (1:1) or DOPC:DOPS (1:1). 
Several approaches in SLB generation exist as well. SLBs can be formed by 
spontaneously bursting vesicles on a solid surface (also known as a ‘substrate’), often 
in the presence of Ca2+ and salt – a useful approach for AFM, as AFM can distinguish 





overcoming the inherent heterogeneous limitations arising from this SLB generation 
method89. Another approach is to dry vesicles on a solid surface and slowly rehydrate 
them in an atmosphere of high relative humidity, often in the presence of saturated 
K2SO4 at 30 °C. This way, depending on lipid amount, multistacked membranes arise, 
which can be advantageous for spectroscopy, albeit the structures in a macroscopic 
scale are heterogeneous357. 
Preparation of a single continuous bilayer is also possible, and the gold standard as a 
preparation method is Langmuir-Schaefer dipping. In this method, lipids in organic 
solvents are gently dispersed on a wave-free aqueous reservoir. When the solvent 
evaporates, the lipids orient themselves on the air-water interface, with lipid 
headgroups pointing down against the solvent and tails pointing up in the air. The 
area, where the lipids are dispersed, can then be compressed using barriers that 
prevent the surface lipids from escaping, which essentially increases the molecular 
surface pressure. At the so-called collapse point, the lipids will form a stable 
monolayer, and if a suitable substrate is pulled in a vertical geometry through this 
monolayer from underneath, while maintaining constant surface pressure, a lipid 
monolayer can deposit on the surface of the substrate358. This process is referred to as 
Langmuir deposition. After this, the coated substrate can be rotated into a horizontal 
orientation, where the deposited lipid monolayer inversely faces the monolayer on the 
reservoir surface, and a Schaefer dipping procedure can be performed: the coated 
substrate is gently lowered through the surface of the reservoir, and the two lipid 
monolayers will come together and form a continuous lipid bilayer359. 
In this study, Langmuir-Schaefer dipping was used for neutron reflectometry (NR), 
where the obtained bilayer-coated SiO2 substrate was assembled into a fluid cell, 
which retains the aqueous solvent within, and can be further used for sample 
injections into the cell360. 
In addition to lipids, the effects of several detergents on the proteins were studied 
(Fig. 10C). Above critical micelle concentrations, detergents self-assemble into 
micelle structures in aqueous solutions. Thus, they lack the complexity of the 





can be useful in their simplicity: while they mimic strong membrane curvature and 
headgroups that resemble those of certain lipid species, the fact that they retain their 
size and shape can be useful when proteins tend to disturb lipid phases naturally. 
Detergents are enough lipid-like to bind proteins and induce conformational changes 
that would occur during lipid binding, which makes detergents very useful as control 
substances in probing certain, simplified conditions. Micelles are useful in probing 
the effect on proteins induced by micellar size, which is also related to surface 
curvature, as well as the polarity, charge, and complexity of the detergent 
headgroup361. 
Detergents used in this study include sodium dodecyl sulphate (SDS), n-
dodecylphosphocholine (DPC) and n-dodecyl-N,N-dimethylamine-N-oxide (LDAO), 
which all share the same fully saturated 12-carbon dodecyl tail, but differ from one 
another in either headgroup complexity and net charge. SDS is negatively charged in 
aqueous solutions, whereas DPC and LDAO are zwitterionic. In DPC, the oppositely 
charged phosphate and choline moieties are fairly separated from one another, 
whereas in LDAO, the two charges are adjacent, essentially neutralizing their 
electrostatic effects. Additionally, n-octyl β-D-glucopyranoside (OG), which has a 
bulky, polar headgroup that is uncharged in solution and a slightly shorter 8-carbon 
tail, was included in the study (Fig. 10C). The ultimate goal was to exploit the 
detergents in probing for changes in protein conformation in the presence of the 
different headgroup chemistry, without inducing the formation of complex lipid 







3.3. GENERAL WORKFLOW 
In order to reach the aims of this study, a plan for a general experimental workflow 
was established, illustrated in Fig. 11. Optimization experiments prior to this work 
had been performed for the relevant proteins, which allowed direct advancement to 
protein expression and purification to obtain enough research material. After initial 
protein purification was completed, series of experiments were performed to learn 
about the general stability and quality of the produced proteins. This initial 
characterization contained methods that ensured quality control (QC) over subsequent 
purifications, which was not only important to achieve unbiased data, but to also 
retain reproducibility between different protein purification batches. 
After this, the experimental focus was shifted to more elaborate methods, which were 
used to study (1) the conformation, (2) the lipid binding and membrane insertion, (3) 
the putative membrane stacking properties of the chosen proteins, using synthetic 
model lipid mixtures and detergents. 
 
Fig. 11. Outline of general workflow. Protein constructs, expression, purification and 
optimization thereof had been performed prior to this study (gray). Preliminary 
characterization (blue) was a QC step used to verify the identity and proper stability of the 
purified proteins. Various functional and structural characterization experiments (dark red) 
were carried out afterwards, providing the vast majority of the relevant experimental data. 








3.4. PRELIMINARY CHARACTERIZATION 
Preliminary characterization of proteins was performed to describe their stability, 
purity and monodispersity in solution, prior to more sophisticated experiments. In 
order to gain unbiased data in the main experiments, the purified recombinant 
proteins were subjected to QC to learn about their behaviour in general or at the 
moment after completion of purification. Several of the methods introduced here are 
essentially cross-complementary with each other, as well as with more advanced 
methods described later. 
3.4.1. DENATURING GEL ELECTROPHORESIS 
Gel electrophoresis of proteins under denaturing conditions is commonly performed 
towards the positive anode using a polyacrylamide stationary phase and a mobile 
phase containing high amounts of dissolved glycine, SDS and a slightly alkaline 
buffer. The method is commonly known as SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE)362. The method is by far one of the most globally used ones to check 
protein purity during recombinant protein purification, but it is also useful for other 
purposes. Virtually any sample that contains one or more proteins can be analyzed 
using SDS-PAGE, and in this thesis, it was mostly used to verify the adequate purity 
(>95%) of recombinant proteins for downstream experiments. While SDS-PAGE 
most often cannot be used to analyze monodispersity, except in rare cases of SDS-
resistant oligomers, it does provide an accurate image about the quantitative 
distribution of e.g. a protein and its degradation products, as well as any other 
contaminants. Additionally, after electrophoresis and band visualization, the 
separated protein bands can be isolated, and used further to identify the proteins 
within a single band using mass spectrometry, as explained in Chapter 3.4.2.1. 
When performed correctly, denatured SDS-bound proteins will travel a distance 
through the stationary phase, which is inversely related to the log10 of their molecular 
weight, and by comparing to a standard sample of proteins with known masses, it is 






3.4.2. MASS SPECTROMETRY 
3.4.2.1. Peptide fingerprinting 
The identity of unknown proteins can be analyzed using peptide fingerprinting: a 
denatured protein is treated with the protease trypsin, which has a very defined 
proteolytic specificity only cutting after Arg and Lys residues that do not border a C-
terminal Pro. A trypsinated protein forms a mixture of ‘tryptic peptides’ with defined 
amino acid compositions. The peptide mixtures can be dried on a solid substrate with 
a suitable matrix compound, like α-cyano-4-hydroxycinnamic acid. The peptides in 
this sample are then ionized and their masses and relative abundances determined 
using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry. The obtained mass spectrum is a ‘tryptic fingerprint’ of the protein, and 
based on the protein sequence, the relative abundance and mass of each tryptic 
peptide can be theoretically calculated and compared to the measured mass spectrum 
to identify the protein of interest. An unknown protein can also be identified, if a 
sequence database, e.g. the Mascot Server363, is used for comparison.  
A typical sample for peptide fingerprinting is an SDS-PAGE polyacrylamide gel 
piece with a stained protein band. Due to the sensitivity of mass spectrometers, only 
marginal amounts of proteins are needed for the analysis. The proteins in the gel 
piece can be destained using an organic solvent and reduced with mercaptans. 
Subsequent Cys alkylation using α-iodoacetamide irreversibly prevents spontaneous 
Cys oxidation. The gel piece is then dried using organic solvents and incubated in a 
trypsin solution that digests the protein. Tryptic peptides can be extracted from the gel 
piece under acidic conditions and directly analyzed using MALDI-TOF mass 
spectrometry. 
In this thesis, the identities of purified MBP (Article I), P0ct (Article II) and the P0ct 






3.4.2.2. Protein mass determination 
A common misconception is that the entire mass of a single protein can be 
determined from a tryptic peptide fingerprint. This is untrue, but luckily, mass 
spectrometry is not only limited to peptides – it can be used to determine the masses 
of undigested proteins. This is particularly useful when one is interested in oxidation, 
degradation, or other covalent modifications. Electrospray ionization (ESI)-coupled 
time-of-flight (TOF) mass spectrometry is useful in this sense: ESI is a rather gentle 
ionization method that does not fragment ions as they are brought to the vacuum 
phase for TOF analysis. ESI, however, does ionize proteins with multiple charges per 
chain, and therefore, the TOF analysis will not provide a single mass per charge ratio 
signal, but several of them, which can be back-calculated to reveal the true mass of 
each mass species. Additionally, since ESI essentially depletes solvent content from 
around the analyte proteins, it is of high likelihood that protein molecules present 
themselves as ion adducts from residual salt in the sample solution. This can be 
avoided by including a desalting step prior to ionization. However, if the resolution of 
the mass analyzer is high enough, this might not present a problem, as proteins with 
ion adducts can be resolved from the ion-free proteins. 
In this thesis, ESI-TOF was used to check the integrities and expected masses of 
MBP, P0ct and the P0ct mutants in Articles I, II and IV. ESI-TOF was performed 
after a high-performance liquid chromatography-coupled desalting step, from which 
the output was directly injected to the mass analyzer. Sample requirements for the 
analysis were generally very small, only around nanomolar protein concentrations in 
analysis volumes ranging between 1 – 5 µl, before the chromatography step. 
 
3.4.3. MONODISPERSITY ANALYSIS 
3.4.3.1. Size-exclusion chromatography 
SEC is a chromatography method that separates particles based on their 
hydrodynamic radius (Rh). A sample of dissolved particles is pushed through a gel 





carbohydrate-based beads that contain a porous matrix of defined size. Small 
molecules may enter the matrix, which retains them longer in the gel bed, as opposed 
to large particles that cannot enter the beads and simply bypass them. Hence, particles 
become sorted based on their size in the gel bed, large particles eluting faster than 
small ones364. 
SEC is useful for a number of different applications. Firstly, it can fractionate a 
complex sample, separating different oligomers of a protein from one another, or a 
protein from its degradation products or other contaminating proteins. Secondly, 
soluble aggregates, which are immensely large compared to individual protein 
particles, will exit the column material first in the so-called void volume, the volume 
that is completely excluded from the bead pores. Therefore, removal of soluble 
aggregates from the protein of interest is very efficient using SEC. Thirdly, SEC can 
be used to exchange the protein buffer solution quantitatively, either for downstream 
applications or for improved stability. During protein purification, SEC is the ideal 
last step after other chromatographic stages for all three reasons described above364. 
Finally, since SEC separates based on Rh (which, for globular proteins, is strongly 
related to molecular weight), analytical SEC can be used to estimate the mass and 
oligomeric state of a protein in solution, if a series of standard proteins are analyzed 
as well. Disordered proteins behave slightly differently in SEC, as their Rh is larger 
than those of globular proteins, appearing larger in a SEC run. Additionally, SEC can 
be useful in studying protein-protein or protein-nucleic acid interactions, or in 
quantifying the relative abundance of molecular species in solution, for example. 
SEC was used in all protein purifications throughout the thesis work to gain 
monodisperse protein samples. Additionally, and more importantly, SEC was used in 
an analytical setting to display the monodisperse nature of MBP and P0ct in Articles 
I and II, prior to subsequent experiments, as well as for comparing P0ct mutant 






3.4.3.2. Multi-angle laser light scattering 
If a protein sample is effectively fractionated using SEC, the observed protein peaks 
will momentarily be monodisperse, given high protein purity within the sample. SEC 
can be coupled with multi-angle laser light scattering (SEC-MALS), which introduces 
an analytical method that records the time-averaged scattering of monochromatic 
laser light at different angles. The magnitude of the scattered signal scales with the 
mass of the particle and can be normalized by concentration, which allows the 
determination of the absolute molecular weight of the particle. The concentration of 
the eluted protein at a given time can be determined by measuring ultraviolet (UV) 
absorbance or the refractive index of the solution365. 
SEC-MALS is very useful in determining the oligomeric state of a protein in solution, 
and to complement SAXS data. This is particularly true for more complex mixtures 
with interchanging oligomeric states. Additionally, if several concentration 
determination sources are used, for instance UV spectroscopy and refractometry, 
conjugation analyses for detergent-bound membrane proteins or protein-nucleic acid 
complexes can be performed. With these methods, the mass fractions of each 
molecular species within a monodisperse peak can be obtained366. As opposed to 
regular SEC, SEC-MALS is not limited by protein conformation, and the masses of 
disordered proteins can be accurately determined. 
An important sample requirement is a pure protein sample in solution, or at least a 
sample that will fractionate into separate peaks within the used SEC material. 
Additionally, a matching background buffer needs to be chosen as the mobile phase, 
which has to be extensively degassed to remove dissolved air, especially if refractive 
index measurements are used as a concentration source. These requirements are used 
to ensure a flat baseline in the chromatograms. The required protein amount per 
sample varies with molecular weight, large proteins scattering more light than small 
ones. For P0ct, a protein expected to be ~8 kDa in mass if monomeric, 250 µg of total 
protein was used in Article II in a single SEC-MALS run to gain a light scattering 






3.4.3.3. Dynamic light scattering 
Dynamic light scattering (DLS; also known as quasi-elastic light scattering) is a 
method that measures scattered monochromatic laser light by particles that diffuse in 
solution due to Brownian motion. The scattered light, depending on the positions of 
the diffusing particles over time, can undergo either constructive or destructive 
interference, which manifests as time-dependent intensity fluctuations of the scattered 
light. These fluctuations can be described as an autocorrelation function, which can 
be used to solve the diffusion coefficient of the particle. The rate of diffusion of a 
particle depends on the size of the particle, solvent viscosity, and temperature. 
Therefore, given that the latter two parameters are known, the size of the particle, 
more importantly the Rh, can be solved based on the diffusion coefficient, using the 
Stokes-Einstein equation367. 
DLS is complementary to SEC(-MALS) in determining the monodispersity of protein 
samples, especially the presence of aggregation. Additionally, DLS can complement 
SAXS data (see Chapter 3.5.1.), as Rh and the radius of gyration (Rg) obtained using 
SAXS are related. The Rg/Rh ratio can be used to predict if a protein deviates from 
globularity: a ratio of 0.77 is ideal for a globular particle, whereas an increased ratio 
over 1.00 suggests significant elongation or a disordered chain368.  
A typical DLS sample is a protein solution with a concentration close to 1 mg/ml, and 
depending on the used cuvette, 10 – 50 µl sample volume is required. Due to the 
sensitivity of DLS to the presence of large particles (e.g. dust), samples should be 
either centrifuged or filtered prior to measurements. 
In this thesis, DLS was used to determine protein Rh and monodispersity, particularly 





3.5. PROTEIN CONFORMATION 
The conformation of proteins can be considered on several distinct levels: the primary 
structure refers to the sequence of the covalent amino acid chain. Secondary 
structures denote local changes induced by intramolecular hydrogen bonding, such as 
changes in dihedral angles of protein chains seen in helical structures, β-sheets, and 
random coil. Tertiary structure describes the overall fold of a protein chain, regardless 
of secondary structure, at its energy minimum: This most often involves collapsing 
into a globular conformation. Finally, quaternary structure is the homo- or 
heterogenic association of one or more proteins, respectively, which together form a 
physiologically functional unit. 
In this thesis, the tertiary and secondary structures of proteins were examined using 
SAXS and synchrotron radiation circular dichroism spectroscopy (SRCD), 
respectively. 
 
3.5.1. SYNCHROTRON SMALL-ANGLE X-RAY SCATTERING 
SAXS is the measurement of the total X-ray scattering of a sample on an area 
detector, usually from an incident beam with a monochromatic wavelength (λ). In 
these measurements, the scattering intensity is recorded at small scattering angles (θ) 
with regard to the incident beam, hence the name small-angle scattering. Radial 
averaging of this data will produce a scattering curve, which is defined as recorded 
intensity on the Y-axis as a function the momentum transfer vector (s) on the X-axis, 





This also means that the recorded scattering is inversely related to resolution, and 
since scattering data at small θ angles are collected, SAXS essentially is a low-
resolution method369. 
In the case of a monodisperse protein sample, total sample scattering can be recorded, 





in the isolated scattering profile of the protein itself. Since X-ray scattering from 
proteins is fairly low in intensity compared to the solvent, high concentrations of 
proteins (2 – 5 mg/ml) need to be used to record scattering data with high accuracy. 
This is especially true for small proteins, as the scattering of X-rays scales with 
molecular weight. Thus, the presence of aggregates is a major issue in SAXS 
measurements, as their molecular weight compared to the particle of interest is 
generally very large370. 
Since synchrotron SAXS involves an intense hard X-ray beam, eventual radiation 
damage to the sample is expected, which can change its scattering properties. 
Therefore, several frames of short illumination periods of the sample are collected, 
compared and averaged. In case of frames showing scattering artifacts from radiation 
damage, the affected frames are discarded from the averaging. In case of a radiation 
damage-resistant sample, low sample concentration can be compensated by acquiring 
more frames for averaging, resulting in better scattering statistics. 
Many choose to use SAXS to measure and analyze the tertiary and quaternary 
structures of proteins in isotropic solutions, which can greatly complement crystal 
structures, CD spectroscopy, NMR spectroscopy and EM369, 371, 372. Since the 
measurements are done in solution, the obtained data often represent the true 
individual oligomeric and conformational states of the monodisperse scattering 
particle, being independent of artificial states induced by e.g. crystal packing. The 
obtained scattering curve can be subjected to Guinier analysis, which provides useful 
parameters, such as the forward scattering intensity, I0, directly related to particle 
molecular weight in solution, and the radius of gyration, Rg, which is the average 
distance of all scattering entities within a single particle from its mass center. Thus, 
Rg is a measure of particle size and shape in solution
373. Kratky analysis is useful for 
proteins in particular, as the shape of the rearranged scattering curve, the Kratky plot, 
easily reveals the major conformational states of the protein. Kratky analysis can be 
used to describe whether a protein is folded or extended374. 
The shape of the original scattering curve can be used to extract a size distribution of 





the maximum dimension (Dmax) of the particle
375. As SAXS is often used to 
complement other structural methods, several modeling approaches exist for 
modeling globular particles from measured SAXS data, some of which use Dmax as a 
starting parameter376, 377. However, as SAXS measures the average scattering from the 
entire sample over time, it can be also used to study the distribution of different 
conformationally interchanging particles in solution. This is useful for disordered 
proteins, since using advanced ensemble optimization modeling (EOM) approaches, 
the distribution of sizes in a conformational ensemble can be estimated, and 
compared in different conditions and between different proteins347, 378, 379. 
In this thesis, SAXS was used as a control method to characterize MBP, P0ct, and 
P0ct mutants in Articles I, II and IV, to compare their size, oligomeric state and 
conformation in solution. EOM was used to analyze and model conformational 
flexibility in the samples, in addition to more classical ab initio modeling 
approaches379, 380. 
 
3.5.2. SYNCHROTRON RADIATION CIRCULAR DICHROISM SPECTROSCOPY 
3.5.2.1. Isotropic samples 
Chiral molecules exhibit different absorption properties between left- and right-
handed circularly polarized light, compared to achiral molecules or racemic mixtures 
of chiral molecules. The measured absorption difference between the two 
polarizations is called circular dichroism (CD), which can be determined for a sample 
using CD spectroscopy. This is useful for studying proteins, for which most amino 
acids are chiral and absorb left- and right-handed circularly polarized light differently, 
depending on their dihedral angles. The total contribution of these angles, which also 
make up regular secondary structures, affect the differential absorption spectrum for a 
given wavelength range, which is usually between 170 and 280 nm for far-UV CD 
measurements. 
CD is semi-quantitative, albeit exploiting the method of SRCD, not suffering from 





levels381, 382. Generally, CD and SRCD are considered methods to check for the 
overall presence of protein folding, but their power lies in probing the folding 
differences between different sample conditions. This is especially useful for proteins 
that present a notable gain in regular secondary structure content upon binding to 
lipids or other molecules that induce folding383.  
The drawback of CD is that the applied light tends to get absorbed by high 
concentration of different ions and compounds. Certain compounds are considered 
CD-compatible, and the most commonly used ones are inorganic phosphate as a 
buffer, and F- as an anion to increase ionic strength, typically obtained by including 
KF or NaF in the solution384. Lipids can be troublesome as well, not to mention 
protein-induced lipid aggregation, which generally decreases protein CD signals383. 
Some lipids, like cholesterol, even have a strong intrinsic signal in CD385. Similarly to 
SAXS measurements, a CD spectrum of a single sample is often acquired as several 
scans to check for sample stability over the CD measurement, as some proteins are 
sensitive to temperature- or UV light-induced aggregation, denaturation or 
degradation. In case the scans overlay with each other, they are averaged to reduce 
overall noise in the spectrum. 
A background CD spectrum is measured and subtracted from the sample spectrum to 
correct for the background CD contribution as well as instrumental contributions. The 
obtained CD units, expressed in millidegrees, are converted to a more suitable unit by 
taking into account protein concentration, the molecular weight, and the number of 
amino acid residues. Additionally, the pathlength of the cuvette is taken into account. 
One of the commonly used units is Δε, expressed in M-1 cm-1, which can be directly 
derived from the Lambert-Beer law. Δε describes the difference in the molar 
absorption coefficients per residue for left and right handed circularly polarized light 
at a given wavelength. Software tools have been developed to streamline this 
analysis386, 387.  
The shape of the far-UV CD spectrum contains information about the regular 
secondary structure elements in the studied protein, most notably between random 





Greenfield384, but briefly put, random coil exhibits a strong negative signal peaking at 
198 nm, whereas α-helical structures generate a strong positive peak at 192 nm and 
two negative peaks of similar magnitude at 208 and 222 nm. β-sheet structures 
generally produce a signal strength lower than that of the two other secondary 
structures, and they present a single positive peak at 196 nm and a single negative 
peak at 216 nm. Mixed secondary structure content blends features from all of the 
above features, and it is important to note that the largest difference between random 
coil and folded secondary structures occurs around 185 – 210 nm, making this area of 
the spectrum very sensitive to changes in secondary structure content. These 
wavelengths are very short, and thus susceptible to noise arising from 
sample/background absorption or low photon flux. Here, the use of short cuvette 
pathlengths and synchrotron light is highly advantageous. 
In this thesis, SRCD was applied in Articles I – IV to study the structural 
composition of proteins in the presence and absence of lipids, detergents, and ionic 
species at various concentrations. Additionally, TFE, a molecule decreasing the 
dielectric environment when it comprises a major solvent fraction of the sample, was 
used to test for any intrinsic folding tendency of the proteins. To avoid buffer-induced 
folding artifacts, namely from the binding of inorganic phosphate to proteins, thereby 
reducing protein-phospholipid interactions, the proteins were studied at dilute 
concentrations (0.1 – 0.5 mg/ml) under unbuffered conditions. A typical sample 
volume was 25 – 40 µl in 100-µm cuvettes (0.3 – 0.5 mg/ml) or 250 µl in 0.5 – 1.0-
mm cuvettes (0.1 mg/ml). 
 
3.5.2.2. Oriented samples 
CD measurements performed for proteins in solution are essentially measured in an 
isotropic setting. Oriented circular dichroism (OCD) spectroscopy is a method that 
can be used to study the orientations of proteins and peptides, and a commonly 
employed system is the use of SLBs with membrane-interacting peptides that adopt 
defined orientations357. When a helical structure is illuminated with circularly 





However, an anisotropic sample containing oriented lipid bilayers is illuminated with 
a beam perpendicular to the bilayers. When a membrane-bound helix approaches a 
perpendicular orientation in the membrane, the minimum at 208 nm is lost. This 
allows the screening of peptides and/or membrane compositions to qualitatively 
estimate the tilt angles of peptides in a membrane388. While useful for peptides, the 
method is less useful for proteins that typically contain several secondary structure 
elements in various orientations with respect to each other and the incident beam, 
masking out the anisotropic effect. 
OCD samples are prepared on quartz or CaF2 plates by drying a peptide-lipid mixture, 
typically containing around 10 µg of peptide per sample. The dried film is slowly 
rehydrated at high relative humidity (>97%) to spontaneously form oriented 
membranes. The quartz plate is then mounted perpendicular to the incident beam and 
measured at several rotational angles, which are averaged in the end to correct for 
linear dichroism artifacts. OCD was used in Article II to study the orientation and 
folding of P0ctpept in oriented SLBs. 
 
3.5.2.3. Stopped-flow kinetics 
Due to folded and unfolded proteins producing different CD spectra, monitoring the 
process of (un)folding is technically possible as a function of time, by choosing a 
wavelength, at which a major change in CD signal occurs between the two folded 
states. Such experiments are often performed to follow thermal unfolding, which 
allows the determination of the melting temperature of the protein. 
Monitoring protein (un)folding to uncover kinetic details is also possible, although 
the formation of secondary structures occurs in sub-second time scales. Stopped-flow 
kinetics enable the measurement of such events: the contents of two containers, 
usually syringes, are simultaneously loaded into a mixing chamber, and changes in 
the resulting sample are monitored, in this case the CD signal. The entire loading 





a folded protein with a denaturant, resulting in unfolding, or the mixing of a 
denatured protein with a renaturant, resulting in folding. 
In this work, stopped-flow SRCD measurements were carried out in Article III to 
monitor the folding of MBP and P0ct when interacting with lipids. Unfortunately, the 
folding kinetics were too rapid to be accurately monitored (See Chapter 4.3. and 5.4.), 
but a secondary effect that arose from vesicle aggregation was observed: the CD 
signal decreased strongly upon the nucleation and formation of larger lipid 
aggregates. Fitting of the obtained kinetic data was performed with two-state decay 
functions, from which two kinetic constants could be obtained, describing slow and 
fast processes occurring simultaneously. Therefore, stopped-flow SRCD 
measurements were used to determine the effects of ionic strength and Ca2+ on MBP- 
and P0ct-induced vesicle aggregation kinetics. 
 
3.6. PROTEIN-LIPID INTERACTIONS 
In myelin, several proteins bridge apposing lipid bilayers, which forms the basis of 
compact myelin stability. Such interactions and their strength can be studied in 
controlled systems using various biophysical methods, uncovering the involved 
binding affinities, thermodynamics and molecular distances. 
 
3.6.1. SURFACE PLASMON RESONANCE 
SPR is a method that is popular not only in determining binding constants of different 
interacting molecules, but especially in gaining information about association and 
dissociation mechanisms and rates. A thin gold surface exhibits a surface plasmon 
effect when it encounters light in the infrared-visible wavelength range. The presence 
of the effect is very sensitive to material being deposited on the surface, which 
changes the refractive index of the interface and thus the reflection angle of the 
incident light that travels through a prism. Measuring the change in angle of the 





and this can be performed as a function of time to monitor association and 
dissociation events.  
SPR is usually carried out in a fluidics system with several channels that can be 
monitored simultaneously, usually on a chip390. Various chips exist, in which the gold 
surfaces are functionalized against the mobile phase with different structures or 
compounds that suit the needs of the experiment. An analyte sample with a known 
concentration is injected with a chosen flow rate and contact time, allowing it to 
associate with the chip and dissociate once the analyte injection ends and a 
continuous flow of the medium is applied. The association and dissociation patterns 
can provide kinetic constants (ka and kd, respectively), which in turn can be used to 
calculate the equilibrium dissociation constant: 
𝐾 =  . 
Lipid vesicles can be captured to form a lipid-rich surface on an SPR instrument 
sensor chip. The chip is coated with lipophilic compounds attached to a 
carboxymethylated dextran matrix, and it is capable of incorporating lipids with high 
affinity and very slow dissociation kinetics391. By choosing a parallel channel on the 
chip without lipids and by using a suitable blocking procedure, the specific 
association of protein samples onto the lipids can be studied. The sensorgrams from 
the lipid-free channel are subtracted from the lipid channel to cancel out unspecific 
binding. In the case of ambiguous kinetics or irreversible binding, the steady-state 
response levels, where no more protein associates to the surface and the sensorgram 
appears flat, can be recorded. These levels can be plotted against analyte 
concentration to obtain a binding curve, and one of various fits can be performed, 
which can provide Kd.  
In this work, Kd values for different proteins binding to lipid structures were obtained 
using SPR in Articles I, II and IV. It should be noted that in the case of irreversible 
binding, the term ‘dissociation constant’ is misleading, as dissociation phases of MBP 
and P0ct from lipids could not be measured directly. Therefore, an ‘apparent 





3.6.2. DIFFERENTIAL SCANNING CALORIMETRY 
Calorimetry measures the absorption or release of energy in the form of heat by a 
sample that undergoes a physical or chemical transition. DSC is used to scan a 
temperature range and record exothermal or endothermal events that occur in the 
sample cell as opposed to a reference cell. The measured events are expressed as gain 
or loss in heat capacity. DSC is a useful method to analyze the Tm values of lipids that 
undergo phase transition events, in which they most often either bind or release 
energy when transiting between phases392. Lipids present a fairly strong endothermic 
signal in DSC when heated past their Tm, which allows monitoring of changes in 
phase behaviour induced by proteins. DSC is quite sensitive for lipid-induced heat 
events, and as little as 160 – 320 µM lipid is usable per sample, which corresponds to 
0.1 – 0.2 mg/ml DMPC:DMPG (1:1), for instance. 
In this thesis, DSC was used to probe for any protein-induced changes in Tm or the 
melting landscape of DM-lipids in Articles I, II and IV. A typical sample consists of 
MLVs or LUVs of lipids with added protein at a certain P/L ratio, in this work 
normally between 1:100 – 1:1000. At these P/L values, protein concentrations are 
very low, and any protein denaturation or aggregation events remain undetectable by 
DSC, allowing specific monitoring of the lipids. 
 
3.6.3. LIPID VESICLE TURBIDIMETRY 
Mixing MBP with negatively charged lipids results in vesicle aggregation due to 
MBP bridging the vesicle surfaces together197. This process can be followed with 
methods like turbidimetry or X-ray diffraction in a P/L-dependent manner. 
 
3.6.3.1. Visible-light turbidimetry 
Much like absorption spectroscopy, turbidity, or measurement of optical density, 
measures the amount of transmitted monochromatic light through a sample. The 
presence of particles larger than the wavelength of the used light induces light 





particles can, for instance, be aggregating vesicles, when a protein or an ion is added. 
While events like aggregation or increase in vesicle size cannot be distinguished from 
each other with this method, it is possible to establish relationships between the 
amount of induced turbidity and the P/L ratio, for instance. Additionally, kinetic 
studies can be performed on samples that display reactions within a timescale of 
minutes to hours. 
In this study, MBP, P0ct, and mutants of P0ct were examined with regard to their 
vesicle aggregation or fusion properties using visible-light turbidimetry in Articles I 
– IV, similarly to what has been reported before94, 96, 197, 243. Care was taken with 
proper sample mixing, as well as to measure all samples in a manner, in which they 
appeared uniformly homogeneous, ensuring independence from the presence of 
substantially large aggregates that accumulate on the bottom of the sample chamber. 
 
3.6.3.2. Synchrotron small-angle X-ray diffraction 
Protein-induced vesicle aggregation and fusion can be studied using SAXD. Like 
SAXS, SAXD measures the position of scattered X-rays on a 2D detector, and the 
recorded images are converted into scattering curves with s as the X-dimension. The 
presence of repetitive structures within the sample, such as a protein bridging lipid 
membranes together, or a protein forming a lattice, results in either constructive or 
destructive interference of the scattered X-rays. In case of high order, these waves 
sum together accordingly to the Fourier transform and produce diffraction rings in the 
scattering image, which result in Bragg peaks in the scattering curve. This is true for a 
uniform sample where the repetitive structure is isotropically present, as opposed to a 
crystal that has a certain orientation, along with the contents of its unit cell, in the 
incident beam. The position of the observed diffraction peaks in s are related to the 
molecular distance d, as described by Bragg’s law, nλ = 2d sin θ, which can be 
reduced to d = 2π/s, since s is described as above. The mean repeat distance d 
corresponds to a repetitive structure in the sample, such as two apposing membranes 





structures, such as proteins forming periodic macrostructures or the lipids themselves 
existing in periodic structural phases204, 393, 394. 
In this thesis, SAXD was used in Articles I, II and IV to probe for diffraction peaks 
arising from periodic mean repeat distances in vesicle-aggregated samples, as has 
been performed for MBP and P2 earlier94. 
 
3.6.4. ATOMIC FORCE MICROSCOPY 
AFM is a high-resolution scanning probe method employed in the study of sample 
surface topology and mechanical properties. Unlike light microscopy, AFM is 
independent of the wavelength of light, and examines a surface based on mechanical 
properties using a cantilever, which is either physically in continuous contact with the 
surface or oscillates at a known frequency, tapping the surface. A piezoelectric 
system is used to adjust the position of the sample and the cantilever in a feedback 
loop. A laser is reflected from the back of the cantilever onto a position-sensitive 
photodetector. The deflection signal is used to measure the position of the cantilever 
in the height dimension, as well as the sample interaction itself395. 
AFM can be performed in aqueous conditions to image flat surfaces with SLBs or 
proteins. It is sensitive to height differences and mechanical differences between 
bilayer edges and the underlying substrate, for instance. Therefore, even if a protein 
binding to an SLB would not influence the thickness of the bilayer, changes in the 
stiffness of the surface can be revealed. AFM can complement other methods that 
provide information about layered systems, such as NR, especially since AFM scans 
an area and is, for example, capable of distinguishing lateral inhomogeneity or holes 
in an SLB89, 395.  
AFM was used in Articles I and II to investigate the effect of MBP and P0ct on the 






3.6.5. NEUTRON REFLECTOMETRY 
Neutron radiation with a suitable wavelength (range) can be scattered by matter, but 
unlike X-ray scattering from electron clouds, neutrons are scattered by atomic nuclei. 
Scattering length density (SLD) is the propensity of matter to scatter radiation when 
exposed to an incident beam. In the case of X-rays, SLD scales with the amount of 
electrons and is therefore linear as a function of atomic number. Nuclear scattering is 
peculiar in the sense that neutron SLD does not scale in a mathematical pattern. A 
very noteworthy example is hydrogen, as its isotope deuterium has drastically 
different neutron scattering properties. In biology, dominated by aqueous solutions, 
neutron methodology obviously presents a great tool due to the SLD difference 
between water (H2O) and heavy water – deuterium oxide (D2O)
396. H2O and D2O can 
be mixed at different volume ratios, resulting in a linear continuum in solvent 
scattering length density. As atomic nuclei present specific SLDs, the atomic 
composition of a molecule, or part of it, defines the SLD of that scattering entity. 
Generally, neutron methods excel compared to X-rays in ‘contrast matching’ – the 
ability to tune the SLD of a given parameter, such as the solvent, with another 
parameter one wants to distinguish from another. In practice, proteins, nucleic acids, 
lipids and detergents all have specific SLDs, and the solvent SLD can be matched 
with these, meaning that the matched parameter will scatter identically to the chosen 
solvent composition. Given the appropriate background and parallel samples, 
individual molecular species and structures can be distinguished from a complex 
system by the use of contrast matching397, 398. 
NR is relatively simple in physical terms, as it is a method that merely records the 
specular scattering of neutrons from a planar, layered sample, as a function of the 
scattering vector qz, expressed as s in SAXS/SAXD. Not only are neutrons excellent 
in distinguishing the interfaces resulting from SLD differences within a layered 
system, but they are highly penetrative and transfer little to no ionizing energy to the 
sample. In general terms, neutrons probe deep into the system without resulting 
radiation damage, which is advantageous considering the long measurement times 
neutron methods generally require360, 399. This is highly useful in case of SLBs and 





highly reproducible. Therefore, it is advantageous to prepare SLBs using Langmuir-
Schaefer deposition to ensure lateral integrity. 
NR was used in Articles I and IV to determine the layer thickness and coverage of 
membranes and bilayer-adhered MBP and P0ct phases. Different solvent contrasts 
were used in order to distinguish interfaces and the related thickness differences 
accurately. 
 
3.7. EXPERIMENTS PERFORMED IN COLLABORATION 
Whilst the characterization of the proteins described in this thesis could be performed 
in-house or at synchrotron/neutron sources, some experiments were carried out in 
collaboration. This involved the use of TEM in imaging lipid structure behaviour in 
the presence of MBP and P0ct in Articles I, II and IV, as well as cryogenic electron 
microscopy (cryo-EM) to investigate the fine structure of protein-membrane 
adhesions in Articles I and II. Additionally, small-angle neutron scattering (SANS) 
was used to study the detergent-bound structure of MBP, to complement detergent-
free experiments carried out using SAXS in Article I. 
 
3.7.1. ELECTRON MICROSCOPY 
TEM is a method capable of direct imaging of a sample using electrons, providing 
information about the density and structure of the sample. A spray of electrons is 
generated and focused on the sample, and the amount of electrons that are transmitted 
through the sample are measured using an area detector. Negative staining, which 
stains the surroundings of the sample structures of interest, can be used to improve 
the contrast within the sample, as less electrons pass through the negative stain than 
through unstained parts of the sample400. TEM can be used to directly visualize the 
size and morphology of lipid vesicles and other lipid structures. It can also be used to 
image supramolecular complexes, and it can be useful in the case of smaller proteins 





In this thesis, TEM experiments were carried out through collaboration in Articles I, 
II and IV, to observe how MBP, P0ct, and the P0ct mutants aggregate or otherwise 
influence the size and morphology of lipid vesicles. TEM data acquisition was carried 
by Dr. Salla Ruskamo at the Biocenter Oulu Electron Microscopy Core Facility, 
Biocenter Oulu, University of Oulu (Oulu, Finland) and Dr. Julia Kowal at the Center 
for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel (Basel, 
Switzerland). 
Cryo-EM is a method used to obtain high-resolution electron micrographs from 
unstained samples in vitrified ice, usually obtained through sample immersion into 
liquid ethane. By the use of cryogenic temperatures, molecular movement and 
tumbling in samples are slowed down substantially, enabling detailed imaging and 
structural characterization of proteins and other nanoscale structures. The 
development of advanced area detectors with very low noise has allowed the accurate 
detection of transmitted electrons, pushing the resolution limit of TEM even further 
and essentially removed the need for contrast-enhancing agents in sample 
preparation402. 
In this thesis, cryo-EM experiments were performed on lipid-bound MBP and lipid-
reconstituted full-length P0 in Articles I and II. The experiments were carried out by 
Dr. Salla Ruskamo and Dr. Julia Kowal at the Center for Cellular Imaging and 
NanoAnalytics, Biozentrum, University of Basel (Basel, Switzerland). Full-length P0 
isolated from bovine nerves was obtained from Prof. Paolo Riccio, University of 
Basilicata (Potenza, Italy). 
 
3.7.2. SMALL-ANGLE NEUTRON SCATTERING 
Like in SAXS, SANS records the intensity of scattered radiation by particles in 
solution at small θ angles, expressed as a function of momentum transfer, s (or q). 
Neutrons are scattered by atomic nuclei, where the same scattering rules apply as in 
NR. Therefore, SANS measurements can be used to distinguish between the 





in determining the conformation of a detergent-bound protein403. By mixing H2O and 
D2O, solvent scattering can be matched to the scattering of the detergent, allowing the 
scattering of the protein to be separated from the detergent scattering. By subtracting 
a background scattering curve, the protein scattering alone can be extracted, and 
subsequently analyzed and used for modeling, similarly to SAXS data. 
In Article I, SANS measurements were carried out for MBP in the presence of DPC. 
The SANS experiment was carried out by Dr. Salla Ruskamo and Dr. Anne Martel at 
Institut Laue-Langevin (Grenoble, France). The obtained scattering curve was used to 
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4.1. ARTICLE I 
The study outlined in Article I was undertaken to apply a vast selection of 
biophysical methodology to study MBP and MBP-like proteins. The objective was to 
establish these methods to be used as tools in the characterization of MBP and other 
similar proteins, and to gain a deeper insight into the function of MBP in the stability 
and formation of the MDL and compact myelin, particularly in the CNS. 
An intact MBP construct corresponding to the mouse 18.5–kDa isoform was 
successfully expressed and purified. The construct lacked an affinity tag after the 
final purification steps, as confirmed using mass spectrometry. The initial 
characterization and QC using SDS-PAGE, SEC, DLS, SAXS and SRCD indicated 
that MBP was pure, monomeric, monodisperse and conformationally extended in 
solution, while presenting very low levels of regular secondary structure content 
(Article I, Fig. 1a-c, Supplementary Fig. S1). Further SRCD experiments showed 
that MBP folded in the presence of DPC, SDS and TFE, but not with OG or LDAO, 
indicating a tendency to gain structure when introduced to certain dielectric 
environments (Article I, Supplementary Fig. S1d). EOM analysis of the SAXS data 
showed that the scattering of MBP in solution was best described by a wide ensemble 
of conformational states, rather than a fully elongated random coil (Article I, Fig. 1c, 
Supplementary Table 1). SANS experiments revealed that DPC-bound MBP 
collapsed into a clearly more compact state, but it still remained fairly elongated 
(Article I, Fig. 1d-f). 
To gain an insight into the membrane interaction and subsequent folding of MBP, 
SRCD spectra were measured of MBP mixed with SUVs of various lipid 
compositions. The negative surface net charge of selected lipid compositions, such as 
equimolar mixtures of DMPC:DMPG and DOPC:DOPS, induced folding, whereas 
the net neutral lipids DOPC and DMPC did not, confirming that the membrane 
association is driven by electrostatics. The folding of MBP was slightly favored by 
DM-lipids compared to DO (Article I, Fig. 2a). 
As compact myelin is rich in cholesterol, SM and PE, we studied an equimolar 





but none of the introduced additives affected folding significantly (Article I, Fig. 2b). 
To determine the effect of MBP on the behaviour of lipids themselves, DSC 
measurements were carried out using MLVs of DMPC:DMPG mixtures at 1:1, 4:1 
and 1:0 molar ratios. The presence of MBP affected the phase transition behaviour of 
DM hydrocarbons as a function of temperature, without significantly altering the Tm 
itself. The effect was increased with higher protein concentrations, as well as with 
more negatively charged lipids, and absent in net neutral headgroups (Article I, Fig. 
2d). SRCD temperature scans around the Tm of DMs showed no effect on the 
conformation of MBP, indicating folding independence from the lipid phase itself 
(Article I, Fig. 2c). 
The interaction of MBP with immobilized LUVs of DMPC:DMPG and DOPC:DOPS 
was studied using SPR. MBP irreversibly bound to both lipid compositions. The 
headgroup net charge is the same for both compositions, and similar apparent Kd 
values were obtained in both lipid mixtures. Interestingly, DM-lipids could 
accommodate more bound MBP than DO-lipids, indicating an effect by lipid 
hydrocarbon saturation in the quantity of bound protein (Article I, Fig. 2e, Table 1). 
Noteworthy was that the association phases of binding could not be fitted confidently 
into simple mathematical models, suggesting several surface processes being present 
during binding (Article I, Supplementary Fig. S3). 
As MBP is known to be a classical membrane stacking protein70, its stacking function 
was investigated by imaging MBP-treated DOPC:DOPS SLBs using AFM. The data 
showed that MBP needs to associate with net negatively charged membranes above a 
certain concentration to produce de novo membrane stacks of physiologically relevant 
thickness. Cholesterol was not essentially required for this function89, but including it 
enhanced the stacking effect notably, without influencing the required critical MBP 
concentration (Article I, Fig. 3a). To look into this effect further, turbidity 
measurements were performed using DMPC:DMPG and DOPC:DOPG vesicles with 
and without added cholesterol. The level of SUV aggregation was not significantly 
different between the choice of lipid saturation degree or cholesterol content (Article 





SAXD data was collected from MBP-aggregated DMPC:DMPG SUVs. A Bragg 
peak at P/L 1:100 (Article I, Fig. 3a), corresponding to a repeat distance of 80 Å, was 
observed. The value is in corroboration with earlier diffraction studies as well as 
dimensions observed cryo-EM micrographs of endogenous myelin42, 45, 94. 
Since AFM and SAXD studies allowed the formation of myelin-like membrane 
stacks using SLBs and SUVs, TEM and cryo-EM imaging were carried out for SUVs 
mixed with MBP. The lipid compositions were chosen to be net negatively charged, 
and aggregated vesicles could be imaged successfully (Article I, Fig. 4a, 
Supplementary Fig. S4). Using MBP-His, the protein could be labeled with 
nanogold and localized between adhered SUV interfaces (Article I, Fig. 4a). Cryo-
EM imaging illustrated that MBP formed a continuous 2.5-nm protein phase between 
two apposed membranes, rather than well-defined, globular protein particles – this 
phase separation had been suggested earlier206. The measured stack thickness was 
similar to that of myelin (Article I, Fig. 4b-c)42. 
Interested in the membrane association mode of MBP, NR studies were carried out on 
an MBP-treated SLB. MBP associated and inserted into a depth of 3 nm within the 
membrane, but formed an additional ~7–8-nm protein layer over the membrane 
surface (Article I, Fig. 5a, Table 2, Supplementary Table 3). The size of DPC-
bound MBP in SANS was similar to this (Article I, Fig. 1f). Time-resolved NR 
measurement series were performed with a similar sample setup, where the 
association of MBP with a membrane, subsequent folding, and finally insertion could 
be observed (Article I, Fig. 5b). 
In conclusion, a biophysical workflow was established to study MBP and proteins of 
similar function in membrane-adhesion and stacking. The study revealed the MBP-
driven molecular landscape of MDL formation: the irreversible lipid association, 
charge neutralization, and folding of MBP into a pre-stack conformation on a single 





4.2. ARTICLE II 
In Article II, the established methodology from Article I was implemented in the 
characterization of P0ct as a potential membrane stacker at the MDL. The folding of 
the neuritogenic peptide segment of P0ct in membrane-like environments was 
investigated. Additionally, experiments on full-length P0, purified from bovine 
nerves, were conducted to understand its oligomeric state and molecular architecture 
between adhered membranes in the IPL. 
A P0ct construct that was straightforward to express and purify was generated. The 
protein appeared as a single band in SDS-PAGE. While mass spectrometry confirmed 
the size of P0ct to have the expected mass of 8 kDa, the protein migrated 
ambiguously in SDS-PAGE. Further QC revealed that P0ct was aggregation-free and 
monomeric in solution as shown by SEC-MALS (Article II, Supplementary Fig. 
S1a). 
SAXS and SRCD measurements demonstrated that P0ct was highly extended, lacking 
major regular secondary structure content like MBP in Article I, and behaved like an 
ensemble of disordered chains as suggested by EOM analysis (Article II, Fig. 1, 
Supplementary Fig. S1a-b, Supplementary Table 1). Further SRCD studies 
revealed that increasing TFE content as well as the presence of SDS and DPC 
induced folding, whereas LDAO and OG did not, essentially demonstrating very 
similar behaviour to MBP (Article II, Supplementary Fig. S1b). 
Very similarly to MBP in Article I, P0ct bound irreversibly to negatively charged 
lipid structures with similar affinity as MBP and folded in the process, as shown by 
SPR and SRCD, respectively (Article II, Fig. 2a-b,d, Table 1, Supplementary Fig. 
S2, Supplementary Table 2). The folding of P0ct was influenced by the presence of 
SM and cholesterol, unlike in the case of MBP, suggesting that these lipid types, or 
their phase behaviour, can influence the folding of P0ct (Article II, Fig. 2b). 
P0ct had previously been suggested to form β-sheet-rich structures in myelin244, and 
to investigate this, we studied the folding of P0ct in the presence of native myelin- 





of β-sheet-rich structures, but a mixed secondary structure content was observed. The 
folding of P0ct was notably different between the two lipid compositions. 
Importantly, the native-like myelin composition produced a similar SRCD spectrum 
to the ones observed in model lipid compositions, validating the simplified approach 
to study P0ct (Article II, Fig. 2b). 
In DSC, P0ct behaved differently compared to MBP. Addition of P0ct to MLVs 
produced a separate population of lipids that presented a Tm value 1.5 – 2.0 °C lower 
than expected for DMs, depending on P/L ratio. This indicated that P0ct strongly 
interacts with lipids and segregates them in thermodynamic behaviour (Article II, 
Fig. 2e). 
To study the potential membrane stacking function of P0ct, vesicle aggregation 
studies using visible light turbidimetry, SAXD, AFM and TEM were performed. P0ct 
was able to induce turbidification of DOPC:DOPG and DMPC:DMPG vesicles with 
and without 10% cholesterol (Article II, Fig. 3a), but as opposed to MBP (Article I), 
cholesterol seemed to increase the observed level of turbidity. 
SAXD produced two intensive diffraction peaks (peak 1 and 2) when P0ct was mixed 
with DMPC:DMPG SUVs. The diffraction peaks moved as a function of P/L ratio, 
and increasing protein concentration tightened the observed repeat distance. The 
distances varied between 75 – 81 Å, based on peak 1, and peak 2 behaved like a 
harmonic of peak 1 (Article II, Fig. 3b-c). This suggested the presence of 
multilamellar systems, but surprisingly, multilamellar structures could not be detected 
in AFM or TEM (Article II, Fig. 3d, Fig. 4). 
In AFM, P0ct was able to accumulate on the imaged SLBs and increase their 
thickness by up to 2 nm. P0ct also changed the mechanical properties of the 
membrane in thickened patches (Article II, Fig. 3d). In the TEM experiments, SUVs 
treated with P0ct seemed to form larger lipid bodies, indicating that P0ct could induce 
vesicle fusion (Article II, Fig. 4a-f). These lipid bodies sometimes formed loose 
aggregates, but myelin-like multilamellae were not observed unless the P/L ratio was 





endogenous protein fraction of P0ct. With these observations at hand, P0ct can 
putatively act as a membrane bridging protein, although it does not spontaneously 
form repetitive stacks that were observed with MBP in Article I. 
Interested in the structure of the neuritogenic region in P0ct, the folding of the 
segment was studied through SRCD measurements and molecular modeling of the 
20-residue peptide P0ctpept (Article II, Fig. 5). The peptide was disordered in water, 
but gained helical structure in the presence of TFE, SDS, and DPC (Article II, Fig. 
5b). Interestingly, SDS was able to fold P0ctpept more than 70% TFE, indicating a 
great contribution of charge neutralization in the folding process. Negatively charged 
lipid SUVs induced folding of P0ctpept, whereas net neutral lipid SUVs did not 
(Article II, Fig. 5a). 
The orientation of P0ctpept in SLBs was studied using OCD: P0ctpept adopted a nearly 
perpendicular orientation in the SLBs when negatively charged lipids were present 
(Article II, Fig. 5c). Modeling of P0ctpept resulted with the first eight N-terminal 
residues modelled as a flexible chain, followed by a Pro residue, another eight 
residues that were modelled as an α-helix. The remaining three C-terminal residues 
remained flexible. The N-terminal flexible part was rich in Arg and Lys, and given 
the correct electrostatic environment, such as negatively charged phospholipid 
headgroups, this part may also adopt a helical conformation and reside in the 
headgroup region of a membrane (Article II, Fig. 5d-e). 
Experiments on the oligomeric state and stacking-architecture of full-length bovine 
P0 were performed (Article II, Fig. 6). SEC-MALS experiments uncovered the 
existence of P0 as dimers and tetramers as reported previously236-238. The 
oligomerization depended on the chosen detergent, with DPC inducing 
tetramerization (Article II, Fig. 5b-c, Supplementary Fig. S3). DPC is noteworthy 
as P0ct also gained secondary structure content in the presence of this detergent. P0 
was able to form membrane stacks regardless of the chosen lipid species, and cryo-
EM experiments unraveled an intermembrane zipper composed of Ig-like domains, 





arrangement suitable for an earlier proposed homophilic dimerization mechanism 
based on crystal packing227 (Article II, Fig. 5d-f). 
To conclude, P0ct is hereby described as a potential structural factor in myelin, which 
might as such contribute to intermembrane stacking. P0ct might form an ordered 
system within membranes and detergents, contributing to the formation of the 
physiologically relevant oligomeric state of P0 in the IPL. Investigations on P0ctpept 
revealed the folded nature of this segment when bound to lipids, which might have 
relevance in anchoring P0ct tightly to the membrane. The study opens up new 
approaches in the functional characterization of P0 mutations that ultimately cause 
CMT or DSS. 
 
4.3. ARTICLE III 
The effect of ionic content and divalent cations has been shown to influence the 
function of MBP197, 200, 201, and similar effects could potentially be extrapolated to 
P0ct. Hence, in Article III, vesicle aggregation and CD studies were employed in the 
characterization of MBP and P0ct in the presence of various salt and Ca2+ 
concentrations. 
The studies performed in Articles I and II were complemented by performing MBP- 
and P0ct-induced turbidimetry of DMPC:DMPG 1:1, 4:1 and 9:1 SUVs, with 
emphasis on assessing the effects of different concentrations of NaCl, NaF and CaCl2. 
In addition to NaCl, NaF was chosen as a salt due to its compatibility with CD, which 
was carried out later in the study. CaCl2 was included due to the fact that compared to 
other biological compartments, myelin is abundant in Ca2+,35 which is involved in 
signaling404-406 but also likely binds phospholipids due to the crowdedness of 
headgroups in the water-deficient MDL. 
CaCl2 at the used concentrations (0.5, 1.0 and 1.5 mM) was able to induce turbidity in 
lipid samples without proteins, with more CaCl2 being required for turbidity when the 





vesicle turbidity at the chosen concentrations of 75, 150 and 300 mM (Article III, 
Fig. 1a-c). 
MBP generally induced higher levels of turbidity than P0ct, especially in the presence 
of NaCl and NaF. The measured P0ct-induced turbidity levels were much less 
boosted by NaCl and NaF compared to salt-free conditions. While the levels observed 
in NaCl and NaF samples were not fully identical, the concentration-dependent trends 
in each lipid composition were the same (Article III, Fig. 1a-c). In DMPC:DMPG 
(9:1), a turbidity boost was only observed in 75 mM salt concentration, whereas 
anything above that plummeted to a level comparable to control samples without 
protein. Additionally, in the absence of salt, P0ct was more efficient in turbidification 
than MBP in this lipid composition (Article III, Fig. 1c).  
The concentration of CaCl2 in the experiments was only a fraction of the other salts, 
but still induced vesicle turbidity compared to salt-free conditions. Significant 
turbidification was present in protein-free samples as well, and the levels of turbidity 
varied between CaCl2 concentration and vesicle net charge (Article III, Fig. 1a-c). 
1.5 mM CaCl2 was required for aggregating DMPC:DMPG (1:1) SUVs, whereas 
(4:1) SUVs were aggregated efficiently at 1.0 and 1.5 mM CaCl2 and (9:1) SUVs 
only aggregated at 0.5 mM CaCl2. The level of aggregation in the latter case was 
much lower than for the other two lipid compositions (Article III, Fig. 1c). 
The turbidity induced by CaCl2 was inhibited by the presence of proteins – and the 
other way around. An almost comparable level of protein-induced turbidity was 
observed in DMPC:DMPG (1:1) regardless of the tested CaCl2 concentrations, and in 
this lipid composition, the turbidity levels were lower than those observed in 1.0 and 
1.5 mM CaCl2 in the absence of protein (Article III, Fig. 1a). In DMPC:DMPG 
(4:1), protein-induced turbidity dropped sharply at 1.5 mM CaCl2 (Article III, Fig. 
1b), and in DMPC:DMPG (9:1), only low turbidity levels were detected, the highest 
at 0.5 mM CaCl2, which was already significantly lower than in salt-free conditions 





SRCD experiments were performed to investigate the folding of MBP and P0ct in the 
presence of salt and Ca2+. Since similar turbidity levels were observed with NaCl and 
NaF, 150 mM NaF was chosen as the salt to increase ionic strength, as NaCl is 
incompatible with CD. While the CD spectra of MBP and P0ct were unaffected by 
the presence of salt or calcium in the absence of lipids or in the presence of 0.5% SDS 
(Article III, Supplementary Fig. S1), the spectral magnitudes in the presence of 
lipids decreased with the additives (Article III, Fig. 2a-c). The positions of the peaks 
indicated that the folding of the proteins were similar in the different ionic conditions 
within the same lipid compositions, with the exception of DMPC:DMPG (9:1), in 
which the proteins appeared much less folded with salt and Ca2+ (Article III, Fig. 
2c). 
Initially, SRCD-coupled stopped-flow experiments were undertaken to study the 
folding kinetics of MBP and P0ct when encountering SUVs of different 
DMPC:DMPG ratios in the presence of 150 mM NaF or 1 mM CaCl2. Unfortunately, 
these kinetics were too rapid to follow in practice, as the folding was completed 
within the dead time of the used instrument (data not shown). An unexpected kinetic 
behaviour was observed in conditions containing NaF or CaCl2 – a strong decay in 
the CD signal within 5 – 10 s, which in most cases could be fitted into one- or two-
step exponential functions (Article III, Fig. 3, Supplementary Table 1). This was 
speculated to be initial vesicle nucleation, as the measurement wavelength of 195 nm 
was in a similar range to the size of LUVs or small SUV aggregates, and the effect 
occurred with CaCl2 in the absence of proteins as well. 
DMPC:DMPG (1:1) SUVs aggregated slower in the presence of 1 mM CaCl2 than 
DMPC:DMPG 4:1 and 9:1 SUVs, owing to the underlying electrostatics (Article III, 
Supplementary Fig. S2, Supplementary Table 1). In the presence of proteins, the 
fast turbidification process of DMPC:DMPG (1:1) stands out from the other two lipid 
compositions, as the effects of NaF and CaCl2 on k1 increase with the fraction of 
DMPG. In the case of MBP, the ratio of the two obtained rate constants increases in a 





(Article III, Fig. 3b). Here, the highest ratio arises from the low k2 value (Article III, 
Supplementary Table 1). 
In DMPC:DMPG (9:1), the obtained rate constants were almost equal for samples 
with CaCl2 regardless of the presence of proteins, suggesting a dominant behaviour 
from the cation itself (Article III, Supplementary Fig. S2, Supplementary Table 
1). MBP and P0ct were only able to aggregate vesicles in the absence of any salts, 
and these observations correlate with the steady states observed in turbidimetric 
experiments (Article III, Fig. 1c, 3b). In the other lipid compositions, protein-
induced aggregation was practically absent when compared to background samples 
(Article III, Fig. 3b-c). 
In conclusion, the effect of ionic strength and Ca2+ on MBP and P0ct mediated vesicle 
turbidification and the involved kinetics was studied. It became evident that the 
presence of a monovalent salt enhances the observed turbidification, but only to the 
extent to which protein-lipid charge neutralization can occur to produce protein-
mediated lipid bridging. As apparent from the chosen concentrations, Ca2+ interacts 
much more specifically with the lipids, as concentrations around 1 mM can influence 
the activity of proteins. Similarly, the effect of calcium as a lipid turbidifier is 
influenced by MBP and P0ct.  
A novel SRCD-based method was described in following rapidly forming vesicle 
bodies that cause sample turbidity. While our kinetic data correlates with steady states 
from turbidimetry, what kinds of processes specifically are described by k1 and k2 is 
still uncertain. A notable observation was that k1 changed most between different 
sample setups, whereas k2 remained unchanged. Therefore, k1 values were mostly 







4.4. ARTICLE IV 
The study undertaken in Article IV was to broaden the existing knowledge stemming 
from Article II to include the known disease point mutations within P0ct, essentially 
to uncover any molecular effects that arise from these mutations and how these 
possibly result in peripheral neuropathies. More specifically, these mutations were the 
six known mutations in P0ct, all related to CMT and DSS332, 334-339: T216ER, A221T, 
D224Y, R227S, K236E, and K236del (Article IV, Fig. 1a).  
Mutations were individually generated using the P0ct construct from Article II via 
site-directed mutagenesis, producing six disease mutant variants. The presence of the 
mutations was verified by DNA sequencing and subsequent mass spectrometric 
characterization after successful protein purification (Article IV, Table 1). All 
mutants but one behaved very similarly to the wild-type protein in terms of 
expression and purification. The outlier, D224Y, had significantly lower expression 
levels and yields (Article IV, Table 1, Supplementary Fig. S1), and appeared to 
undergo minor degradation during expression. More interestingly, the mutant could 
not be subjected to SEC in the standard buffer used for the chromatography of P0ct, 
but instead, a buffer with a higher salt concentration and increased pH was required, 
which influenced the retention time of the mutant variant (Article IV, Fig. 1b). 
Similar QC as described in Articles I and II was performed using SEC, SAXS, DLS 
and SRCD, and freely in solution the mutants were monomeric, monodisperse, and 
disordered, just as the wild-type (Article IV, Fig. 1b-c, Fig. 2, Fig. 3a, 
Supplementary Fig. S2, Supplementary Tables 1-2). SRCD experiments with TFE 
and various detergents demonstrated that all proteins folded in an identical manner to 
the wild-type, with the exception of K236del, which seemed to gain more secondary 
structure content than the other variants in the presence of SDS (Article IV, Fig. 3b-
c, Supplementary Fig. S2). 
We characterized the folding of P0ct wild-type and mutants using SRCD, similarly as 
in Article II. In water, all variants presented an identical level of folding, and in 
DMPC, none of the variants gained secondary structure content. D224Y deviated 





DMPC (Article IV, Fig. 3a, Supplementary Fig. S2g). Notable differences were 
present in lipids with different ratios of DMPC and DMPG. In DMPC:DMPG (1:1), 
the spectra of P0ct wild-type and K236E were slightly more intensive in magnitude 
than the others, but generally all variants had the observed peak minima and maxima 
close to the same wavelength values. D224Y deviated from the other variants 
producing the two minima observed at 208 and 222 nm at almost equal magnitude, 
whereas in the other variants the minimum at 208 was significantly more pronounced 
(Article IV, Fig. 3d). The folding of all variants were more comparable in 
DMPC:DMPG (4:1). Here, the folding of all variants was seemingly the same, with 
D224Y deviating more obviously from the others, presenting a slightly higher degree 
of secondary structure content (Article IV, Fig. 3e). In DMPC:DMPG (9:1), the 
spectral magnitudes varied drastically from one another, with the wild-type and 
K236E again showing the most intensive spectra. The magnitude variation was from 
the inevitable aggregation within samples, resulting in loss of signal due to light 
scattering. This led us to interpret the data cautiously. From the two minima, it 
seemed that D224Y deviated most from the other variants, with T216ER, A221T and 
K236del producing marginally shifted peak minima compared to wild-type, R227S 
and K236E (Article IV, Supplementary Fig. S2h).  
SPR experiments were carried out using DMPC:DMPG (1:1) LUVs, similarly to 
Article II. The obtained Kd values for all variants were in a similar range, but a 
notable difference to the wild-type and other mutants was D224Y, which could 
accumulate in higher amounts to the immobilized lipids (Article IV, Fig. 3f, Table 
2). 
We continued the characterization by performing DSC measurements similarly to our 
past studies. We increased the amount of lipids in the experiment to gain a better 
baseline level and to reduce noise. The trends seen for the P0ct variants were 
reproducible, and a separate lipid population with a Tm formed as in Article II. The 
mutants had minor effects on this behaviour: K236E and K236del reduced the Tm 





different from the others, producing a wider, less symmetric transition, which might 
be a product of several smaller overlapping peaks (Article IV, Fig. 4a). 
Vesicle turbidimetry was carried out to quantify the lipid aggregating/fusing effects 
of the variants. Statistical analysis revealed that at 1:100 P/L, D224Y, R227S and 
K236E produced significantly reduced turbidity (P<0.001) and the effect with 
K236del was slightly reduced (P<0.05). At 1:50 P/L ratio, the only mutant with 
strongly reduced turbidity was still D224Y. K236E also produced a weak but 
statistically significant turbidity reduction (Article IV, Fig. 4b, Supplementary Fig. 
S3). 
To understand the impact of mutations on molecular order in lipid-bound P0ct, 
SAXD measurements were performed similarly to Articles I and II. While all 
variants presented a similar trend of molecular distances as a function of P/L ratio, 
some subtle differences in either the increment rate or distances themselves were 
observed. Most notable ones were D224Y, which presented distances systematically 5 
– 8 Å shorter compared to wild-type. R227S, K236E, and K236del, on the other hand, 
displayed increased distances, indicating looser packing. K236E generally produced 
the most loosened distances across the used P/L range (Article IV, Fig. 4c). 
To directly observe the effect of P0ct variants on vesicles, TEM studies were 
performed. For all variants except D224Y, we observed large lipid bodies that formed 
from SUVs, some of which were loosely attached or aggregated to one another. In the 
presence of D224Y, dense multilamellar structures formed, which resembled those of 
stacked bilayers in compact myelin (Article IV, Fig. 5). These lamellae appeared 
more ordered and denser at increasing lipid fraction, although the measured repeat 
distances evolved oppositely in SAXD (Article IV, Supplementary Fig. S4). 
As in Article III, stopped-flow SRCD kinetics were performed in the presence of 150 
mM NaF for DMPC:DMPG SUVs with P0ct variants at 1:200 P/L (Article IV, Fig. 
6a). The obtained kinetic constants from all experiments were in a similar range for 
all variants, with K236E and K236del presenting k1 values and thus k1/k2 values 





fast process. D224Y produced a k1 value about 10% higher compared to wild-type 
(Article IV, Fig. 6b, Table 3). Due to an unclear effect, the kinetic starting level of 
K236del was notably higher compared to the other variants, and reproducibly 
remained as such for ~0.3 s. The end level of all variants was identical after the 5 s 
measurement period ended (Article IV, Fig. 6a). 
To investigate the membrane-binding mode of P0ct on a single SLB, NR 
measurements were performed similarly to MBP in Article I (Article IV, Fig. 7a). 
P0ct was observed embed almost entirely in to the membrane, producing only a 
marginal exposed protein layer, unlike MBP. The thickness, roughness, and water 
content of the membrane increased in the presence of P0ct (Article IV, Fig. 7b-c, 
Table 4). The SLB thickened by 2 nm, which corresponded to what was measured in 
AFM (Article II, Fig. 3d). Furthermore, NR data was collected for D224Y, but no 
observable difference to wild-type was present after binding (Article IV, 
Supplementary Fig. S5). 
To conclude, a fully embedded membrane association mode of P0ct has been 
observed, and that the mutations at hand do not seem to affect this. Most mutants 
characterized here behaved much like the wild-type protein, especially T216ER and 
A221T, which suggests their disease mechanisms are not directly related to their 
function in mature compact myelin or its formation.  
Based on this characterization, the functionally most unique mutant, D224Y, is 
capable of forming membrane multilayers efficiently, thus resembling MBP in its 
mode of action rather than P0ct wild-type. 
While the effect of R227S, K236E and K236del were much less dramatic than 
D224Y, we identified Arg227 and Lys236 as potentially important amino acids in the 
function of P0ct. Mutating Lys236 decreased the amount of vesicle turbidity and the 
rate of vesicle aggregation, as well as loosened the molecular order as shown by 
SAXD, with the charge-inverting K236E pronouncing the effect more than the 



































Compact myelin is novel from a biological perspective. Immensely rich in lipids, the 
unique proteome within and the absence of water make it stand out from other 
systems. The formation and stability of compact myelin needs to be considered if one 
wants to understand demyelinating conditions. MBP is a central protein in the 
formation of the MDL in the CNS, and one of the most abundant myelin proteins in 
general66. In the PNS, P0 makes up the major fractions of all proteins82, and its 
importance in myelin stability is reflected by numerous disease mutations332, 333, 335, 
336. In the current study, MBP and P0ct were studied using a biophysical approach to 
unravel their function and folding in myelin compaction, as well as the effect of ionic 
factors that influence these. Additionally, point mutant variants of P0ct were 
characterized to unravel any determinants in the molecular etiology of CMT. Since a 
strictly biophysical approach was used, the involved methods and samples will be 
discussed, before moving on to more biologically relevant aspects. 
 
5.1. METHODOLOGICAL CONSIDERATIONS 
5.1.1. RESEARCH MATERIAL AND QUALITY CONTROL 
This study focused on the detailed biophysical characterization of biomolecules 
centrally involved in the formation and maintenance of the vertebrate myelin sheath. 
A variety of biophysical techniques were used, and simplified, controlled conditions 
were employed in the experiments. This essentially involved the use of synthetic 
lipids and recombinant proteins, which could be obtained in high amounts. 
The proteins were designed to be label- and tag-free to avoid any artifacts arising 






certain conditions, which might influence electrostatic binding to phospholipids and 
introduce unwanted metal cation coordination. On the other hand, given the small size 
of P0ct, a His-tag composed of six His residues would increase the length of the 70-
residue construct by almost 10%, which in turn can influence its physical behaviour. 
Solid protein QC throughout the project enabled robust reproducibility of downstream 
experiments. Achieving proper protein integrity, purity, monodispersity, and stability 
was crucial, as the goal was to obtain data that specifically represent the functional 
and structural behaviour of MBP and P0 under controlled conditions. Effects arising 
from aggregation, degradation, or oxidation were minimized. The chosen QC 
methods complement each other in the data they provide: the use of mass 
spectrometry, SDS-PAGE, and SEC(-MALS) supported each other by providing the 
mass and purity of the proteins at different levels of accuracy. Another example is the 
use of DLS, SAXS, and SEC-MALS, which not only provide useful parameters, like 
molecular weight, Rg, and Rh, but they are all especially sensitive in probing 
aggregation within the samples. Therefore, at times when only some of the methods 
were available, other methods were used to gain complementary information 
 
5.1.2. MYELIN BASIC PROTEIN, THE REFERENCE MOLECULE 
The goal of this study was to study the biologically relevant structure-function 
relationships of abundant myelin proteins. This was achieved using a biophysical 
setup that allowed thorough characterization of the lipid binding and membrane 
stacking properties of basic proteins. Decades of work has been devoted to the 
characterization of MBP before the conception of this study, providing a substantial 
amount of reference data, as extensively reviewed before70, 168, 342, 407, 408. 
Based on earlier literature, the tag-free recombinant MBP construct behaved (Article 
I) as expected in AFM89, CD171, turbidimetry197, 210, SAXD94, and SAXS171, 172. This 
increased the confidence in the recombinant protein material and simplified lipid 
compositions, allowing the development of a workflow for the characterization of 





gangliosides409-411, but the impact of MBP on mixtures consisting of net neutral and 
negatively charged lipid species had not been performed. NR had been used to study 
MBP before, but as opposed to the DMPC:DMPG (1:1) SLBs used here, DMPA 
membranes were used412, and no membrane insertion of the protein was observed. 
This may be an artifact of the heavily acidic lipid headgroups – the lipid compositions 
chosen for Article I reflected the expected physiological function of MBP and 
unveiled a substantial insertion of MBP to the SLB. 
In this study, all experiments were performed without protein labeling. This is of 
major importance considering the function and natural environment of myelin 
proteins. The cytoplasmic compartment of compact myelin is very narrow, which 
excludes large tags, such as GFP65. The methods used in the current work follow the 
intrinsic molecular attributes of the proteins and lipids, abolishing the need of tags 
that can interfere with the experiments. 
On the downside, there are certain aspects that can decrease the attractiveness of the 
described methods. One factor is the required protein purity and monodispersity. 
These are absolutely needed if one wants to follow a single attribute in a meaningful 
way, as several methods are based on absorbance, which does not distinguish between 
oligomeric states, and scattering, which is sensitive to molecular size and order. 
Considering the size of the proteins, reasonably high concentrations of purified 
proteins are required for the characterizations at hand – this can be practically 
difficult, especially if the study of PTM variants is desired, most often omitting 
bacterial expression systems. Finally, some methods required fairly concentrated 
samples. SAXS and SANS are notable examples, as the quality of the measured 
scattering pattern improves directly with concentration. The concentrations used in 
experiments may not be physiologically relevant, and this might translate into 
observations that show more compacted protein folds than present in vivo, since 
molecular crowding can affect the folding behaviour of individual proteins413, 414. 
The limiting factor of biophysical studies is often either the stability of the studied 
protein, or its yield per purification. QC was established to rule out sample stability 





Many of the used methods are rather sensitive, allowing characterization of a single 
protein batch using several approaches and controls. For example, with SRCD, the 
purified proteins were always tested for expected folding, usually in water, in the 
presence of a detergent, and with a standard lipid composition. Individual protein 
batches behaved well with respect to each other; more variation was observed 
between lipid batches. Therefore, control experiments were carried out always when 
lipids were used, most notably in CD, in which the observed spectral magnitudes are 
very sensitive to aggregation-induced light scattering415. Such experiments were 
needed to gain high reproducibility, as evident from the small standard deviations in 
Articles I – IV. 
One notable limitation within the study was the employment of PG and PS lipids in a 
mixed fashion. Both lipids are negatively charged at physiological pH, but present 
different headgroup structure. This adds another variable to the sample material. The 
optimal solution would be to employ only PS or PG in all samples, but as explained 
and justified in Chapter 3.2., we included both headgroups as DOPS or DMPG as the 
major negative lipids, partially due to their physiological significance, but also based 
on their physical characteristics. 
 
5.2. THE FORMATION OF THE MAJOR DENSE LINE 
The experiments carried out in Article I allowed to uncover new aspects of MDL 
formation and the pivotal role of MBP therein. Most notably, the involved molecular 
interactions, the role of cholesterol, the conformation of MBP on a single membrane, 
and the MBP concentration dependency in membrane stacking were studied. 
The disordered MBP irreversibly bound negatively charged lipids and folded in the 
process.142, 143, 168-171. In the absence of negative charge components, folding was not 
induced, indicating the absence of binding. This was verified using NR, underlining 
the importance of electrostatic interactions in the activity of MBP. Comparison of 
lipid saturation degree had minimal role in the lipid binding and structure of MBP. In 





dominating as the single most abundant fatty acid group55. In saturated lipid 
compositions, however, more MBP could associate with the lipids as shown by SPR. 
DSC revealed an effect on the lipid phase transition behaviour, which indicated that 
MBP could influence the (thermo)dynamic behaviour of the lipid tails, as shown 
before90, 416, 417, possibly through membrane insertion. 
The formed lipid aggregates displayed a repeat distance that corresponded to the 
width of the MDL, around 3 nm43, between bilayers, and this was confirmed using 
AFM where multilayered membranes formed after a sufficient surface-bound MBP 
concentration was reached. The real amount of bound MBP on the membranes is 
difficult to estimate in our experiments, hence, it is difficult to draw conclusions on 
how the surface bound MBP concentration and stacking induction are related in terms 
of the apparent Kd determined using SPR. 
The presence of cholesterol was earlier postulated to be essential for the formation of 
stacked membranes89, but the current study contradicts this, as stacked membranes 
formed in cholesterol-free SLBs as well. However, the past study is not fully 
comparable with the current one since the lipid composition was different, especially 
considering the fraction of negatively charged lipid species89. In the current study, the 
presence of cholesterol did, however, visibly enhance membrane stacking, most likely 
due to altering the fluidity of the membranes. In turbidimetry, inclusion of cholesterol 
did not display a significant effect, suggesting that the enhanced effect of cholesterol 
arises from elsewhere than intermembrane bridging by the protein. In turbidimetry, 
vesicles tumble freely in solution, which means that given enough time, MBP-
decorated membranes will meet due to Brownian motion and become adhered to each 
other. In SLB systems, like in AFM, SLBs were treated with MBP and no excess 
lipids were added after this, which means that any stacks need to form from the pre-
existing SLBs. Thus, a likely explanation for the observed cholesterol-enabled effect 
could be that the fluidity of the SLBs change, allowing MBP to stack lipids easier 
when cholesterol is present. During myelination, cholesterol-modulated membrane 





MBP60, 61, 350, as cholesterol abundance is crucial for the development of 
oligodendrocytic myelin60. 
Using NR and SANS, a novel conformation of MBP was observed. When MBP binds 
to a single membrane, it partially inserts into a depth of 3 nm and assumes an 
elongated 7–8-nm pre-stacking conformation on top of the membrane. In cryo-EM, a 
dense protein phase in between stacked membranes was observed, rather than 
individual folded MBP particles, which supports the presence of the earlier proposed 
protein meshwork206. During membrane binding, MBP undergoes charge 
neutralization, folding, and insertion to a membrane, but stacking of two membranes 
occurs only when a sufficient concentration of membrane-bound MBP is reached. A 
model outlining the MBP-driven formation of the MDL is proposed (Article I, Fig. 
6), which features the steps described above. 
The proposed model is logical if one considers the translation of MBP, which occurs 
in the vicinity of the membrane during myelin compaction418. As free MBP needs 
binds to the membrane for the entire cascade to proceed spontaneously, the amount of 
MBP is a determining factor in the process. Therefore, the translation of MBP needs 
to be controlled during myelination, and other proteins, most notably the cytoskeleton 
and CNPase, are likely to be involved191, 257, 419, 420. These factors are known to be 
important in the formation of correct myelin morphology102. The proposed model can 
be used to speculate on the development of MS as well, as changes in the translation 
levels, affinity, or folding of MBP will likely affect its association with the 
membranes. The extended MBP conformation in the pre-stack state could leave MBP 
susceptible to proteolysis311, 421, producing peptide fragments displaying antigenic 
properties through molecular mimicry (Fig. 12). The model provides a good starting 
point for further experiments involving citrullination variants of MBP, as well as 






Fig. 12. The role of MBP in the formation of membrane stacks and disease. The 
translation levels of MBP (red) govern the fate of MDL formation. The destabilization of 
compact myelin and the formation of an autoimmune response can be speculated to arise 
from a lagging pre-stack state, which does not form stable membrane stacks rapidly enough. 
The effect could stem from lowered MBP translation, from PTMs that reduce the net charge 
of MBP and from changes in ionic and lipid content201, affecting the abundance of active 
membrane-bound MBP. Subsequent proteolysis of exposed MBP could form autoantigenic 
peptides, promoting the formation of an autoimmune response. The related loss-of-MBP 








5.3. THE STRUCTURE AND FUNCTION OF MYELIN PROTEIN ZERO IN 
PERIPHERAL MYELIN 
The characterization of MBP in Article I is a starting point for expansion to other 
proteins. P0ct was a logical follow-up candidate, since it had been studied in a similar 
fashion by others243-245, and it might stack myelin membranes similarly to MBP. 
An identical characterization was performed for P0ct as for MBP, which essentially 
revealed similarities between the two proteins: P0ct was disordered in solution, 
irreversibly bound negatively charged lipid compositions and various detergents, and 
displayed significant folding in the process. The affinity towards lipids was very 
similar to that of MBP. In DSC, however, P0ct produced a new population of lipids 
with a destabilized gel phase, which was a clear difference to MBP. This hints that 
P0ct can affect the thermodynamics of the lipids it associates with, which might have 
relevance in the partitioning of P0 into lipid rafts422. 
Cholesterol and SM affected the folding of P0ct, which was not observed for MBP. 
This is notable, as some myelin proteins, like PMP22 that is known to interact with 
P0, are dependent of the presence of SM when forming myelin-like membrane 
adhesion structures63, 240, 423, suggesting that the fluidity of the membrane has an 
impact on P0ct. Therefore, P0ct and lipids most likely affect each other in the 
membrane more than in the case of MBP. Very importantly, the folding of P0ct in 
native myelin-like lipids was similar to the used simplified model lipid compositions, 
suggesting that P0ct does not present a β-sheet-rich fold in vivo244.  
The level of order P0ct induced when bound to vesicles was higher than that of MBP, 
as suggested by the diffraction peaks in SAXD. The membrane-stacking activity of 
P0ct remains slightly obscure, as adding P0ct to SLBs in AFM never induced 
stacking, only association and membrane thickening. In these experiments, the 
protein concentrations were an order of magnitude higher than what was performed in 
similar experiments involving MBP. In EM, P0ct caused SUVs to become larger lipid 
bodies, which appeared to loosely associate with each other. This is likely the effect 
observed in turbidity experiments, and while it is tempting to label P0ct as a 





length P0 in Article II, and P296. More experiments are required to study this aspect: 
microscopy experiments with full length P0 lacking P0ct should be conducted using 
vesicle samples as well as nerve cross-sections from knock out animals. Additionally, 
studying the fine architecture of P0ct-decorated membranes using cryo-EM might be 
advantageous, as TEM using negative staining cannot reach sufficient magnification 
to reveal the interface between P0ct-treated vesicles. While P0ct is small, the putative 
membrane stack it forms is in the same size range as those measured for MBP in 
Article I, which indicates that visualization of P0ct as phase separation or individual 
particles between the membranes should be possible. Given the small size of P0ct, its 
structure elucidation might also be possible through NMR spectroscopy or 
crystallization using lipidic mesophases. To determine whether the observed 
diffraction emerges from P0ct-bridged bilayers or from within a P0ct-embedded 
bilayer itself, grazing-incidence small-angle scattering (GISAS) experiments should 
be performed using a single SLB with bound P0ct. 
P0ct contains a conserved neuritogenic segment which has been previously used as a 
peptide to induce EAE in animals255. This segment was found to fold in net 
negatively charged lipids, similarly to many other peptides that originate from myelin 
proteins324. Differences in folding correlated with the saturation degree of the lipids, 
and the importance of electrostatic neutralization was obvious. OCD showed that in 
the peptide assumes a perpendicular orientation in the membrane. This distinguishes 
P0ct from MBP, for which the known helical segments are thought to insert in a 
horizontal orientation to the myelin membrane, based on their amphipathic character 
observed using helical wheel projections342, 424, 425. The neuritogenic segment might 
function as an important anchor for P0ct in its membrane-bound state, and likely does 
not become exposed to other factors, such as the immune system, in intact, healthy 
myelin. 
Cryo-EM displayed periodic homophilic adhesion between Ig-like domains, which 
was independent of the chosen lipids (Article II, Fig. 2d-f). The spacing between the 
adhered apposing membranes was 5 nm – a physiologically relevant value for the IPL 





domains in a zipper-like arrangement. The crystal packing of the rat P0 Ig-like 
domain (PDB ID 1NEU227) revealed a possible dimerization mode, in which two β-
strands form a short intermolecular β-sheet (Article II, Fig. 7). In this arrangement, 
the C-terminus of each Ig-like domain points towards the membrane, and the C-
terminus is followed by the transmembrane domain in full length P0. SEC-MALS 
revealed dimers and tetramers of P0, as reported earlier236, 237. The oligomeric state 
depended on the chosen detergent: strikingly, tetrameric P0 was present only in DPC, 
which also induced folding of P0ct, raising an important point: the folding of P0ct 
might affect the oligomerization of P0. 
The model proposed for the organization of P0 in membrane stacks is realistic, based 
on the measured distances, which match those of endogenous myelin42, 43, and the 
packing of the crystal structure227. Since the folding of P0ct seems to be coupled to 
the oligomeric state of P0 itself, the measured distances from SAXD data could also 
represent lateral assemblies of P0ct molecules, rather than bilayer bridging, although 
distinguishing between the two is not possible from the measured data. One might 
speculate that an ordered P0ct assembly locks P0 in place, forcing the Ig-like domains 
to adopt an orientation in the IPL that results in productive homophilic adhesion and 
the observed protein zipper. Nevertheless, P0 must harbor a role in MDL compaction 
as well, as mice lacking both MBP and P2 develop normal myelin in the PNS98, and 
the absence of P0 extensively disrupts myelin formation and morphology279. 
 
5.4. THE IMPACT OF IONIC CONTENT ON THE ACTIVITY OF BASIC PROTEINS 
In the studies carried out in Articles I and II, the effect of ion concentration remained 
unconsidered. In Article III, the effects of salt and Ca2+ on the function of MBP and 
P0ct were studied. 
Turbidimetric studies demonstrated the effect of salt concentration of protein-induced 
vesicle aggregation. While only minor turbidification was observed without salt, 
increasing ionic strength boosted vesicle turbidity and the involved kinetics. The net 





was recorded, with vesicles with less negative net charge being more susceptible to 
salt concentration competing with the proteins. MBP generally produced higher 
turbidity levels than P0ct. 
The effect of Ca2+ seems more specific than that of monovalent ions, as suggested by 
the magnitude of differences and the concentrations used of Ca2+ that were 
substantially lower than NaCl or NaF. Ca2+ could induce vesicle turbidity by itself, 
but in the presence of MBP or P0ct, the turbidity levels fluctuated rather little 
between the three Ca2+ concentrations, although Ca2+ generally lowered turbidity 
levels. In each lipid composition, a certain level of Ca2+ became high enough to block 
protein-induced turbidity. Thus, an optimal level of Ca2+ is expected to carry out its 
function in myelin, at least when it comes to membrane-bridging258, as changes in 
ionic conditions or lipid composition might drive the system towards demyelination, 
as already speculated in Fig. 12. 
The kinetics of vesicle aggregation were studied using SRCD, as following protein 
folding was not possible. Such an approach has not been described before. While it is 
unclear what the two obtained kinetic constants actually represent, comparing the k1 
constant for MBP and P0ct revealed that P0ct generally performs its activity slightly 
faster than MBP. This could be due to the smaller size of P0ct, allowing it to interact 
with phospholipids faster than MBP due to Brownian motion. Additionally, since 
proteins bound on the surface of vesicles change the net charge of the surface, MBP 
due to its larger size and higher positive charge could experience electrostatic 
repulsion, as more protein continues to bind the lipids. 
In the end, the study provides new insights into the roles of ionic strength and 
divalent cations in myelin formation and the molecular amounts involved, and 
provide a solid foundation for further studies focusing on the protein affinity and 
involved kinetics of myelin bilayer bridging. Ca2+ is an important ion in myelin at a 
concentration of 1 mM35, being involved in signaling and myelin development201, 404-
406. While too high Ca2+ amounts can be detrimental for myelin stability199, 201, the 
concentration of Ca2+ in myelination needs to be maintained to promote the formation 





direct interaction with both players. Ca2+ is known to bind MBP426, and this study 
highlights the importance of the correct ionic conditions in the activity of MBP and 
P0ct. 
 
5.5. THE EFFECT OF PERIPHERAL NEUROPATHY MUTATIONS ON THE MYELIN 
PROTEIN ZERO C-TERMINAL SEGMENT 
A follow-up study including the known CMT and DSS mutations of P0ct was 
conceived. As in the structural enzymology of CNPase earlier113, 139, 427, 428, the 
established method ensemble was used to study protein variants displaying single-
amino-acid changes compared to the wild-type protein. Many quality control 
experiments produced nearly identical outcomes for the six P0ct mutant variants. The 
lipid binding characterizations produced meaningful differences between the mutants 
and P0ct wild-type. An overview of these is listed in Table II. 
 
Table II. P0ct mutant comparison to wild-type. Various experiment were employed to 
determine the effect of the six chosen point mutations on the function and folding of P0ct. 
An increased or enhanced effect is indicated as one or more plus signs (+), decreases are 
oppositely indicated with minus (–) signs. No change is indicated with a zero (0). Control 
experiments are not included in the table. 
Method T216ER A221T D224Y R227S K236E K236del 
SRCD, SDS 0 0 0 0 0 + 
SRCD, DMPC 0 0 – 0 0 0 
SRCD, DMPC:DMPG 4:1 0 0 + 0 0 0 
SPR, Kd
* + 0 + + + 0 
SPR, Rhi
** 0 0 ++ 0 0 0 
DSC, Tm 0 0 *** 0 + + 
Turbidimetry 0 0 – – – – – – – – 
SAXD, d1 0 0 – + ++ + 
EM 0 0 +++ 0 0 0 
Stopped flow, k1 0 0 + 0 – – 
Yield per l + + – + + + 
*Generally very subtle differences. 
**Maximum response level from fitting. 






Characterization of the mutant variants identified a mutation distinct from all the 
others: D224Y. While other mutants were similar or almost identical to wild-type 
P0ct in terms of folding, lipid binding affinity, effect on lipid Tm, and vesicle 
aggregation, D224Y stood out with subtle, but meaningful differences. As opposed to 
P0ct and the other mutants, EM imaging revealed that D224Y induced heavy 
membrane stacking, similarly to MBP. This is an important result, as D224Y 
manifests as an abnormal CMT phenotype, displaying abnormally thickened compact 
myelin336. Nearly all studied parameters were changed: turbidimetry displayed a 
decreased level of optical density, most likely due to tighter lipid aggregates. In DSC, 
a wider, multimodal distribution in the thermodynamic landscape of DMPC:DMPG 
(1:1) was observed. In SAXD, molecular repeat distances collapsed by nearly 1 nm. 
The affinity of D224Y was only marginally decreased compared to wild-type P0ct, 
but more D224Y accumulated onto the immobilized lipids, as revealed by the 
increased response levels in SPR. All of these observations were present in 
DMPC:DMPG (1:1), where the folding of D224Y was not notably different from the 
other variants, although in DMPC:DMPG (4:1) it displayed slightly more folding. 
The single amino acid change from Asp to Tyr at this specific position allows P0ct to 
become a hyperactive stacker, capable of inducing multilayer formation and leaning 
towards the known physiological phenotype336. The endogenous effect of D224Y is 
so substantial that P0ct as a part of P0 becomes a determining factor in disease 
etiology. 
The difference to wild-type P0ct displayed by D224Y was substantial, but even 
though some mutants displayed milder effects, functionally important amino acids 
could be identified: Arg227 and Lys236. The changes in these amino acids introduced 
mild, but meaningful effects in lipid-bound P0ct. Lys236 gradually presented 
differences when proceeding from the wild-type to a deletion of Lys236, and finally 
to a charge-inverting mutant, K236E. Vesicle aggregation was most notably affected, 
indicating that Lys236 could be important for a potential vesicle fusion or stacking 
function. The mutation of Arg227 into a Ser deletes a positive charge, indicating that 
Arg227 could carry a role in charge neutralization and subsequent folding, as R227S 





distances in SAXD. The impact of R227S might be independent of UPR activation, as 
R227S has been shown to undergo normal trafficking from the ER to the plasma 
membrane and the disease phenotype arises only when myelin is properly matured429. 
Arg227 and Lys236 could thus be speculated to be involved in forming ionic 
interactions with phospholipid headgroups, driving the charge neutralization, folding 
and membrane insertion of P0ct. 
To elucidate the membrane insertion mechanism of P0ct, NR was performed. A 
striking difference to MBP was the complete insertion of P0ct into the SLB, without 
displaying a major non-inserted protein segment that could participate in 
intermembrane adhesion. Additionally, the binding of P0ct increased the roughness of 
the entire system, indicating notable mobility of the membrane (Fig. 13). This might 
be an effect arising from altered fluidity, which could be linked to the destabilized 
lipid population observed in DSC. 
 
 
Fig. 13. The membrane insertion differences of MBP and P0ct. Based on NR data, the 
membrane association of MBP results in partial protein insertion to the bilayer, slightly 
increasing membrane thickness. A notably thick protein layer forms over the membrane. 
P0ct undergoes nearly complete membrane insertion, also increasing the membrane 
thickness, but as opposed to MBP, only a small portion of P0ct remains on the membrane 
surface. The roughness of the membrane changes drastically, indicating increased lipid 








Since P0ct was found to participate in membrane-bridging (Article II), and the MDL 
in the PNS is known to form correctly in the absence of MBP and P298, P0ct is left 
with two options for achievable membrane stacking: either P0ct inserts into a 
membrane and bridges two membranes together across the MDL by interacting with 
another P0ct molecule, or P0ct interacts with or fully inserts into an apposing 
membrane across the MDL, whilst the transmembrane domain remains on the other 
side of the MDL (Fig. 14). At this point, it remains difficult to answer which 
mechanism is correct; logically thinking the latter should be impossible, given that 
P0ct is attracted to a phospholipid membrane directly after translation. Additionally, 
P0ct becomes fatty acylated at Cys182247, 248, which anchors into a membrane. Given 
that P0ct is translated together with full length P0, its membrane-bound state is 
destined before it reaches the stacked compact myelin, as will be described below. As 
shown by NR, D224Y and P0ct wild-type appeared identical on a single SLB, which 
indicates that the mutation does not influence the insertion of P0ct into a single 
membrane directly, but it is likely to enable specific interactions that result in tightly 
stacked membranes. These interactions remain to be further elucidated. 
 
Fig. 14. Possible membrane stacking modes of P0ct. The P0ct-mediated bridging of two 
apposing membranes together in MDL formation/stability can be speculated to occur through 
several different arrangements. Homophilic stacking involves either P0ct being fully present 
in one membrane and weakly interacting with an apposing P0ct molecule (1) or spanning the 
MDL, forming an oligomer with an apposing P0ct molecule (2). Another possibility is 
unimolecular stacking, which lacks the formation of oligomeric states. These could occur 
through P0ct directly interacting with the apposing membrane (3) or by fully inserting into 
the apposing membrane (4). P0ct is shown in red and the transmembrane helix of P0 is 






Compared to wild-type P0ct, the results appear mild for all other mutants except 
D224Y. It should be acknowledged that the characterization in this study is limited, 
as the samples involve only the cytoplasmic ‘soluble’ part of P0 instead of the full-
length protein. The transmembrane segment that could largely influence the 
conformation and/or depth of P0ct in the membrane is absent. Obviously, P0ct is not 
translated alone in vivo, but as a part of P0 that needs to be inserted into the ER 
membrane before undergoing PTMs and trafficking to the plasma membrane via the 
Golgi apparatus256, 430. 
Model lipid compositions were employed in this study, which work well with the 
chosen methods but might influence the behaviour of the proteins. In a native myelin 
lipid composition, differences between the mutant variants may be larger. 
Additionally, the membrane lipid composition changes when transiting from the ER 
to the Golgi apparatus and finally to the plasma membrane431. The lipid composition 
of the ER should be included in the study of these particular mutants, as many of 
them have been reported to induce UPR340. Misfolded P0ct in the ER membrane 
might cause the aggregation and/or unfolding of P0, resulting in ER stress. Disease 
mechanisms possibly arising from P0 trafficking, such as directly removing or 
modifying the YAML-motif as in the case of A221T256, are not covered in this study, 
nor is the activation of the unfolded protein response. These remain possible 
scenarios in CMT disease etiology involving the mutants at hand. This being stated, 
future studies should involve animal and cell culture studies that allow the 
pinpointing of P0 and P0ct in mutant models432, combined with structural studies 







5.6. FUTURE CONSIDERATIONS 
The ensemble of methods described in this thesis is useful for probing the 
conformation and lipid-binding properties of basic proteins, assuming adequate QC. 
This biophysical approach would benefit from the inclusion of several other methods 
as well as complementation using cell culture studies and experiments on natural 
myelin extracts. Nevertheless, the study paves way for the characterization of other 
proteins, domains, and peptides that harbour similar molecular characteristics as MBP 
and P0ct, as well as the expansion of the study on these two proteins. 
As the methodology is now established, it will be straightforward to include more 
lipid compositions. The use of PEs as phospholipids or plasmalogens would make the 
lipid composition more physiologically relevant. As shown by the SRCD experiments 
on P0ct in Article II, myelin- and EAE-like phospholipid compositions can be 
included. It is worth mentioning that similar compositions were also used for MBP, 
but the data were deemed unusable due to the strong CD signal of cholesterol and 
light scattering arising from vesicle aggregation (data not shown). Studies with more 
physiologically relevant lipid compositions are required, and notable progress has 
been made recently200, 204. More complex sample compositions will not only change 
the ratios of lipids in vesicles or SLBs, but are also likely to introduce various phase 
domains to the system via lipid segregation and internal interactions in the lipid 
structures62, 350, 351. In such cases, AFM could prove to be useful, as it is capable of 
distinguishing rafts and patches of different lipid phases in a membrane sample395. 
An addition that could complement AFM studies in distinguishing the time-resolved 
formation of lipid domains or changes in a membrane structure is Brewster angle 
microscopy433. The method is often used together with NR, as NR is unable to 
distinguish lateral heterogeneity in the sample434. The use of a quartz crystal 
microbalance with dissipation, which complements SPR by providing association and 
dissociation data of proteins binding to supported lipid structures, can provide 
additional information about the stiffness and thickness of the studied system435. 
GISAS using neutrons and X-rays could help in uncovering lateral organization in a 





complemented by methods providing a picture of lateral surface structures, like AFM 
and the above-mentioned Brewster angle microscopy. Additionally, infrared 
spectroscopy could allow in situ spectroscopic characterization of protein-lipid 
systems in SLB samples simultaneously to NR or GISAS measurements437, 438, and 
solid-state NMR spectroscopy439 could prove extremely useful for uncovering the 
molecular determinants in protein-lipid samples described in this thesis. While NMR 
spectroscopy is not a new method in the characterization of MBP70, P0ct has not been 
studied with NMR, and its small size would definitely enable such experiments. 
Hydrogen-deuterium exchange of lipid-bound MBP and P0ct might provide useful 
information about solvent-exposed surfaces440 and intein-mediated coupling of 
protein segments could be used to produce partially labeled full-length proteins441, 
introducing contrast variation in methods like NR. Single-residue labeling in proteins 
and peptide fragments might enable the probing of orientational parameters of 
specific protein segments. Such experiments have been performed for integral 
membrane proteins and amphipathic peptides using 19F labels and solid-state NMR 
spectroscopy442, 443. Similar SLB experiments as described here using NR should be 
pursued to uncover which peptide segment(s) of MBP initially insert into the 
membrane to produce the pre-stack state342. 
A logical step further would be to screen different ionic conditions and their impact 
on the activity of MBP and P0ct. K+ is an abundant ion in myelin35. The results of 
Article III suggest that the choice of monovalent anion, in this case Cl- vs. F-, has 
negligible impact on protein function, but similar comparative experiments remain to 
be performed for monovalent cations. An attractive choice of divalent cation to 
include in follow-up studies is Zn2+, the most abundant trace element in myelin34. 
Zn2+ has relevance in demyelinating conditions444, 445 and has been shown to interact 
with MBP171, 446-450. In compact myelin, Zn2+ is likely to interact with phospholipid 
headgroups within the tight cytoplasmic compartment451, 452. 
As already discussed above, the inclusion of more relevant lipid compositions should 
be done eventually – especially the presence of cholesterol is highly desired60, 61, 197, 





related changes in lipid proportions in disease57, 58, presents a putative disease-
inducing mechanism, especially when combined with amino acid changes in myelin 
proteins, such as mutations or PTMs. The impact on protein binding by individual 
lipid components, such as PE, has been demonstrated by others197, 198. 
Protein modifications involved in demyelinating conditions212, 407 should also be 
characterized. While a substantial amount of literature is available regarding the 
impact of citrullination on MBP and its function210, 211, 225, 407, 454, 455, membrane-
binding characterizations involving phosphorylated variants or phosphomimicking 
mutants is lacking. Phosphorylation has a similar impact on the net charge of MBP as 
citrullination, but the reversibility of phosphorylation allows natural regulatory 
mechanisms to exist. When disturbed, however, similar consequences that stem from 
heavy citrullination could be speculated to surface in the form of demyelination, 
especially since MBP-phosphorylation levels are known to be age-dependent and 
altered in MS212, 456. 
Proteins involved in myelination, myelin maintenance, and demyelination are all 
attractive characterization targets, MOBP being a very notable candidate. The true 
function of MOBP in myelin is not known, but it MOBP is likely to be partially 
unfolded, since it possesses similar amino acid content as MBP73. MOBP has a 
putative FYVE-domain76, implying Zn2+ binding and interactions with PIs457, thus 
possibly harboring a segregation role for lipids and Zn2+. 
The study of isolated peptide segments is also of interest, including the intracellular 
loops of the tetraspan protein PLP324, as well as smaller other segments of PLP or 
PMP22. Both proteins are among some of the most hydrophobic proteins in 
humans458, 459, which is a reason why high resolution structural data remains 
unavailable86, not to mention the structural relationship to the (putative) function of 
these integral transmembrane proteins. 
Multiprotein systems should be pursued to uncover any synergistic and competitive 
systems. MBP and P2 have been demonstrated to work together89, and the 





between these proteins are known to exist240. To conclude, it cannot be stressed 
enough that basic research involving biophysical approaches is required to understand 
disease conditions, especially arising from a biological environment of such a unique 










6 CONCLUDING REMARKS 
A biophysical characterization of MBP, P0ct, and its disease mutants has been 
performed in this thesis. Through an in vitro characterization, the structure-function 
relationships of MBP and P0ct in the MDL are starting to unravel. MBP, a classical 
membrane-stacker in compact myelin cytoplasm, appears to be heavily dependent on 
its translation and modification levels, as a pre-stack state, which might be a key 
factor in the molecular etiology of demyelination, precedes the formation of the 
MDL. This pre-stack state is likely to be influenced by the ionic content and lipid 
composition present at a given time, as changes in these two parameters have been 
shown to be altered in MS-like conditions. Indeed, the characterization described here 
raises an important factor in MBP-mediated membrane stacking outside of PTMs: the 
charge-balance arising from general ionic content, the presence of divalent cations, 
and phospholipid net charge. 
P0ct is the short cytoplasmic domain of P0 – a poorly characterized segment that 
shares many similarities to MBP in terms of folding and function. The importance of 
P0ct might very well be in MDL formation, especially since MBP, which is very 
abundant in the CNS, is not as prominent in the PNS and is not required for MDL 
formation in vivo98. The true membrane-bridging mode of P0ct remains to be 
determined, but putative models have been proposed for achieving the stable MDL 
ultrastructure in the PNS, where P0 dominates over all other proteins in terms of 
quantity. These proteins include P2, which does harbour membrane stacking 
properties but appears to be redundant in mice when the formation of peripheral 
myelin is followed98. The current study shows that some mutations in P0ct have 
relevance in CMT pathology outside of UPR induction, most notably explaining the 






on the cellular level336. Key amino acids relevant for the folding and membrane 
stacking function of P0ct have also been identified. 
To conclude, the current study evokes new directions in the study of myelin proteins. 
Biophysical studies are a necessity to understand the structure-function relationships 
of proteins on the biomolecular level, especially in a biologically unique, lipid-rich 
environment such as myelin. The approach described here enables strict control over 
the studied proteins and conditions, and robust, established systems can be further 
expanded to more physiologically relevant conditions that allow the dissection of 
molecular fundamentals of myelin formation and stability in health and disease. 
Incurable demyelinating diseases remain as such until novel remedies are developed, 
and such developments cannot be performed without adequate basic characterizations 
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basis for saltatory conduction of nerve impulses. The major dense line (MDL) is a 3-nm 
compartment between two cytoplasmic leaflets of stacked myelin membranes, mostly 
occupied by a myelin basic protein (MBP) phase. MBP is an abundant myelin protein 
involved in demyelinating diseases, such as multiple sclerosis. The association of MBP with 
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onto a single membrane leaflet to the organisation of a stable MDL. Our results support the 
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Membrane Association Landscape 
of Myelin Basic Protein Portrays 
Formation of the Myelin Major 
Dense Line
Arne Raasakka1,2, Salla Ruskamo2, Julia Kowal3, Robert Barker4,5, Anne Baumann1,6,  
Anne Martel  5, Jussi Tuusa2, Matti Myllykoski2, Jochen Bürck7, Anne S. Ulrich7,8,  
Henning Stahlberg  3 & Petri Kursula  1,2
Compact myelin comprises most of the dry weight of myelin, and its insulative nature is the basis for 
saltatory conduction of nerve impulses. The major dense line (MDL) is a 3-nm compartment between 
two cytoplasmic leaflets of stacked myelin membranes, mostly occupied by a myelin basic protein 
(MBP) phase. MBP is an abundant myelin protein involved in demyelinating diseases, such as multiple 
sclerosis. The association of MBP with lipid membranes has been studied for decades, but the MBP-
driven formation of the MDL remains elusive at the biomolecular level. We employed complementary 
biophysical methods, including atomic force microscopy, cryo-electron microscopy, and neutron 
scattering, to investigate the formation of membrane stacks all the way from MBP binding onto a 
single membrane leaflet to the organisation of a stable MDL. Our results support the formation of an 
amorphous protein phase of MBP between two membrane bilayers and provide a molecular model for 
MDL formation during myelination, which is of importance when understanding myelin assembly and 
demyelinating conditions.
Compact myelin (CM) is the most important and abundant structure of the vertebrate myelin sheath in both the 
central and peripheral nervous systems (CNS and PNS, respectively). The foundation of myelin-accelerated sal-
tatory conduction lies in the insulative nature of CM, which can be disturbed by damage caused by de- or dysmy-
elination, as well as in the myelin-guided distribution of ion channels on the axonal plasma membrane. Myelin 
damage often results in chronic neurological conditions, such as multiple sclerosis (MS), Charcot-Marie-Tooth 
disease, or Dejerine-Sottas syndrome, all of which display a broad spectrum of symptoms, have at least a partial 
genetic background, and remain difficult to treat, even at an early onset1, 2.
Myelin basic protein (MBP) is one of the crucial factors in CM membrane stacking in the CNS, its 
18.5-kDa isoform being most abundant3. The presence of many MBP isoforms is further complicated through 
post-translational modifications, including deimination, which produces a pool of citrullinated variants with 
decreased net charge4. The high positive net charge of MBP is related to the intrinsically disordered conforma-
tion of MBP in solution; on the other hand, it allows MBP to interact with the phospholipid-rich cytoplasmic 
face of myelin membranes. This close interaction results in charge neutralisation, folding, and partial membrane 
insertion5. MBP promotes myelin membrane stacking and the formation of the major dense line (MDL), which is 
disturbed in demyelinating conditions, including MS and demyelinating neuropathies6, 7.
MBP is known for its autoantigenic properties in MS, and the major immunodominant epitope of MBP bound 
to a T-cell receptor complex has been structurally characterised5, 8. The autoantigenic character may arise from the 
susceptibility of MBP to proteolysis in a lipid composition-dependent manner5, 9. Additionally, deimination alters 
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the structure and function of MBP, promoting lowered CM stability and increased protease susceptibility10, 11. 
Hence, the membrane association mode, structure, and stability of MBP must be considered when investigating 
the molecular mechanisms of MBP-related diseases.
MBP has been suggested to form an ordered, self-assembled protein meshwork of either anti-parallel or 
stacked MBP molecules with confined degrees of freedom between myelin cytoplasmic leaflets9, 12, 13. This protein 
meshwork stabilises CM, while other factors, such as the myelin protein P2, may be involved in the process14, 15. 
The surface adsorption behaviour of MBP has been intensively studied, and it was proposed that MBP associates 
with the membrane surface prior to folding to its adhesive conformation16. This model, based on hard model 
surfaces, is in corroboration with earlier studies on lipid bilayers17, and a mostly disordered intermediate MBP 
folding state has been proposed based on titration experiments and modelling under conditions with decreasing 
dielectric constant18.
To elucidate the membrane association mechanisms of MBP, we performed a comprehensive characterisation 
of recombinant tag-free MBP (rMBP) binding to model membranes. Our combined approach using electron 
microscopy (EM), atomic force microscopy (AFM), and neutron reflectometry (NR) provides evidence for the 
formation of a dense protein phase on a single membrane leaflet, suggesting the existence of a protein meshwork13 
that forms above a critical MBP concentration. Our results illustrate a step-wise formation of the MDL at the 
biomolecular scale.
Results
Although much is known about the molecular properties of MBP and its interaction with membranes, a com-
prehensive picture of different steps in the process of myelin membrane compaction has been lacking. We set 
out to investigate the fine details of MBP-membrane interactions using a panel of biophysical methods to follow 
membrane binding, protein embedding, and bilayer stacking.
Characterisation of untagged rMBP. A notable amount of past MBP research has been performed using 
C-terminally His6-tagged recombinant MBP (MBP-His)12, 14, 15, 19, 20 or MBP purified from nerve tissue4, 9, 10, 16, 17, 21. 
To overcome problems arising from construct design or contaminants and heterogeneity in tissue extracts, we 
used untagged recombinant murine MBP (rMBP) corresponding to the major 18.5-kDa isoform, similarly to 
other recent studies18, 22–24. rMBP appeared as a single band in denaturing gel electrophoresis (SDS-PAGE) and 
monomeric and monodisperse in size-exclusion chromatography (SEC) and dynamic light scattering (DLS), with 
a hydrodynamic radius (Rh) of 3.5 nm (Supplementary Fig. S1). The identity of rMBP was confirmed using tryptic 
peptide mass analysis, and the molecular weight of pure rMBP was as expected (18544 Da).
In the absence of additives, rMBP was always disordered in aqueous solution according to synchro-
tron radiation circular dichroism (SRCD) spectroscopy, which further revealed moderate helical folding in 
2,2,2-trifluoroethanol (TFE) as well as with negatively charged sodium dodecyl sulphate (SDS) and several neutral 
detergent micelles (Supplementary Fig. S1). Using synchrotron small-angle X-ray scattering (SAXS), we found 
that rMBP was monomeric and highly elongated in solution (Fig. 1a, Supplementary Fig. S1, Supplementary 
Table S1). This explains the obtained radius of gyration (Rg; 3.7–4.0 nm, depending on method) being higher 
than the measured Rh; this is typical for particles deviating significantly from globularity25. The ab initio model 
(Fig. 1b) is elongated and similar to previously described models20, 21. Ensemble optimisation analysis (EOM) 
revealed distinct subpopulations of both Rg and maximum particle dimension (Dmax), suggesting the presence 
of different rMBP conformational species in solution (Fig. 1c). rMBP mostly adopts a reasonably compact con-
formation, close to that expected for a random polymer, instead of being fully extended (Fig. 1c, Supplementary 
Table S1). To study this further, we collected small-angle neutron scattering (SANS) data of rMBP in the absence 
and presence of n-dodecylphosphocholine (DPC) micelles (Fig. 1d, Supplementary Fig. S2, Supplementary 
Table S1). Size comparison of a computationally modelled DPC micelle26 and a single rMBP conformer sug-
gests that each micelle can most likely only embed a single rMBP molecule (Fig. 1e), as suggested earlier19. It is 
noteworthy that the number of detergent molecules can vary within DPC micelles, with effects on micellar size 
and surface curvature26. Micellar scattering was masked using the contrast match-point of DPC, which allowed 
us to focus on the scattering of rMBP alone: EOM analysis of the SANS data revealed that DPC-bound rMBP 
shifted quantitatively to the more compact population, with a sharpened Rg distribution of 2.6–3.8 nm and a Dmax 
distribution of 8–12 nm (Fig. 1f, Supplementary Table S1). Whilst being still relatively elongated, the data fit to 
a scenario where part of rMBP is embedded within a DPC micelle and partially folded, which is also supported 
by SRCD experiments (Supplementary Fig. S1) as well as SANS data analysis (Supplementary Fig. S2) using the 
Porod-Debye law27.
Membrane interaction and folding of rMBP. We next investigated the membrane association of rMBP. 
For rapid screening of interactions, we used solution-state SRCD, as MBP gains secondary structure upon lipid 
binding20. rMBP reproducibly presented a clear increase in α-helical content with negatively charged small unila-
mellar vesicles (SUVs), with a slightly higher increase in the presence of saturated (dimyristoylphosphatidylcho-
line (DMPC): dimyristoylphosphatidylglycerol (DMPG)) than unsaturated lipids (dioleylphosphatidylcholine 
(DOPC): dioleylphosphatidylserine (DOPS)) (Fig. 2a). The importance of membrane surface charge is very clear, 
as rMBP does not undergo conformational changes with net neutral phosphatidylcholine lipids, indicating abol-
ished, or at least altered or weakened, binding, as described previously28. To assess the effect of the abundant mye-
lin lipids cholesterol, sphingomyelin, and phosphatidylethanolamine (DMPE) on folding, we included 10% (w/w) 
of each lipid separately in a standard DMPC:DMPG (1:1) mixture (Fig. 2b). None of these additives significantly 
affected the rMBP helical content, indicating that the surface net charge of the membrane dominates over lipid 
fluidity or hydrocarbon tails in initiating MBP folding.
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Figure 1. rMBP conformation in solution. (a) rMBP is significantly elongated based on SAXS data. GASBOR 
and EOM fits have been plotted over the raw data with their respective χ2 values indicated. (b) The GASBOR ab 
initio model is elongated, with a maximum dimension around 12 nm. (c) EOM analysis of rMBP reveals wide 
Rg and Dmax populations in an ensemble that represents the measured SAXS data. Selected models from EOM 
analysis (right) with their mass fractions within the total population are indicated. The coloured arrows denote 
the Rg and Dmax of each model within the distributions. (d) SANS curves of rMBP in the absence and presence of 
DPC micelles (black and magenta, respectively). The EOM fits have been plotted over the data. (e) Stereoscopic 
image illustrating the size of an rMBP conformer and a DPC micelle of 54 detergent molecules26. (f) SANS EOM 
distributions of rMBP in the absence and presence of DPC micelles (solid and dashed lines, respectively). In the 
presence of DPC micelles (grey sphere), a distinct compacted population dominates (magenta cartoon) over the 
mixed elongated and compacted populations (black cartoons).
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4SCIeNTIFIC RePoRTs | 7: 4974  | DOI:10.1038/s41598-017-05364-3
The SRCD experiments provided evidence for membrane binding being mostly affected by electrostatics. 
Since the effect was practically the same with different lipid tails, we employed other strategies to observe possible 
membrane insertion. Differential scanning calorimetry (DSC) allows the determination of lipid phase transition 
temperatures, which reflect the conformational freedom of the lipid hydrocarbon tails. As a function of increasing 
temperature, dimyristoyl lipids present a small endothermic pre-transition (Tp) from the planar gel phase (Lβ′) 
to the rippled gel phase (Pβ′), which is shortly followed by a major endothermic transition (Tm) from Pβ′ to the 
liquid crystalline phase (Lα) typically at +23–+24 °C29. We screened several protein-to-lipid (P/L) ratios of rMBP 
against DMPC:DMPG multilamellar vesicles (MLVs) with varying net negative surface charges using DSC, mon-
itoring any rMBP-induced effects on the observed lipid Tm (Fig. 2d). Upon increasing the concentrations of rMBP, 
the endothermic main phase transition signal of negatively charged lipid membranes was broadened. Net neutral 
DMPC showed no difference in phase transition behaviour in the presence of rMBP. The data suggest MBP mem-
brane insertion after charge neutralisation, supporting the conclusions from SRCD data.
DSC suggested lipid tail interactions with rMBP, even though the observed changes in rMBP conformation in 
SRCD with different lipid tails were minor. Next, we followed the conformation of rMBP in DMPC:DMPG (1:1) 
vesicles as a function of temperature (Fig. 2c). Scanning around the apparent Tm of dimyristoyl tails did not alter 
the conformation of rMBP, suggesting that lipid tail phase behaviour does not notably affect folding after rMBP has 
bound, but the dielectric environment inside the membrane is a maintaining factor for folding. To shed light on 
factors affecting binding affinity, we performed binding experiments of rMBP to immobilised DOPC:DOPS (1:1) 
and DMPC:DMPG (1:1) large unilamellar vesicles (LUVs) using surface plasmon resonance (SPR) (Fig. 2e). In a 
previous study20, we used SPR to address MBP-His binding to PC membranes in the presence of phosphoinositides, 
and we observed more binding with increased negative membrane charge, as well as a sigmoidal dependence of 
binding on MBP concentration. The association of rMBP with lipid vesicles was irreversible, as reported before for 
Figure 2. Lipid interactions of rMBP. (a) rMBP gains secondary structure in the presence of liposomes with 
increasing net negative surface charge, whereas it remains unfolded with net neutral lipids. (b) Cholesterol, 
sphingomyelin, or DMPE do not alter the secondary structure content of rMBP in net negatively charged 
DMPC:DMPG (1:1) vesicles. (c) Scanning around the lipid tail phase transition temperature does not affect the 
folding of MBP (right). (d) rMBP changes the lipid tail endothermic phase transition behaviour only when the 
MLV surface charge is net negative. (e) The association of rMBP with immobilised lipid vesicles probed using 
SPR. Error bars represent standard deviations.
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MBP-His20, since we observed essentially no rMBP dissociation from the lipids (data not shown). This suggests that 
the conformational change from disordered to helical structure occurs after initial electrostatic binding and anchors 
rMBP tightly onto the lipid surface. We performed saturation experiments by rMBP titration, which allowed the 
acquisition of key parameters of membrane binding (Fig. 2e, Table 1). While dimyristoyl-based lipids generally had 
higher responses (Rhi) upon rMBP injection, the obtained saturation midpoint concentrations (A1), which can be 
considered apparent dissociation constants (Kd), were similar for both DOPC:DOPS (1:1) and DMPC:DMPG (1:1), 
sharing the same surface net charge (Table 1). We performed a kinetic analysis by fitting the association phases of 
rMBP binding into a one-phase exponential association model (Supplementary Fig. S3). While the calculated kon 
values are similar for both lipid compositions (Supplementary Table S2), the one-phase association model does not 
fit our data well enough to draw solid conclusions regarding association kinetics, and therefore, we conclude that 
MBP binding to a membrane surface is a complex binding event. It is clear that the initial association of rMBP onto 
a membrane surface is mostly governed by surface electrostatics, but the lipid tails do influence the amount of rMBP 
that can be integrated into liposomal bilayers, with a minimal effect on binding affinity or folding. Our results thus 
far clearly indicate rMBP membrane insertion and folding upon membrane binding.
Effect of membrane fluidity and rMBP concentration on membrane stacking. We have earlier 
shown spontaneous bilayer stacking by MBP and myelin protein P2 using AFM14. To observe this process in more 
detail, we prepared oriented DOPC:DOPS (1:1) bilayers with and without 10% (w/w) cholesterol on mica, and 
different concentrations of rMBP were added. After removal of unbound rMBP, the samples were imaged. rMBP 
bound onto the membrane surface and reproducibly induced membrane stacking, but the presence of cholesterol 
was not essential. However, the inclusion of cholesterol did cause the stacked membrane patches to appear larger 
and more uniform (Fig. 3a), suggesting that membrane fluidity plays a major role in stack formation, as demon-
strated earlier using vesicle experiments30. We tested several concentrations of rMBP and found that a critical 
amount of rMBP has to accumulate onto the membranes before stacks emerge spontaneously: at 0.9 µM rMBP, 
membrane stacks were not typically observed, but at 1.8 µM, multilayers were always visible (Fig. 3a). Cholesterol 
did not affect this trend. In our earlier study, 1.8 µM MBP-His caused only minimal stacking of brain lipids, while 
extensive stacking was present at higher concentrations14. It is noteworthy that the observed critical concentration 
for membrane stacking in AFM corresponds to the rMBP concentration after reaching plateau for membrane 
surface binding in SPR. Thus, membrane stacking apparently requires surface saturation with MBP.
We next assessed the effect of lipid tail saturation and cholesterol on vesicle aggregation, similarly to our earlier 
experiments on P231. The aggregation behaviour was the same for both DMPC:DMPG (1:1) and DOPC:DOPG 
(1:1), both with and without 10% (w/w) cholesterol (Fig. 3b), implying that the association of protein-decorated 
membranes is not dependent on cholesterol or lipid tail saturation. The differences in membrane fluidity result-
ing from cholesterol are most likely the reason to the observed stacking behaviour differences in AFM, as the 
presence of 10% (w/w) cholesterol did not notably affect the folding of rMBP either. Finally, we investigated 
whether rMBP produces vesicle aggregates with a distinct repeat distance. A Bragg peak corresponding to a 
mean repeat distance of 80 Å was present in our small-angle X-ray diffraction (SAXD) data from rMBP bound 
to DMPC:DMPG (1:1) vesicles (Fig. 3c). Bragg diffraction has been observed before from model vesicles and 
membranes as well as myelinated tissue9, 15, 31, 32. The result confirms the induction of ordered membrane stacks by 
rMBP, which were further used in imaging experiments.
A membrane stack is uniformly occupied by a gel-like rMBP phase. To gain more detailed infor-
mation about the assembly of MBP within membrane stacks, we studied MBP-aggregated vesicle samples using 
EM. As shown by nanogold labelling, in vesicle aggregates, MBP-His expectedly resided mostly between vesicle 
surfaces (Fig. 4a), as demonstrated earlier33, 34.
We investigated rMBP assembly between membranes using cryo-EM. We imaged rMBP-adhered vesicle 
membrane stacks and picked images of MBP between membranes for single particle analysis (Fig. 4b,c). rMBP 
settled tightly between the membranes and formed stacks with a total thickness of 11–13 nm (two 5-nm bilayers 
with a 1–3-nm protein phase between them). Particle analysis revealed that, as opposed to the membranes with-
out rMBP that presented a loose space with a varying distance between apposing membranes, the intermembrane 
space in the presence of rMBP was occupied by a narrow uniform protein phase with no distinct globular particles. 
The space between lipid membranes was ~1 nm, with protein present both between and inside the membranes. 
Distances of ~2.5 nm between MBP molecules can be estimated, but the distances vary and the proteins are not 
clearly visible. This resembles the cohesive MBP meshwork proposed earlier13. Thus, further particle averaging and 
higher-resolution structure determination were not carried out. Despite the lipid bilayers in these experiments being 
symmetric, unlike in myelin, it is noteworthy that in cryo-EM, we only observed protein-containing stacks of two 
apposing lipid bilayers (Fig. 4b,c). This suggests that once MBP inserts into the membrane, it changes the membrane 
properties and can prevent further MBP insertion from the opposite side, unless a great excess of MBP is present. 
As shown by neutron scattering, the molecular dynamics of a lipid bilayer are affected by MBP 15, 35, 36. MBP can thus 
alter the overall structural and dynamical properties of an entire lipid bilayer, driving it towards asymmetric behav-
iour even when the lipid composition is symmetric. The molecular details of this asymmetry are currently unknown.
Rhi Rlo A1 A2 R2
DOPC:DOPS (1:1) 5751 ± 79.84 −3.647 ± 48.78 389.5 ± 10.77 2.374 ± 0.1117 0.9978
DMPC:DMPG (1:1) 7624 ± 118.1 85.57 ± 73.49 455.5 ± 12.36 3.061 ± 02189 0.9968
Table 1. Surface plasmon resonance fitting parameters.
www.nature.com/scientificreports/
6SCIeNTIFIC RePoRTs | 7: 4974  | DOI:10.1038/s41598-017-05364-3
Figure 3. Membrane-stacking properties of rMBP. (a) In AFM, rMBP binds to supported DOPC:DOPS (1:1) 
lipid bilayers and spontaneously produces bilayer stacks after reaching sufficient protein concentration. The 
quality and area of the observed membrane stacks are influenced by the presence of cholesterol, without a 
significant effect on the measured stack thickness. Red lines denote the walk sections in the images, for which 
height diagrams have been plotted below. The walks from the cholesterol images have been extracted from 5-µm 
image insets for better quality. A single bilayer and stack are ~4 and 12 nm in height, respectively. (b) Turbidity 
measurements show that the tendency of rMBP to aggregate vesicles remains mostly unaffected by the lipid tail 
saturation degree or the presence of cholesterol. Error bars represent standard deviations. (c) rMBP mixed with 
DMPC:DMPG (1:1) SUVs displays a Bragg peak in SAXD that corresponds to a mean repeat distance of 80 Å at 
1:100 molar P/L. A running average (black line) has been added for clarity over the raw measurement data (grey 
circles).
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Figure 4. Architecture of rMBP in membrane stacks. (a) MBP aggregates vesicles and settles between 
membranes. rMBP-His was labelled with nanogold particles to localise the protein between vesicles (black 
arrow). (b) In cryo-EM, membrane stacking by MBP is evident when mixed with lipid vesicles (white asterisks). 
MBP also slightly flattens the membrane curvature of vesicles when more than one stack builds up (white 
arrows). (c) Particle analysis of cryo-EM imaged vesicles unveils an intermembrane compartment occupied by a 
uniform rMBP phase devoid of clear single particle boundaries, which brings the two apposing membranes into 
close vicinity to each other. The space between adjacent vesicle bilayers in the absence of rMBP is notably wider. 
(d) MBP coats GalCer-DOGS-NTA-Ni2+ nanotubes, displaying an extended conformation (white arrow). MBP 
also aggregates nanotubes, as evident from negatively stained samples (right).
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For observing concentration dependence of MBP-induced membrane stacking, we imaged vesicles with var-
ying amounts of rMBP (Supplementary Fig. S4). While membrane multilayers were present in vesicle mixtures at 
high rMBP concentrations, stacking was lost as rMBP concentration decreased. Despite a different sample setup 
(freely tumbling vesicles) compared to AFM experiments (supported lipid bilayers), these observations do again 
suggest a critical MBP concentration for inducing membrane stacking.
We also imaged rMBP binding to lipidic nanotubes (Fig. 4d). rMBP bound nanotubes together, which was 
visible both with negatively stained samples as well as in cryo-EM. Compared to vesicles, nanotubes have different 
membrane fluidity, composition, and curvature. Importantly, we also observed the accumulation of rMBP onto 
nanotube exposed surfaces without stacking, corresponding to the accumulation of MBP onto a single membrane 
surface. As opposed to the more compact confinement within membrane stacks formed from vesicles, MBP 
appeared elongated when bound to nanotubes, similarly to DPC-bound rMBP in SANS.
The formation of a protein phase on a single bilayer prior to stacking. The EM experiments raised 
a question regarding the conformation of rMBP on lipid bilayers prior to stacking. This is likely a physiologically 
relevant state during myelination; AFM demonstrated concentration dependence upon stack induction, and MBP 
can insert into membranes. Does MBP insert into a single membrane before a stack forms, and will MBP fold into 
a compact conformation before stacking? To answer these questions, we carried out NR experiments on uniform 
proteinous lipid bilayer samples.
The Langmuir-Blodgett/Schaefer approach to depositing lipid bilayers on solid substrates involves the sequen-
tial transfer of lipids from a Langmuir monolayer, with controlled area per molecule, by first slowly pulling the 
substrate out through the monolayer, with the interface perpendicular to the water surface (Langmuir-Blodgett) 
and then rotating the substrate by 90°, so that the interface is parallel to the water surface, and slowly pushing the 
substrate through the monolayer to deposit the outer leaflet of the bilayer (Langmuir-Schaefer). This approach 
allows precise control of the composition and coverage of both leaflets of the lipid bilayer independently, ensuring 
a high-coverage bilayer across the entirety of the large substrate surfaces necessary for NR measurements. NR is 
an excellent tool for studying in-situ the structure, perpendicular to the surface, of buried, hydrated thin films of 
biological and soft-matter molecules at the solid–liquid interface. The large penetrability of neutrons, combined 
with their high sensitivity to hydrogenated and deuterated materials, makes NR an ideal probe of interactions 
between proteins and biomembranes, simultaneously providing information on the interaction both at the sur-
face and buried within the membrane.
Using the Langmuir-Blodgett/Schaefer technique, we prepared uniform lipid bilayers of hydrogenated and 
perdeuterated DMPC:DMPG (1:1) on Si-crystal substrates with water as a subphase solvent. A flow cell setup 
allowed us to exchange the bulk solvent to buffers and to characterize the membranes with different solvent 
contrasts, as well as to inject rMBP inside the cell and follow its association as a function of time (Fig. 5a,b). 
Based on SPR and AFM, we chose to add rMBP onto the membrane at 0.5 µM, which retained the integrity of 
the membrane and did not induce spontaneous stacking (Fig. 5a). Initially, we observed that after injecting the 
protein, there was a time window that presented a rearrangement within the sample (Fig. 5b). After stabilisation 
of the sample and washing out unbound protein, the resulting reflectivity curve was best fitted to a model with a 
uniform protein layer, having a defined thickness and low roughness, on top of the existing DMPC:DMPG (1:1) 
bilayer, with full insertion of the protein into the outer leaflet of the bilayer, potentially displacing both lipid and 
water molecules from this leaflet (Fig. 5a, Table 2). Similar behaviour was observed with both hydrogenated 
and perdeuterated lipids (Fig. 5a, Supplementary Fig. S5), but not with DMPC alone (Supplementary Fig. S5), 
again demonstrating the importance of membrane surface charge. The parameters used to describe the best fit to 
each set of data clearly show that the protein layer covered ~25% of the membrane surface and was 7.5–8.5 nm 
thick. An additional ~3 nm of the protein was inserted within the outer leaflet of the bilayer, displacing ~40% of 
the lipids in this leaflet and leading to a rearrangement of the membrane to support this. The analysis suggests 
compaction compared to the most elongated conformers suggested by SAXS, fitting well to the narrowed EOM 
population observed by SANS for DPC-bound rMBP. The protein layer, however, does not represent a completely 
collapsed MBP, thought to reside within the mature bilayer stack5, but a previously undetected pre-stack MBP 
conformation: a brush-like layer of mostly disordered protein, anchored onto the membrane most likely via one 
or more helical segments. The introduction of another membrane leaflet could result in a second insertion event, 
followed by protein folding and compaction, a single MBP molecule potentially penetrating both bilayer surfaces. 
The protein meshwork has been suggested to be composed of laterally self-assembled12 or dimeric MBP12. Taking 
into account our observations and earlier data, it is obvious that MBP forms a protein phase onto a membrane 
surface, and this process involves also self-association. However, we find it unlikely that MBP would, even when 
bound to membranes within compact myelin, fold into structurally highly ordered assemblies with a well-defined 
oligomeric state.
To further study the protein-membrane association, we added 0.5 µM rMBP to a membrane in a time-resolved 
NR experiment (Fig. 5b, Supplementary Table S3). While this concentration is not high enough to provide infor-
mation about stacking, we could observe the entire association process of rMBP. It should be noted that this 
experiment was carried out with a single contrast, increasing the uncertainty in the fitted parameters. However, 
clear trends were still seen, as the association took place on a reasonably long time scale, during which three 
distinct phases could be resolved: initially a 7-nm thick, diffuse protein layer formed on the membrane, with a 
very high roughness, indicating high heterogeneity and no insertion into the membrane. Next, this layer col-
lapsed into a denser, more homogeneous layer with some insertion into the headgroup region of the bilayer 
outer leaflet. Only after this, one can observe full membrane insertion, displacing lipids from the outer leaflet of 
the bilayer, which suggests that rMBP has to accumulate and fold onto the membrane prior to embedding. The 
coverage of the protein was very high during these time-resolved measurements, up to 50%, as opposed to the 
buffer-exchanged sample (~25%; Table 2), with less displacement of lipid from the outer leaflet, indicating that 
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the rinsing of the membrane may remove some additional lipid molecules along with excess protein. The third 
phase in our time-resolved measurement was essentially the steady state, and the system remained stable beyond 
this time point (phases 4 & 5 in Fig. 5b).
Discussion
Using a recombinant form of MBP accurately mimicking the major 18.5-kDa isoform, we have provided a full 
physicochemical picture of MBP-induced stacking of lipid bilayers. MBP is an intrinsically disordered protein in 
solution, which after lipid membrane binding gains secondary structure and embeds deep into the bilayer. On 
top of the membrane, an amorphous protein brush is formed, which is likely to be of high importance, when an 
apposing membrane is bound. A fully compacted MBP conformation is only present between two bilayers. Our 
results provide a comprehensive molecular framework for membrane binding and stacking by MBP, which is a 
peripheral membrane protein with unique molecular properties.
Our extensive characterisation of tag-free rMBP shows that MBP is disordered in solution and binds lipid 
membranes through electrostatic interactions. While the lipid composition of myelin is more complex than that 
used in the current study, we decided here to focus on simple lipid mixtures that generally behave well in various 
biophysical techniques and can be used to screen for basic membrane properties, including surface charge, lipid 
headgroup, level of saturation, and fluidity. While the lipid hydrocarbon tails do not affect the binding affinity, 
kinetics, or folding of MBP substantially, the dynamic freedom and spatial occupation of the tails define how 
much MBP can bind to saturate the membrane surface. MBP also affects the biophysical properties of the entire 
lipid bilayer, as for example highlighted by the observation of MBP-induced stacks of only two, but not more, 
bilayers in cryo-EM, as well as previous studies with cultured oligodendrocytes37, 38. The importance of both the 
lipid and protein components in affecting the dynamics and function of each other has been highlighted earlier 
for both MBP17, 35, 36, 39 and myelin protein P240, 41.
Figure 5. Accumulation of rMBP onto lipid bilayers. Data and fits are plotted on the left and scattering 
length density (ρ) profiles on the right. All reflectivity curves have been offset for clarity. (a) Steady-state NR 
experiment of DMPC:DMPG lipid bilayers with and without rMBP at different solvent contrasts. (b) Time-
resolved NR experiment. The phases represent 15-min time-slices of rMBP associating with a d54-DMPC:d54-
DMPG bilayer in an H2O contrast. The fitting curve for phase 3 has also been overlaid with phases 4 and 5, 
demonstrating steady state. The error bars represent standard deviations.
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Our results demonstrate that charge neutralisation is a key event before MBP folding and membrane insertion 
can take place. Once charge neutralisation and membrane saturation with MBP occur, a string of downstream 
events is triggered, ultimately leading to stable myelin-like membrane stacks. Based on our observations, and 
considering earlier literature, we now propose a molecular mechanism for the stepwise, MBP-driven formation 
of the MDL (Fig. 6).
In the initial step, the highly positively charged, disordered MBP is attracted to a negatively charged mem-
brane surface by electrostatic interactions, which starts the association cascade. When encountering the mem-
brane surface, MBP binds through electrostatics, and opposite charges are neutralised – this allows other factors, 
such as hydrogen bonding and the hydrophobic effect, to take over and causes MBP to fold and subsequently 
insert deeper into the inner membrane leaflet, and even partially into the outer, as proposed already decades 
ago30. The process occurs in a fairly small volume: only partial protein insertion and folding occurs, while most 
of MBP remains elongated outside the membrane, maintaining a positive net charge. This is plausible, as several 
distinct segments of MBP have been shown to have propensity to fold independently upon interacting with lipids/
detergents42–46. This initial association, however, may already be essentially irreversible12, 20, 42, although it is likely 
that there are folded species in the system that present weak affinity and are removable, possibly due to electro-
static repulsion.
Next, given the fairly confined electrostatic field of the lipid bilayer, which gets neutralised by the embedded 
protein, more MBP continues to bind and integrate within the single membrane leaflet. A fairly thick amorphous 
peripheral protein phase emerges, which translates into a strong accumulation of positive charge covering the 
membrane surface. This protein layer is likely to represent the distinct MBP protein phase described earlier13. 
Brush-like phases consisting of disordered proteins and peptides have been recently reported47, 48. Our SANS 
data in the presence of detergent micelles provide evidence for a brush-like property for membrane-bound MBP, 
although the detailed organisation of this protein phase currently remains unknown. This phase was also visual-
ised by cryo-EM on the surface of lipid nanotubes, providing a starting point for further studies into its molecular 
details.
Finally, when a critical surface-bound MBP concentration has been reached, the soft protein brush adheres to 
a second membrane leaflet, resulting in full charge neutralisation. MBP undergoes a second compaction event to 
fit into the confined space between the two bilayers, forming a meshwork of extraordinary stability between the 
two cytoplasmic membrane leaflets. It is likely that this phase transition is governed by specific aromatic residues 
in MBP13. The meshwork may involve lateral MBP assembly9, 12, and the 3-nm MDL can easily be spanned by a 
single MBP monomer, as suggested earlier5, 16, 17, 49. During myelination, both membrane bilayers involved in stack 
formation are likely to accumulate MBP continuously. Since the membranes are in close proximity to each other, 
the stacking could proceed via a zipper-like mechanism, whereby only the leading part of accumulated MBP 
reaches the critical concentration at a given time and effectively transitions into a molecular adhesive. Interactions 
of MBP with cytosolic proteins, such as calmodulin20, 50 or the cytoskeleton19, 51, may regulate this process.
The above string of events is a feasible molecular model for myelin membrane stacking, assuming enough 
MBP is available locally. During CNS myelination, MBP is translated in the vicinity of the growing mem-
brane from transported mRNA52. The local synthesis of MBP is likely to be a key triggering factor for mye-
lin membrane compaction. In myelin formation and maintenance, cytoskeletal networks and other proteins, 
such as 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase), play central roles53. An interplay between MBP 
and membrane-bound CNPase may be important, as both CNPase and MBP bind microtubules and actin19, 51. 
Recent data also suggest that myelin formation is driven by cytoskeletal disassembly54, in addition to proteo-
lipid protein-driven myelin formation55–57. CNPase overexpression inhibits MBP-based myelin compaction and 
causes aberrations in the periaxonal membrane58. A model outlining the interplay between CNPase and MBP 
Parameters
DMPC:DMPG (1:1) d54-DMPC:d54-DMPG (1:1)
Bilayer alone With rMBP Bilayer alone With rMBP
Substrate
Oxide thickness (Å) 14 ± 1 10 ± 1
Oxide coverage (%) 75 ± 1 90 ± 4
Oxide roughness (Å) 3 ± 1 3 ± 2
Hydration layer between oxide and bilayer (Å) 5 ± 1 5 ± 2 20 ± 5 25 ± 6
Bilayer
Bilayer area-per-molecule (Å2/molecule) 60 ± 4 45 ± 3 63 ± 8 52 ± 10
Water molecules per lipid head 3 ± 1 10 ± 2 3 ± 1 10 ± 1
Water molecules per lipid tail 4 ± 2 17 ± 3 6 ± 2 17 ± 2
Global bilayer roughness (Å) 5 ± 1 8 ± 1 18 ± 6 22 ± 3





Local bilayer outer roughness (Å) 11 ± 2 0 ± 3
rMBP
MBP in outer leaflet (%) 39 ± 7 44 ± 9
MBP layer thickness (Å) 84 ± 2 75 ± 4
MBP layer coverage (%) 26 ± 1 23 ± 3
MBP layer roughness (Å) 3 ± 2 10 ± 4
Table 2. Neutron reflectometry parameters.
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in maintaining the interface and balance between CM and cytosolic channels was recently proposed, showing 
antagonistic effects of CNPase and MBP on channel formation59.
Changes in the expression patterns of key proteins (e.g. CNPase) during myelination and in mature myelin 
could switch the formation and stability of the MDL to a point where MBP is re-exposed to the cytosol, making it 
susceptible to proteolysis. While we do not yet know enough about the reversibility of myelination at the molec-
ular level, MBP accumulated on a single membrane surface is a more suitable substrate for proteases and other 
modifying enzymes than a folded, membrane-embedded MBP. This could further decrease the stability of the 
MDL through disruption of the MBP meshwork, setting out a rolling wheel that may eventually result in a neuro-
logical condition, possibly by exposing autoimmune epitopes of MBP and other myelin proteins. Autoantigenic 
MBP peptides, as well as molecular mimics thereof, have been discovered and characterised60. These could be 
disease-triggering or even preventive factors when modified correctly61, 62, the underlying mechanisms currently 
being unclear. Picturing the above molecular steps of MDL formation should allow to better understand the mye-
lination process as well as demyelinating disorders.
Stability of the proteolipid membrane multilayer is a key factor for keeping myelin healthy. Initial interactions 
between MBP and lipid membranes are mostly electrostatic, and deiminated charge variants of MBP have been 
linked to MS4. Decreased positive charge on MBP leads to weaker membrane interactions20, 42, 63. Modified var-
iants could affect myelin stability through slight structural, functional, and compositional differences, as well as 
susceptibility to proteolysis10, 11, 20. The concentration of divalent ions, most importantly Ca2+ and Zn2+, is likely 
to influence the formation and stability of compact myelin64. An obvious factor to consider is the membrane lipid 
Figure 6. The association landscape of MBP with myelin membranes leads to the formation of MDL. MBP 
(red) in solution is disordered and approaches the cytoplasmic membrane surface through electrostatic 
interactions (1), which eventually leads to charge neutralisation, subsequent folding, and membrane insertion 
(2). Membrane-adhered MBP accumulates on the surface, which increases the binding propensity of a second 
membrane leaflet (3). Once a critical surface occupancy is reached, another insertion and possible folding event 
occurs, resulting in a dense protein phase that forms the 3-nm MDL within the 12-nm membrane stack (4). 
CM, compact myelin; N, non-compact myelin; P, periaxonal space; MDL, major dense line; IPL, intraperiod 
line.
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composition; the negatively charged cytoplasmic leaflet and the high cholesterol content of myelin are most prob-
ably in a delicate balance with the rest of the different lipid species, as shown by experimental disease models9, 49, 65. 
The high abundance of cholesterol has a major impact on membrane fluidity as well as myelin development30, 66, 67, 
likely being a key requirement together with various phosphoinositides68–70 to provide a suitable physiological 
medium for membrane-embedded proteins, including MBP. The stability of the MDL, the condition of MBP 
within it, and the post-natal myelinating machinery should be taken into account when it comes to understand-
ing and possibly treating demyelinating diseases.
To conclude, through the use of multidisciplinary methodologies, the structural importance of MBP as a 
multifunctional compact myelin protein is unfolding. An MBP-driven scheme outlining the formation and sta-
bility of the myelin MDL unravels, while the MDL remains a poorly understood compartment of developmental, 
functional, and medical importance. The molecular steps of formation of the myelin MDL rely on an equilibrium 
between electrostatic and hydrophobic interactions, protein concentration, membrane association, and charge 
accumulation to form the final product: a stable, dense protein phase that occupies the MDL and binds lipid bilay-
ers tightly together. The elucidation of the molecular foundation of MBP-mediated membrane stacking allows 
us to better understand this intriguing biological system, and it could act as a key to unlock the discovery of 
remedies to conditions that present aberrant myelination and disturbed myelin ultrastructure. To further refine 
the model, more complex molecular systems should be studied, such as multiprotein systems including integral 
membrane proteins of myelin. Other myelin proteins, e.g. the cytoplasmic extension of myelin protein zero71 and 
P214, 15, 31, function similarly to MBP, likely leading to functional synergies and possibly competition. Once the 
underlying detailed kinetics and the effects of other molecular components of myelin, including proteins and 
ionic species, on proteolipid membrane association and stacking are deciphered, we can truly understand the 
complexity of myelination in a logical, structured manner.
Methods
Cloning, expression, and purification. A synthetic gene encoding the 18.5-kDa isoform of mouse MBP 
(DNA2.0) was subcloned into the Gateway donor vector pDONR221 (Life Technologies). A Tobacco Etch Virus 
(TEV) protease digestion site (ENLYFQG) was added before the gene, and attB1 and attB2 recombination sites 
before and after the gene, respectively. This entry clone was used to generate an expression clone in the pTH27 
vector72, which codes for an N-terminally His6-tagged protein (His-rMBP).
The expression of His-rMBP was performed in the E. coli BL21(DE3)pLysS RARE strain in LB medium at 
+37 °C using a 2-h induction with 1 mM isopropyl β-D-1-thiogalactopyranoside, after an initial culture OD600 
of 0.3 had been reached. After harvesting, cell pellets were re-suspended into 50 mM HEPES (pH 7.5), 500 mM 
NaCl, 6 M urea, 20 mM imidazole, 1 mM phenylmethylsulphonyl fluoride, with added EDTA-free protease inhib-
itors (Roche), and lysed by ultrasonication. His-rMBP was purified using Ni-NTA chromatography. Elution was 
done using 40 mM HEPES (pH 7.5), 400 mM NaCl, 4.8 M urea, 500 mM imidazole, and the elution fraction was 
dialysed sequentially against several dialysis reservoirs, lowering the urea content in a stepwise manner from 4.8 
to 2 M. After this, recombinant TEV protease was added to digest the N-terminal His6-tag of His-rMBP, resulting 
in a near-native 18.5-kDa rMBP with one extra N-terminal Gly residue from the TEV digestion site. Cleavage 
was carried out overnight at +4 °C, while dialyzing against 40 mM HEPES (pH 7.5), 400 mM NaCl, 1 M urea. 
The digested protein was dialysed back into 50 mM HEPES (pH 7.5), 500 mM NaCl, 6 M urea, 20 mM imidazole, 
and another Ni-NTA purification was performed. The unbound and wash fractions were combined and dialysed 
against 40 mM HEPES (pH 7.5), 400 mM NaCl overnight. After the final dialysis step, protein was concentrated 
and subjected SEC on a Superdex 75 pg column (GE Healthcare). Either HBS (10 mM HEPES, 150 mM NaCl, 
pH 7.5) or 20 mM HEPES (pH 7.5), 300 mM NaCl, 1% (w/v) glycerol was used as the running buffer, depending 
on downstream experiments. The purity of the protein was checked using SDS-PAGE and DLS using a Malvern 
Zetasizer Nano ZS instrument. The SEC fractions containing pure rMBP were snap-frozen using liquid N2 and 
stored at −80 °C. The protein fractions were thawed, pooled, and concentrated immediately before downstream 
experiments.
C-terminally His-tagged MBP (MBP-His20) was expressed and purified similarly to rMBP, omitting TEV 
digestion and the second Ni-NTA step. After the first Ni-NTA step and stepwise dialysis, the protein was imme-
diately subjected to SEC, and the fractions containing pure MBP-His were snap-frozen.
Mass spectrometry. The accurate molecular mass of rMBP was determined using liquid 
chromatography-coupled electrospray ionisation time-of-flight mass spectrometry in positive ion mode, using 
a Waters Acquity UPLC-coupled Synapt G2 mass analyser with a Z-Spray ESI source. The identity of rMBP was 
further verified using peptide fingerprinting by in-gel trypsin proteolysis and matrix-assisted laser desorption/
ionisation time-of-flight mass spectrometry with a Bruker Ultra fleXtreme mass analyser. The peptide finger-
prints were compared directly against theoretical peptides from the protein sequence.
Small-angle scattering. SAXS data for rMBP were collected from samples at 1–4 mg ml−1 on the EMBL 
P12 beamline, DESY (Hamburg, Germany). The buffer contained 20 mM HEPES (pH 7.5), 300 mM NaCl, and 1% 
(w/v) glycerol. Monomeric bovine serum albumin was used as a molecular weight standard. See Supplementary 
Table S1 for further details.
SANS data for 2.3 mg ml−1 (124 µM) MBP in the absence and presence of 0.25% (7.1 mM) DPC micelles were 
collected on the D22 beamline, ILL (Grenoble, France) using a 1-mm pathlength Hellma 100-QS quartz cuvette 
at +10 °C with a 1-h exposure time. The used buffer was 20 mM Tris-HCl (pH 7.5), 150 mM NaCl. The measure-
ments were carried out at 4-m collimation and sample-detector distances, using a monochromatic neutron wave-
length of 6 Å ± 10%. Data were corrected for the transmission, the pathlength, the empty cell, and the blocked 
beam, and scaled to absolute intensity using the measurement of beam flux at the sample position. Neutron 
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scattering data for 5 mg ml−1 DPC micelles in 100, 80, 60, 40, 20, and 0% D2O were collected, and a contrast match 
point of DPC was determined to be 9% D2O, as previously described73. The used D2O solvent contrasts were 9% 
and 98% for MBP with and without DPC, respectively. Initial data processing was done using GRASP (www.ill.
eu/instruments-support/instruments-groups/groups/lss/grasp/home/) and NCNR SANS reduction macros for 
Igor74.
Data were processed and analysed using the ATSAS package75. GNOM was used to calculate distance distri-
bution functions76, and ab initio modelling was performed using GASBOR77. Ensemble optimisation analysis was 
performed using EOM78.
Liposome preparation. Cholesterol, DMPC, DMPE, DMPG, dioleylphosphatidylglycerol (DOPG), 
DOPC, and sphingomyelin were from Larodan Fine Chemicals AB (Malmö, Sweden). DOPS and the deuterated 
d54-DMPC and d54-DMPG were from Avanti Polar Lipids (Alabaster, Alabama, USA).
Lipid stocks were prepared by dissolving dry lipids in chloroform or chloroform:methanol (1:1 v/v) at 
5–10 mg ml−1. Mixtures were prepared from the stocks at desired ratios, followed by solvent evaporation under a 
gentle stream of N2 and freeze-drying for at least 4 h at −52 °C under vacuum. The dried lipids were either stored 
air-tight at −20 °C or used directly to prepare liposomes.
Liposomes were prepared by adding either deionised water or HBS to the dried lipids to reach a final concen-
tration of 2–10 mg ml−1, followed by vigorous mixing and gentle sonication for 15 min in a water bath sonicator at 
ambient temperature, to ensure that no unsuspended lipids remained in the vessel. MLVs were prepared by seven 
cycles of freeze-thawing using liquid N2 and a warm water bath, with vigorous vortexing after each cycle. LUVs 
were prepared by extruding MLVs 11 times through a 0.1-µm membrane on a +40 °C heat block and used imme-
diately in experiments. SUVs were prepared using sonication of MLVs. Either probe tip sonicators (a Branson 
Model 450 and a Sonics & Materials Inc. Vibra-Cell VC-130) or a strong water bath sonicator with temperature 
control (UTR200, Hielscher, Germany) were used to clarify the liposome suspensions, while avoiding overheat-
ing. The SUVs were immediately used in experiments.
Synchrotron radiation circular dichroism spectroscopy. SRCD data were collected from 0.3–
0.5 mg ml−1 protein samples in water on the UV-CD12 beamline at ANKA (KIT, Karlsruhe, Germany)79 and the 
AU-CD beamline at ASTRID2 (ISA, Aarhus, Denmark). Samples with lipids were prepared on-site by mixing 
rMBP and freshly sonicated SUVs, followed by 5–10 min of degassing using a water bath sonicator at ambient 
temperature. 100-µm pathlength closed circular cells (Suprasil, Hellma Analytics) were used. SRCD spectra were 
measured from 170 to 280 nm at +30 °C, and the raw CD units were converted to Δε (M−1 cm−1), using rMBP 
concentration determined from absorbance at 280 nm. SDS and TFE were purchased from Sigma-Aldrich and the 
detergents LDAO, OG, and DPC from Affymetrix. The unfolded nature of rMBP, as well as its tendency to fold in 
DMPC:DMPG (1:1) and DOPC:DOPS (1:1), were reproducible between beamtime sessions.
Differential scanning calorimetry. Various concentrations of rMBP were mixed with MLVs in HBS 
containing 160 µM of either DMPC, DMPC:DMPG (4:1), or DMPC:DMPG (1:1), in a final volume of 700 µl. 
Lipid samples without added rMBP were prepared as controls. The P/L ratio was 1:250–1:1000. The samples 
were incubated at +37 °C for 10 min to ensure thorough protein association with the vesicles, and degassed in a 
vacuum with stirring at +10 °C prior to measurements. All samples were prepared and measured in duplicate, the 
observed trends being reproducible.
DSC was performed using a MicroCal VP-DSC with a cell volume of 500 µl. A HBS reference was used for all 
samples. Each calorimetric cycle (one per sample) was performed from +10 to +50 to +10 °C with 1 °C min−1 
increments. Baselines were corrected and zeroed at +20 °C to make cross-comparison straightforward.
Surface plasmon resonance. SPR was performed on a Biacore T200 system (GE Healthcare). According 
to the manufacturer’s protocol, 100-nm LUVs of 1 mM DMPC:DMPG (1:1) and 1 mM DOPC:DOPS (1:1) were 
immobilised on separate channels on an L1 sensor chip (GE Healthcare) in 20 mM HEPES (pH 7.5), 150 mM 
NaCl, followed by the injection of rMBP. Chip regeneration was done with a 2:3 (v:v) mixture of 2-propanol and 
50 mM NaOH. rMBP was at 20–2000 nM in the running buffer, and a single concentration per each lipid capture 
was studied; all samples were performed in duplicate, with one sample in each series measured twice to rule out 
instrumental artifacts or deviations. The binding response as a function of protein concentration was plotted and 















to gain information about association affinity. For kinetic analyses, all association phases (180 s after injection 
of rMBP) were individually fitted to a one-phase exponential association model using GraphPad Prism 7. The 
obtained kobs values were plotted against rMBP concentration and fitted using linear regression to determine kon 
(slope of the curve) and koff (Y-intercept of the curve). The latter values were extracted from two individually fitted 
datasets: one containing all data (Fitting set 1) as well as one omitting data points below 500 nM rMBP (Fitting 
set 2).
Vesicle aggregation and small-angle X-ray diffraction. SUVs of 0.5 mM DOPC:DOPG (1:1) and 
DMPC:DMPG (1:1), both with and without supplemented 10% (w/w) cholesterol, were mixed with 0.5–10 µM 
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rMBP in duplicate. Turbidity was recorded at 450 nm for 10 min at +25 °C using a Tecan M1000Pro plate reader. 
The results were analysed after turbidity was stable.
SAXD was performed to find the mean repeat distance of rMBP-stacked multilayers in aggregated lipid vesicle 
samples. 2–20 µM MBP was mixed with SUVs of 1–3 mM DMPC:DMPG (1:1) in HBS at ambient temperature 
and analysed at +25 °C on the EMBL P12 BioSAXS beamline, DESY (Hamburg, Germany). Buffer references 
were subtracted from the data. Lipid samples without added rMBP were used to verify the absence of Bragg peaks. 
The peak positions of momentum transfer, s, in rMBP-lipid samples were used to calculate the mean repeat dis-







2 , where s 4 sin
(2)
Atomic force microscopy. Fresh DOPC:DOPS (1:1) and DOPC:DOPS (1:1), 10% (w/w) cholesterol SUVs 
were unrolled on freshly cleaved mica (∅ 1.2 cm) in HBS-Ca (10 mM HEPES, 150 mM NaCl, 2 mM CaCl2, pH 
7.5), by covering the mica entirely with 0.2 mg ml−1 SUVs, incubating for 20 min at +30 °C, and washing twice 
with HBS-Ca.
Freshly prepared samples were imaged in HBS at ambient temperature using an Asylum Research MFP-3D 
Bio instrument and TR800PSA cantilevers (Olympus; spring constant (k) range 0.59–0.68 N m−1, resonance fre-
quency 77 kHz) in alternative current (AC) mode. Square 256 × 256 pixel scans were acquired from areas of 
5–20 µm, with a 90° scanning angle and a scan speed of 0.6–0.8 Hz. The resulting scan images were processed 
with Igor Pro 6.37.
After confirming the presence of lipid bilayers, 0.5–3.6 µM MBP was added onto the bilayer samples in 
HBS. The samples were incubated for 15 min at ambient temperature, washed twice with HBS, and scanned as 
above. For every protein concentration, 2–6 samples were prepared and scanned with excellent reproducibility. 
Scans from at least 3 different areas for each sample were acquired to rule out artifacts originating from sample 
heterogeneity.
Electron microscopy. Protein reconstitution into lipid vesicles. The lipid mixture contained polar brain 
lipid extract (Avanti), palmitoyloleoylphosphatidylcholine (POPC, Avanti), and cholesterol (Anatrace) in the 
ratio 3:1:1. Vesicles were prepared as above, except that organic solvent was evaporated under argon and the 
sample vacuum-dried at room temperature, prior to resuspending in aqueous solvents. For EM experiments, 
0.4 mg ml−1 of rMBP was mixed with 0.4 mg ml−1 polar brain lipid:POPC:cholesterol vesicles in a buffer contain-
ing 20 mM Tris pH 7.5, 200 mM NaCl, 1% glycerol, and the sample was incubated for 24 h at room temperature. 
For negatively stained EM imaging of lipid vesicles, samples containing 730 µM DMPC:DMPG (1:1) SUVs were 
prepared with 0–7.3 µM rMBP, to achieve different P/L ratios. The samples were incubated for 1 h at room tem-
perature before grid preparation.
Negative stain EM. For negatively stained EM, the sample was applied to glow-discharged, thin carbon 
film-coated copper EM grids and incubated for 1 min. The grid was then blotted with paper, washed with 4 drops 
of H2O, and negatively stained with 2 drops of 2% uranyl acetate. Grids were imaged on Philips CM200 TEM 
operated at 200 keV or a Tecnai G2 Spirit 120 kV instrument equipped with a Quamesa CCD camera (Olympus 
Soft Imaging Solutions).
MBP-His reconstituted into lipid vesicles (brain lipids:POPC:cholesterol) was labelled with 5 nm 
Ni-NTA-Nanogold particles (Nanoprobe). The sample was immobilised on a glow-discharged, carbon-coated 
electron microscopy grid prior to labelling. The grid was incubated 30 min upside-down on a droplet of 
0.02 × Nanogold label solution on parafilm. The grid was washed twice with a buffer containing 20 mM Tris pH 
7.5, 200 mM NaCl, 1% glycerol, and 100 mM imidazole, and negatively stained with 2% uranyl acetate.
Nanotube preparation. GalCer-DOGS-NTA-Ni nanotubes were generated as previously described80. MBP-His 
and rMBP (0.4 mg ml−1) were incubated for 1 h with 0.2 nmol ml−1 nanotubes. Samples were imaged with nega-
tive stain or cryoEM.
Cryo EM grid preparation, imaging, and processing. Approximately 3 µl of the samples (~0.4 mg ml−1) were 
applied to glow-discharged Quantifoil holey carbon grids (R 1.2/1.3, R 2/2, or R3.5/1, Cu 400 mesh, Quantifoil 
Micro Tools GmbH, Germany). After 2-s blotting, grids were flash frozen in liquid ethane, using an FEI Vitrobot 
IV (Vitrobot, Maastricht Instruments) with the environmental chamber set at 90% humidity and a temperature 
of 20 °C. Samples were imaged with FEI Titan Krios TEM operated at 300 keV, and images were recorded using 
a Gatan K2-Summit direct electron detector. Images were collected manually in electron-counting mode at a 
nominal magnification of ×22,500 and a calibrated pixel size of 1.3 Å. Each image was dose-fractionated to 40 
frames (8 s in total, 0.2-s frames, dose rate 6–7 e−/pixel/s). Movie frames were aligned with MotionCorr81 and 
preprocessed on the fly with 2dx_automator82. Particles were boxed using e2boxer.py in EMAN283 and further 
processed by SPRING84. In total, from 20 aligned images, 9000 overlapping, CTF-corrected segments with a size 
of 190 Å × 190 Å were used to calculate 2D class averages.
Neutron reflectometry. Supported lipid bilayers were prepared onto flat 80 mm × 50 mm × 15 mm 
Si-crystal blocks (polished by Sil’tronix Silicon Technologies, Archamps, France to a 5 Å RMS roughness 
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tolerance). Three samples were prepared from chloroform-methanol stocks of 1 mg ml−1:DMPC, DMPC:DMPG 
(1:1), and d54-DMPC:d54-DMPG (1:1). The two leaflets of the bilayer were deposited sequentially using the 
Langmuir-Blodgett and Langmuir-Schaefer techniques. Deposition was carried out at a surface pressure held 
constant at 30 mN m−1, following the procedure described previously for mixed, charged lipid systems85, 86. The 
blocks were assembled into low-volume measurement flow cells, to enable the in situ exchange of solvent and 
injection of protein samples87, and transferred directly to the neutron reflectometer for measurement.
Each data point was collected at incident angles of 0.8° and 3.2°, on the D17 neutron reflectometer at the 
ILL (Grenoble, France)88. A slit geometry was used such that full use could be made of the coherent summing 
method for processing the data89, maximizing both intensity and resolution during time-resolved measurements. 
The sample temperature was kept at a constant +30 °C throughout. HBS buffer was used for all measurements, 
prepared at a final concentration of 95% (v/v) deuterium oxide (D2O, Sigma-Aldrich) and in H2O. The bilayers 
were characterised, before and after the introduction of rMBP, at three different solvent contrasts, varying the 
D2O-H2O volume fraction introduced into the sample cell: (1) 95% D2O, (2) water contrast-matched to Si (SMW; 
38-to-62 volume ratio of D2O/H2O), and (3) 100% H2O. During the injection of rMBP, in H2O, time-resolved 
measurements were carried out, cycling between the two angles to give a time resolution of ~15 minutes. rMBP 
was allowed to interact with the membrane for 3 h, until no further changes were seen in the reflectivity. Any 
excess rMBP was then washed out from the bulk solution by pumping solvent slowly through the sample cell, 
until the cell volume had been exchanged 20 times.
Data analysis was carried out using custom procedures with the RasCAL software package (https://source-
forge.net/p/rscl/wiki/Home/). A complete description of the theory and procedures involved in neutron reflec-
tivity analysis for biomembrane systems involving small molecule interactions is discussed elsewhere85. Briefly, 
all equilibrium measurements for one sample, before and after addition of rMBP, were fitted simultaneously with 
the parameters used to describe the silicon oxide thickness, coverage, and interfacial roughness held constant 
between all the contrasts. The lipid bilayers were analysed using just five parameters, using scattering length 
densities and a custom-built model, as described previously in detail86. The parameters used were; area per lipid 
molecule (APM), the number of water molecules associated with the headgroups (H2Ohead) and the tails (H2Otail) 
of each lipid molecule, and the roughness of the system (both local and global). To account for the interaction of 
rMBP with the bilayer after injection, four different models were used to try and fit the data: (1) A layer of MBP 
on top of the membrane but with no penetration in to the bilayer; (2) A layer of MBP on top of the membrane 
and penetrating into the lipid ‘headgroups’ in the outer leaflet of the bilayer, displacing water molecules; (3) A 
layer of MBP on top of the membrane and full insertion in to the outer leaflet of the bilayer, potentially displacing 
both lipid and water molecules from this leaflet; (4) A layer of MBP on top of the membrane and full insertion 
into both leaflets of the bilayer, potentially displacing water and lipid molecules from both. These displacement/
insertion models were set up as quantified and described in earlier work90; in all cases, a new ‘local outer leaflet’ 
roughness was introduced to describe the interface between the lipid heads and the MBP layer. The uncertainty 
on the value of each parameter used to fit the data was calculated by ‘bootstrapping’, a Monte Carlo error analysis 
approach built in to RasCAL, taking into account the error and instrumental resolution per data point91. This 
error estimation provides an indication of the uniqueness of the applied model within the error bars of the data.
Data availability. The datasets generated and analysed during the current study are available from the cor-
responding author on reasonable request.
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Supplementary Fig. 1. The purity, monodispersity, and folding of rMBP. (a) The purity of rMBP 
as determined by SDS-PAGE. (b) Size-exclusion chromatogram of rMBP when analysed using a 
Superdex 75 pg 10/300GL column. (c) Size distribution of rMBP in DLS. (d) The conformational 
changes of rMBP in TFE and various detergents were followed by CD spectroscopy. (e) rMBP 
appears mostly elongated based on SAXS data, when plotted in a Kratky plot.	
 
Supplementary Fig. 2. SANS data analysis. (a) Neutron scattering data of rMBP and DPC-bound 
rMBP. (b) Guinier analysis. (c) Kratky plot. (d) Porod-Debye plot. Comparison of the two datasets 
suggests that in the presence of DPC, rMBP forms a partially folded structure that represents a 
micelle-embedded segment, while still remaining mostly extended. 
  
 
Supplementary Fig. 3. Kinetic analysis of SPR data. The association data (solid lines) of rMBP 
binding to DOPC:DOPS (a) and DMPC:DMPG (b) vesicles were fitted individually to an exponential 
one-phase association binding model (dashed lines). The derived kobs values were plotted against 
rMBP concentration, and the apparent kon and koff values were extracted (see Supplementary Table 2) 
for DOPC:DOPS and DMPC:DMPG by fitting linear functions to the entire data (c) as well as 
omitting all datapoints prior to the critical binding concentration of rMBP (d), which results in a better 
linear function. 
 
Supplementary Fig. 4. Concentration dependence of membrane stacking induced by rMBP 
studied by EM. Vesicle aggregation and membrane stacking is very pronounced when rMBP is 
abundant and gradually decreases together with the concentration of rMBP, as demonstrated by the 
P/L ratios 1:100 (a), 1:200 (b), 1:500 (c), and 1:1000 (d). Empty vesicles are devoid of aggregation (e). 
Scale bar: 100 nm. 
 
Supplementary Fig. 5. NR control binding experiments. (a) rMBP binds perdeuterated d54-
DMPC:d54-DMPG membranes similarly to the hydrogenated membranes. (b) The addition of rMBP to 
DMPC membranes displays reflectograms that are nearly identical to the naked bilayer, indicating that 
rMBP is not binding. Data and fits are plotted on the left. All reflectivity curves have been offset for 
clarity. Scattering length density (ρ) profiles are plotted on the right. The error bars correspond to 




Supplementary Table 1. Small-angle scattering data collection and analysis.		
Data	collection	parameters	
Method;	dataset	 SAXS;	MBP	 SANS;	MBP	 SANS;	MBP	+	0.25%	DPC	
Instrument	 P12,	PETRAIII,	DESY	 D22,	ILL	 D22,	ILL	
Wavelength	(nm)	 0.124	 0.6	 0.6	
Angular	range	(nm-1)	 0.027	-	4.801	 0.12	–	2.364	 0.12	–	2.364	
Exposure	time	(s)	 0.045	 3600	 3600	
Concentration	range	(mg	ml-1)	 1.1	-	4.4	 2.3	 2.3	
Temperature	(°C)	 20	 10	 10	
D2O	contrast	(%,	v/v)	 0	 98	 9	
	Structural	parameters	
I0	(relative)	[from	p(r)]	 5687	 	 	
Rg	(nm)	[from	p(r)]	 4.02	 	 	
I0	(relative)	[from	Guinier]	 5582.53	 0.0178	 0.022	
Rg	(nm)	[from	Guinier]	 3.68	 3.3	 3.5	
Rg	(nm)	[from	EOM	ensemble]	 3.96	 4.4	 3.5	
Dmax	(nm)	[from	GNOM]	 17.82	 12.0	 10.0	
Dmax	(nm)	[from	EOM	ensemble]	 12.92	 13.8	 11.2	
Molecular	mass	determination	
Molecular	mass	Mr	(kDa)	[from	I0	using	p(r)]	 25.8	 	 	
Molecular	mass	Mr	(kDa)	[from	I0	using	Guinier]	 25.4	 	 	
Theoretical	Mr	from	sequence	(kDa)	 18.5	 18.5	 18.5	
	Software	
Primary	data	reduction	 PRIMUS	 GRASP,	NCNR	SANS	 GRASP,	NCNR	SANS	
Data	processing	 PRIMUS	 PRIMUS	 PRIMUS	
Ab	initio	analysis	 GASBOR	 	 	
Conformational	ensemble	analysis	 EOM	 EOM	 EOM	
Validation	and	averaging	 PRIMUS	 PRIMUS	 PRIMUS	
Three-dimensional	graphics	representation	 PyMOL	 	 	
	EOM	model	parameters	
Conformer	#1	
Rg	(nm)	 5.72	 3.38	 3.14	
Dmax	(nm)	 17.81	 10.87	 9.91	
Mass	fraction	 0.07	 0.273	 0.647	
Conformer	#2	
Rg	(nm)	 4.51	 4.75	 5.09	
Dmax	(nm)	 13.31	 13.25	 14.37	
Mass	fraction	 0.14	 0.091	 0.182	
Conformer	#3	
Rg	(nm)	 4.45	 6.42	 3.39	
Dmax	(nm)	 14.20	 19.47	 11.43	
Mass	fraction	 0.07	 0.364	 0.182	
Conformer	#4	
Rg	(nm)	 3.14	 3.57	 	
Dmax	(nm)	 9.34	 12.30	 	
Mass	fraction	 0.07	 0.091	 	
Conformer	#5	
Rg	(nm)	 3.14	 2.92	 	
Dmax	(nm)	 9.47	 9.47	 	
Mass	fraction	 0.36	 0.182	 	
Conformer	#6	
Rg	(nm)	 3.51	 	 	
Dmax	(nm)	 11.82	 	 	
Mass	fraction	 0.14	 	 	
Conformer	#7	
Rg	(nm)	 4.26	 	 	
Dmax	(nm)	 12.83	 	 	
Mass	fraction	 0.07	 	 	
Conformer	#8	
Rg	(nm)	 6.41	 	 	
Dmax	(nm)	 18.65	 	 	
Mass	fraction	 0.07	 	 	












DOPC:DOPS	(1:1)	 4.0		±	0.54	 0.76	±	0.52	 0.77	 5.6	±	0.45	 -1.4	±	0.58	 0.95	
DMPC:DMPG	(1:1)	 3.8	±	0.27	 -0.066	±	0.26	 0.92	 5.0	±	0.23	 -1.8	±		0.30	 0.98	
a Fitting set 1 contains all data points from the linear fit, whereas data points below 500 nM were omitted from 
Fitting set 2. 
b Slope of the linear fit function to kobs(on) vs. [rMBP]. 













Bilayer	 Bilayer	area	per	molecule	(Å2/molecule)	 59	±	7	 58	±	6	 53	±	2	
Water	per	lipid	head	 10	±	2	 10	±	5	 10	±	2	
Water	per	lipid	tail	 6	±	3	 7	±	1	 8	±	2	
Global	bilayer	roughness	(Å)	 20	±	5	 24	±	2	 24	±	2	
Local	bilayer	inner	roughness	(Å)	 5	±	3	 8	±	1	 12	±	1	
Local	bilayer	outer	roughness	(Å)	 1	±	2	 6	±	2	 1	±	1	
rMBP	 rMBP	in	outer	heads	(%)	 0	 28	±	10	 48	±12	
rMBP	in	outer	tails	(%)	 0	 0	 20	±	5	
rMBP	layer	thickness	(Å)	 70	±	20	 56	±	3	 52	±	3	
rMBP	layer	coverage	(%)	 25	±	7	 47	±	10	 37	±	6	
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Abstract 
Compact myelin forms the basis of nerve insulation essential for higher vertebrates. Dozens 
of myelin membrane bilayers undergo tight stacking, and in the peripheral nervous system, 
this is partially enabled by myelin protein zero (P0). Consisting of an immunoglobulin (Ig)-
like extracellular domain, a single transmembrane helix, and a cytoplasmic extension (P0ct), 
P0 harbours an important task in ensuring the integrity of compact myelin in the extracellular 
compartment, referred to as the intraperiod line. Several disease mutations resulting in 
peripheral neuropathies have been identified for P0, reflecting its physiological importance, 
but the arrangement of P0 within the myelin ultrastructure remains obscure. We performed a 
biophysical characterization of recombinant P0ct. P0ct contributes to the binding affinity 
between apposed cytoplasmic myelin membrane leaflets, which not only results in changes 
of the bilayer properties, but also potentially involves the arrangement of the Ig-like domains 
in a manner that stabilizes the intraperiod line. Transmission electron cryomicroscopy of 
native full-length P0 showed that P0 stacks lipid membranes by forming antiparallel dimers 
between the extracellular Ig-like domains. The zipper-like arrangement of the P0 
extracellular domains between two membranes explains the double structure of the myelin 
intraperiod line. Our results contribute to the understanding of PNS myelin, the role of P0 
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Molecular structure and function 
of myelin protein P0 in membrane 
stacking
Arne Raasakka  1,2, Salla Ruskamo  2, Julia Kowal3,4, Huijong Han2, Anne Baumann1,5, 
Matti Myllykoski2, Anna Fasano6, Rocco Rossano7, Paolo Riccio7, Jochen Bürck  8, 
Anne S. Ulrich8,9, Henning Stahlberg  3 & Petri Kursula  1,2
Compact myelin forms the basis of nerve insulation essential for higher vertebrates. Dozens of myelin 
membrane bilayers undergo tight stacking, and in the peripheral nervous system, this is partially 
enabled by myelin protein zero (P0). Consisting of an immunoglobulin (Ig)-like extracellular domain, 
a single transmembrane helix, and a cytoplasmic extension (P0ct), P0 harbours an important task 
in ensuring the integrity of compact myelin in the extracellular compartment, referred to as the 
intraperiod line. Several disease mutations resulting in peripheral neuropathies have been identified for 
P0, reflecting its physiological importance, but the arrangement of P0 within the myelin ultrastructure 
remains obscure. We performed a biophysical characterization of recombinant P0ct. P0ct contributes 
to the binding affinity between apposed cytoplasmic myelin membrane leaflets, which not only 
results in changes of the bilayer properties, but also potentially involves the arrangement of the Ig-
like domains in a manner that stabilizes the intraperiod line. Transmission electron cryomicroscopy of 
native full-length P0 showed that P0 stacks lipid membranes by forming antiparallel dimers between 
the extracellular Ig-like domains. The zipper-like arrangement of the P0 extracellular domains between 
two membranes explains the double structure of the myelin intraperiod line. Our results contribute to 
the understanding of PNS myelin, the role of P0 therein, and the underlying molecular foundation of 
compact myelin stability in health and disease.
Myelin enwraps axonal segments in the vertebrate nervous system, accelerating nerve impulse propagation as well 
as providing trophic and mechanical support to fragile neuronal processes1. The insulative nature of myelin arises 
from its water-deficient structure, compact myelin, where layers of the plasma membrane are stacked upon each 
other and adhered together by specific proteins2. This array of proteins partially differs between the central and 
peripheral nervous systems (CNS and PNS, respectively), and the disruption of PNS compact myelin has a severe 
effect on action potential velocity3. This manifests as a set of medical conditions, including the peripheral neu-
ropathies Charcot-Marie-Tooth disease (CMT) and Dejerine-Sottas syndrome (DSS). Such diseases are incurable 
and difficult to treat, and they show significant genetic background, resulting from mutations in proteins that 
affect the formation or stability of myelin, either directly or indirectly4–7. The development of eventual CMT/
DSS-targeting remedies is hindered by the lack of basic molecular structural knowledge on the formation and 
eventual disruption of PNS myelin8.
Myelin protein zero (P0; also known as MPZ) is the most abundant protein in PNS myelin9. It resides in 
compact myelin and spans the myelin membrane via a single transmembrane helix with an N-terminal immuno-
globulin (Ig)-like domain on the extracellular side of the membrane. A short cytoplasmic tail (P0ct) follows the 
transmembrane domain3. Point mutations in P0 account for 10–12% of all dominant demyelinating CMT type 
1 cases10.
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The extracellular Ig-like domain of P0 is a major contributor to the formation of the myelin intraperiod line11. 
Crystal structures of this domain have provided clues about details of membrane adhesion, and one theory 
involves oligomerization of Ig-like domains from two apposing membranes12,13. This would explain the roughly 
5-nm spacing of the intraperiod line in compact myelin, compared to the 3-nm cytoplasmic compartment, or the 
major dense line, between two cytoplasmic membrane leaflets14–16. Dozens of CMT- and DSS-linked mutations 
have been reported for the Ig-like domain, signifying its importance in myelination17.
At physiological pH, P0ct is a positively charged segment of 69 amino acids, predicted to be disordered in 
solution3. The central part of P0ct (amino acids 180–199 of mature human P0 isoform 1) contains an immu-
nodominant, neuritogenic segment, which can be used to generate animal models with experimental autoim-
mune neuritis (EAN)18. It is noteworthy that most CMT-linked point mutations in P0ct are localized in this 
region17,19–22. P0ct interacts with lipid membranes, and it gains a significant amount of secondary structure upon 
binding23–25. P0ct aggregates negatively charged lipid vesicles23, suggesting that P0ct might harbour a similar 
membrane-stacking function as myelin basic protein (MBP)16 and peripheral myelin protein 2 (P2)26. However, 
the tertiary conformation of P0ct and details of its lipid binding are not fully understood, and the potential func-
tion of P0ct in membrane stacking remains to be further elucidated.
We characterized human P0ct using several complementary methods, to gain a structural insight into its 
membrane binding, insertion, and contribution to myelin membrane stacking. Using electron cryomicros-
copy (cryo-EM), we observed a zipper-like assembly of bovine full-length P0 in reconstituted membranes. 
Additionally, we investigated a synthetic P0ct-derived peptide (P0ctpept), corresponding to the neuritogenic 
sequence, under membrane-mimicking conditions using synchrotron radiation circular dichroism spectroscopy 
(SRCD) and computational predictions. Our results show that P0ct is likely to be involved in maintaining the 
stability of compact PNS myelin together with other cytosolic PNS myelin proteins. A combined approach of EM, 
small-angle X-ray diffraction (SAXD), atomic force microscopy (AFM), and differential scanning calorimetric 
(DSC) suggests that P0ct may have a role in regulating the lateral structure within the membrane, together with 
the ultrastructure formed by the Ig-like domains in the extracellular compartment.
Results
To study the putative function of P0ct as a classical membrane stacking protein, we performed a biophysical char-
acterization, as well as binding experiments with lipids, similarly to our earlier study on MBP16. Additionally, we 
investigated the stacking behaviour of full-length P0 using cryo-EM, and the folding and orientation of P0ctpept 
in membranes with SRCD.
Characterization of P0ct. We purified P0ct to homogeneity using a two-step purification process. P0ct 
appeared as a single band on SDS-PAGE, presenting a monodisperse profile in size exclusion chromatography 
(SEC) with a monomeric mass in solution, as shown with SEC-coupled multi-angle light scattering (SEC-MALS), 
despite its unusual migration in SDS-PAGE (Supplementary Fig. S1a). The obtained mass (7.5 kDa) was very close 
to the one determined using mass spectrometry (7991 Da), matching the expected mass based on the primary 
structure (7990.25 Da).
The folding of P0ct was studied in the presence of different additives using SRCD. The results were as 
expected based on earlier investigations24. P0ct was mostly disordered in solution and gained significant sec-
ondary structure content, when introduced to increasing concentrations of 2,2,2,-trifluoroethanol (TFE), as well 
as n-dodecylphosphocholine (DPC) or sodium dodecyl sulphate (SDS) micelles, but not with n-octylglucoside 
(OG) or lauryldimethylamine N-oxide (LDAO) (Supplementary Fig. S1b).
To investigate the solution behaviour of P0ct, we used small-angle X-ray scattering (SAXS) to reveal that 
P0ct is monomeric and extended (Fig. 1a,b, Supplementary Fig. S1c, Supplementary Table S1), which was best 
explained by a dynamic ensemble of elongated conformers, as observed for MBP (Fig. 1c)16. Similarly to MBP, 
P0ct appeared to favour a slightly compacted conformation over a completely extended one.
P0ct binds irreversibly to lipid structures and influences their properties. A gain in helical struc-
ture of P0ct was observed earlier in membrane-mimicking conditions, including neutral and charged deter-
gent micelles, TFE, and different lipids24. This could represent a physiologically relevant state of folding, which 
prompted us to investigate the lipid interaction propensity of P0ct in the presence of various lipid compositions 
by SRCD (Fig. 2a–c). Magnitude differences in the CD signals were detected between different samples, which 
most likely arose from lipid batch heterogeneity and the resulting differences in protein-lipid turbidity, causing 
light scattering and lowered signal intensity. This did not compromise data interpretation, as the relevant data for 
each comparison were acquired at the same time. Therefore, the SRCD traces in Fig. 2a–c should be compared 
only within panels. We observed a high degree of P0ct folding in the presence of negatively charged small uni-
lamellar vesicles (SUVs), whereas neutral SUVs displayed no gain in secondary structure content compared to 
P0ct in water (Fig. 2a). A 1:1 molar mixture of the fully saturated lipids dimyristoylphosphatidylcholine (DMPC) 
and dimyristoylphosphatidylglycerol (DMPG), enhanced the folding notably compared to a 1:1 mixture of 
dioleoylphosphatidylcholine (DOPC) and dioleoylphosphatidylserine (DOPS), indicating a specific effect by the 
lipid tails, and/or a difference between the negatively charged PG and PS headgroups. The dimyristoyl lipids were 
compared to dioleoyl lipids due to the fact that the bilayer thickness in these cases is nearly identical. Importantly, 
SPR experiments (see below) indicated similar affinities towards both lipid mixtures. To check whether other 
lipid species could influence the folding, we included 10% (w/w) cholesterol, dimyristoylphosphatidylethanola-
mine (DMPE), or sphingomyelin (SM) in DMPC:DMPG (1:1) (Fig. 2b). Cholesterol and SM appeared to slightly 
favour folding, suggesting that P0ct is sensitive to fluidity differences within the membrane, as reported earlier24. 
Additionally, these interactions seem specific from a molecular point of view, as changing between the gel and 
liquid disordered phases of DMPC:DMPG (1:1) via temperature scanning did not influence P0ct folding (Fig. 2c). 
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SM and cholesterol are known to interact27, and together, they contribute to the formation of lipid rafts, in which 
major PNS myelin proteins localize28. These include P0, as well as its known interaction partner peripheral myelin 
protein 22 (PMP22)29,30, for which the presence of SM is absolutely required for reconstitution into functional 
model systems31.
In our model lipid compositions, we did not observe structures rich in β-sheets, and to study more phys-
iologically relevant conditions, we measured SRCD spectra of P0ct in the presence of a native myelin-like 
cytoplasmic leaflet composition, DMPC:dimyristoylphosphatidylserine (DMPS):DMPE:SM:cholesterol 
(25.9:7:29:6.2:31.6), as well as an experimental autoimmune encephalomyelitis (EAE)-like composition, 
DMPC:DMPS:DMPE:SM:cholesterol (20.1:7.4:32.9:2.2:37.4) (Fig. 2b)32. P0ct gained a high amount of second-
ary structure in the presence of native myelin-like lipids, but did not display enriched amounts of β-structure. 
The mixed secondary structure content had a high proportion of α-helix, as evident from the observed double 
minima at 208 and 222 nm. Predominantly β-sheet-rich structures would form a single minimum at 215 nm33. 
The folding was clearly diminished in EAE-like lipids, and a key influencing factor might be the different phase 
behaviour of the two lipid compositions; the EAE lipid composition, which mimics a pathogenic myelin composi-
tion, has been demonstrated to co-exist as mixed lamellar and hexagonal phases in vitro, as opposed to the native 
myelin-like composition, which forms a completely lamellar lipid phase34. Considering the composition, the 
largest relative difference is the much lower fraction of SM in the EAE-like lipids. Judging from the intensity of the 
observed double minima at 209 and 222 nm, the helical folding of P0ct in our model lipids matches the native-like 
lipid composition better than the EAE composition, validating our simplified model system for further studies.
Figure 1. SAXS analysis of P0ct. (a) SAXS data reveals the elongated nature of P0ct. GASBOR and EOM fits are 
plotted over the entire measurement data with their respective χ2 values indicated. (b) The GASBOR ab initio 
model is clearly elongated, measuring up to 8 nm in length. (c) An ensemble of dynamic conformers in solution, 
presenting wide Rg and Dmax populations (left), satisfy the SAXS data well. Most abundant conformers by mass 
are presented as models (right; colored arrows denote the Rg and Dmax values within the analyzed distributions 
from EOM).
www.nature.com/scientificreports/
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The folding of P0ct in the presence of lipid vesicles is a strong indicator of binding, which prompted us to 
study the binding kinetics and affinity using surface plasmon resonance (SPR; Fig. 2d). P0ct irreversibly associ-
ated with immobilized large unilamellar lipid vesicles (LUVs), and comparison of saturated and unsaturated lipid 
tails only revealed differences in maximum response, reflecting the amount of bound P0ct, while the affinity (Kd) 
remained similar (Table 1). These results suggest that the saturated lipids DMPC:DMPG can incorporate more 
P0ct than DOPC:DOPS; furthermore, P0ct gained more secondary structure in the presence of DMPC:DMPG 
(Fig. 2a). We were interested in the underlying kinetics of association; similarly to MBP, we observed a complex 
association pattern16, which could not be analyzed confidently using simple binding models. Data are provided 
here for comparison with earlier data from MBP (Supplementary Fig. S2, Supplementary Table S2). Additional 
studies will be required to shed light on the details of membrane association kinetics of both P0ct, MBP, and other 
myelin proteins.
Having observed a similar lipid-dependent binding behaviour for P0ct as for MBP, we employed differ-
ential scanning calorimetry (DSC) to check for any thermodynamic changes in lipid tail behaviour of large 
Figure 2. Folding and lipid binding properties of P0ct. (a) While P0ct remains disordered in the presence of 
neutral lipid bodies, a large gain in regular secondary structure content is evident especially in the presence 
of DMPC:DMPG (1:1). (b) P0ct appears to fold slightly differently in the presence of vesicles containing 
cholesterol or SM when mixed with a DMPC:DMPG (1:1) composition. Native and EAE-like lipid compositions 
(compositions based on previously published data32) present a different degree of folding. (c) P0ct retains its 
folding in SRCD around the typical DMPC:DMPG (1:1) lipid phase transition temperature. (d) P0ct binds 
immobilized lipid vesicles in SPR. Error bars represent standard deviation. (e) The lipid tails of LMVs with a 
strong negative surface net charge exhibit a second endothermic transition at 22.5 °C upon the addition of P0ct.
Lipid composition Rhi Rlo A1 A2 R2
DOPC:DOPS (1:1) 2617 ± 80.9 29.1 ± 64.7 337.2 ± 20.7 2.44 ± 0.31 0.9800
DMPC:DMPG (1:1) 3309 ± 71.4 19.8 ± 58.4 363.0 ± 15.0 2.76 ± 0.26 0.9893
Table 1. SPR fitting parameters.
www.nature.com/scientificreports/
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multilamellar vesicles (LMVs) in the presence of P0ct (Fig. 2e). While the phase behaviour of neutral lipids 
remained unaffected by the presence of P0ct, displaying only the ~24 °C peak typical for dimyristoyl com-
pounds35, the inclusion of the negatively charged DMPG allowed us to observe an additional endothermic phase 
transition peak around 22.5 °C. The lipid phase transition at 22.5 °C increased in intensity with the addition of 
more P0ct, indicating direct binding to vesicles and concentration dependency. Note that P0ct did not display 
folding differences at temperatures around the observed phase transitions (Fig. 2c), suggesting that P0ct does 
not exist in several temperature-dependent conformational states. P0ct seems to directly interact with lipid tails, 
being capable of affecting the lipid phase behaviour by lowering the phase transition temperature.
P0ct induces the formation of an ordered proteolipid membrane. Since we confirmed the binding 
of P0ct to lipid structures, the next step was to investigate its putative membrane stacking function, as the biologi-
cal function of many myelin proteins relates to multilayer formation. We used turbidimetry to indirectly quantify 
vesicle aggregation by P0ct (Fig. 3a). P0ct induced turbidity in the presence of several lipid mixtures with net 
negative surface charge.
The turbidimetric experiments strongly indicated that P0ct induced vesicle aggregation. To further eluci-
date the level of order within the system, we subjected protein-lipid samples to small-angle X-ray diffraction 
(SAXD) (Fig. 3b,c). While vesicles alone did not show Bragg peaks in the X-ray scattering profile (not shown), 
P0ct induced two intensive Bragg peaks, which changed their position in momentum transfer (s) in a nearly linear 
fashion as a function of protein-to-lipid (P/L) ratio, indicating concentration dependency in the formation of 
order and membrane spacing.
While the vesicle-based experiments provided indirect evidence of membrane stacking, we used atomic 
force microscopy (AFM) to determine whether P0ct can spontaneously stack membranes, similarly to MBP and 
P226 (Fig. 3d). However, under the experimental conditions we employed, P0ct did not form detectable stacked 
systems even at relatively high concentrations, rather appearing to accumulate on membranes, increasing their 
thickness and changing their mechanical properties. The morphology of the membranes changed in the presence 
of P0ct. The smooth, round edges of lipid bilayers appeared much less regular when P0ct accumulated on the 
membrane (Fig. 3c). P0ct seemed to concentrate at the edges of membranes (Fig. 3d), leaving some central parts 
of the SLBs less abundant in P0ct, as suggested by the thickness and rigidity of these regions being similar to SLBs 
not treated with P0ct.
We further exploited EM to check, whether aggregated vesicles form in the presence of P0ct (Fig. 4a–d). 
Surprisingly, the EM data revealed an absence of both vesicle aggregation and well-defined membrane stacks; the 
difference to control lipid samples was the formation of large vesicular bodies in the presence of P0ct, possibly 
formed through P0ct-mediated fusion, at most tested P/L ratios. At high protein concentrations, we observed 
10–20-nm thick filament/tubule-like assemblies, seemingly formed of tightly adhered membranes. This is an 
indication of ordered protein-membrane structures, although such filamentous structures are not present in 
endogenous myelin. It appears that high enough P0ct concentrations may affect membrane bilayer curvature, 
which could be relevant for myelination. It should be noted that in these experiments, the required P/L ratio for 
P0ct to form any kind of visibly stacked systems was roughly an order of magnitude higher compared to MBP16. 
In PNS myelin, full-length P0 can be estimated to comprise up to ~10% of the membrane dry weight. This would 
correspond to a P/L ratio of ~1:300. The concentration of P0 in PNS compact myelin is several-fold higher than 
that of MBP, and P0ct could be functional in membrane stacking in vivo. The large vesicular structures sug-
gest an unexpected mechanism, which does explain the observed turbidity at moderate P/L ratios; at the same 
time, the Bragg peaks in SAXD indicate the presence of well-defined repeat distances, possibly originating from 
local patches of adhered membranes. It is noteworthy that at P/L ratios of 1:50 and 1:100, the Bragg peaks are 
most intensive, and the repeat distance plateaus at 75.0 Å, suggesting that the most condensed structure has been 
reached. A repeat distance of 75 Å is in good corroboration with the thickness of cytoplasmic membrane stacks 
in myelin15; this distance is shorter than that observed with MBP and P2 earlier. These results indicate that P0ct 
can function as a membrane-stacking molecule. Taking all of our results together, the contribution of P0ct in 
membrane stacking per se is most likely low; however, in myelin, P0ct is not free but anchored to the cytoplasmic 
face of the membrane, which could affect its biophysical properties in vivo.
The folding and orientation of P0ctpept in membranes. The P0ctpept peptide has been used to induce 
EAN in animal models18. To shed light on its membrane association and conformation, we studied P0ctpept 
using SRCD and oriented SRCD (OCD). P0ctpept was disordered in solution and gained secondary structure 
in the presence of TFE or negatively charged detergent micelles, and somewhat less in negatively charged lipids 
(Fig. 5a,b). P0ctpept did not fold with neutral lipids, and relatively weakly with negatively charged lipids, except 
with DMPC:DMPG (1:1). In the latter composition, the gain in secondary structure was notable, and the CD 
spectrum does not directly resemble classical α-helical or β-sheet lineshape: the observed maximum and min-
imum at 188 nm and 205 nm, respectively, are close to typical π → π* transitions observed in peptides and pro-
teins with mostly α-helical structures. However, the n → π* band, normally observed as a minimum at 222 nm 
in α-helices, is poorly resolved. While P0ctpept did not gain significant structure in DPC, the negatively charged 
detergent SDS induced higher secondary structure gain than 70% TFE, in contrast to P0ct and several other pro-
teins16,36,37, suggesting a role for electrostatic neutralization in the folding of P0ctpept.
To shed light on the orientation of P0ctpept in membranes, we prepared stacked membranes with P0ctpept on 
planar quartz glass substrates at high relative humidity (>97%). The samples were oriented perpendicular to the 
incident synchrotron radiation beam, and we collected OCD spectra of P0ctpept in DMPC and DMPC:DMPG 
(1:1) membranes (Fig. 5c), which allows the investigation of helix orientation within oriented membranes38,39. 
Comparison of the OCD spectra with isotropic spectra revealed folding in both cases. The OCD spectrum in 
DMPC is weak, but presents helical content, with both minima typical for in-plane helices in bilayers present; 
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Figure 3. P0ct modulates the properties of lipid structures. (a) The turbidity caused by the presence of P0ct in 
SUVs somewhat changes depending on the lipid tail saturation degree or the presence of cholesterol. Error bars 
represent standard deviation. Asterisk: P/L ratio of 1:200. (b) Mixing P0ct with DMPC:DMPG (1:1) SUVs result 
in X-ray diffraction patterns that display two major Bragg peaks per dataset within the measured s-range. Added 
P0ct concentrations of 10 and 20 µM are shown as open and filled markers, respectively. A moving average 
(black line) has been plotted over each dataset, all of which have been offset for clarity. None of the data has been 
scaled in respect to one another. (c) The mean repeat distances, calculated from the s-values corresponding to 
the intensity summit of each Bragg peak, plotted as a function of P/L ratio. Linear fits are shown as solid lines for 
both d1 and d2 distributions. (d) In AFM, P0ct accumulates into supported DOPC:DOPS (1:1) bilayers without 
spontaneous induction of myelin-like membrane stacking, but increases the local thickness of the membrane by 
as much as 2 nm. This is evident especially at the edges of the membranes, where the membrane morphology is 
also changed. The phase difference of the membrane indicates that the mechanical properties of the membrane 
change in these areas, with a larger change at the edges of the membrane, where P0ct is supposedly most 
abundant. Height and phase difference graphs are plotted below the images, with the walk path indicated in red. 
Annotations in phase image walk graphs: m, mica; u, lipid bilayer; p, P0ct-embedded bilayer. Dashed horizontal 
and vertical dividers have been added to aid comparison.
www.nature.com/scientificreports/
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compared to the isotropic spectrum, this reflects the fact that in OCD, there is much less free water phase and the 
peptide is forced to bind to DMPC. In DMPC:DMPG (1:1), the spectral intensity is higher, and the minimum typ-
ically observed at 208 nm is weakened, indicating that the helical segment of P0ctpept is in a tilted orientation with 
respect to the lipid surface, although the shift is not strong enough to represent a completely perpendicular helix.
We generated models of P0ctpept to learn more about its potential conformation. The N-terminal, basic half 
of P0ctpept is likely flexible, whereas the more hydrophobic segment, corresponding to residues 189–199, folds 
into a well-defined helix (Fig. 5d,e). Linking the models to the observed OCD spectra, the peptide most likely 
adopts mixed orientations in DMPC, whereas in the presence of negatively charged headgroups, the N-terminal 
half of P0ctpept can form ionic interactions. This could result in charge neutralization and induce folding into a 
second helical segment, which would adopt a more perpendicular orientation, explaining the measured OCD 
spectrum. The central Pro residue breaks the helix and could allows the two halves to adopt different orientations 
with respect to one another and the membrane. It is possible that as least the central helical segment of P0ct is 
‘anchored’ at the level of the charged headgroups, and as such, is likely to give P0ct a specific orientation in the 
cytoplasmic leaflet of the myelin membrane.
P0 forms an intermembrane zipper composed of Ig-like domains. To complement the character-
ization of P0ct, we investigated membrane stacking by full-length P0, purified from the raft fraction of bovine 
peripheral myelin40. During purification, the protein was embedded in SDS micelles, and after exchange into 
n-decyl-β-D-maltopyranoside (DM), the protein was monodisperse based on negative stain EM (Fig. 6a). SRCD 
investigations of P0 in detergents or net negatively charged lipids showed high structural content (Fig. 6b), and 
monodispersity was further analyzed using SEC-MALS (Fig. 6c, Supplementary Fig. S3). The oligomeric status 
Figure 4. Vesicle fusion and membrane insertion of P0ct. EM concentration series of (a) 1:25, (b) 1:50, (c) 
1:100, (d) 1:250 and (e) 1:500 P/L P0ct in the presence of DMPC:DMPG (1:1) vesicles shows the absence of 
membrane stacks, oppositely to the case of MBP16. The effect resembles vesicle fusion and the formation of large 
lipid bodies. (f) Vesicle control in the absence of P0ct.
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of full-length P0 depended on detergent, and in accordance with earlier studies41,42, both tetrameric and dimeric 
species were observed. The main species in DPC was tetrameric, while LDAO showed the presence of dimeric 
full-length P0. It is noteworthy that the folding of P0ct was different in these two detergents (Supplementary 
Fig. S1b), suggesting a possible involvement of P0ct in the oligomerization of P0.
We reconstituted P0 into SUVs prepared from both DOPC and E. coli polar lipids and imaged the samples 
using cryo-EM. We observed similar membrane stacking in both lipid compositions, suggesting that, under these 
conditions, the lipid composition plays a minor role in membrane stacking by full-length P0 (Fig. 6d–f).
The extracellular domain of P0 was organized between the two apposing lipid bilayers, forming a tightly 
packed zipper consisting of monomers from both apposed membranes (Fig. 6d–f). The thickness of the zipper 
determined the spatial width, measuring 50 ± 10 Å, between the membrane leaflets – a physiologically relevant 
value present in natural myelin, as shown by X-ray diffraction of myelin extracts14,15. Each bilayer measured a 
typical 45-Å thickness. The distance between the apposing P0 monomers was 10–15 Å, if not in direct contact, 
whereas the spacing between lateral P0 monomers was 25–30 Å. It is realistic to assume that similar distances 
are present in native myelin, P0 constituting up to 50% of total protein in myelin. The tightly packed, uniform, 
zipper-like arrangement suggests that even though the underlying intermolecular interactions might be rela-
tively weak at the level of single molecules, the large surface interaction area formed by a P0-enriched membrane 
can generate a strong force for keeping apposed membranes tightly together, both on the extracellular and 
cytosolic sides.
Figure 5. Folding of P0ctpept. (a) SRCD data show that P0ctpept only displays folding with negatively charged 
SUVs. The most notable spectrum is the DMPC:DMPG (1:1) spectrum, which does not resemble classical 
helical content, nor β-sheets. (b) The effect of TFE and detergents on the conformation of P0ctpept. While P0ctpept 
only displays marginal folding with DPC, SDS induces an even higher secondary structure gain than 70% TFE, 
indicating the major importance of electrostatics in the folding of P0ctpept. (c) OCD data of P0ctpept in DMPC 
and DMPC:DMPG (1:1). Isotropic spectra are shown for reference. The DMPC OCD data is weak, typical for 
an aggregated sample, while also showing traces of helical content. The DMPC:DMPG (1:1) data displays clear 
folding and a more perpendicular orientation within the membrane. A simple cartoon has been drawn for 
clarity for both OCD datasets. Colors match the shown data. (d) Superposition of five predicted structures of 
P0ctpept reveal the N-terminus likely to be disordered, followed by a kinking Pro (black asterisk), and a helical 
C-terminal segment. (e) Helical wheel projections of the basic N-terminal half (left) and the hydrophobic 
half (right) of P0ctpept. The residues are colored based on chemical properties with matched indications in the 
peptide sequence (down). The underlined segments are shown in the projections. The potentially helix-breaking 
Pro has been indicated with an asterisk.
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Discussion
The cytoplasmic domain of P0 is disordered in solution, and once it irreversibly interacts with negatively charged 
lipids, it folds and becomes embedded, influencing the physical behaviour of the lipids within the membrane, but 
also potentially inducing larger-scale structural membrane reorganization. P0ct gains helical secondary structure 
with lipids, rather than the β-sheet-rich structures suggested earlier24. This was notable also in a lipid composition 
that resembles the cytoplasmic leaflet of myelin, and the degree of folding was diminished in an EAE-like lipid 
composition.
Similarly to MBP16, the initial association of P0ct with lipids is governed by electrostatics, suggesting that 
P0ct possesses similar physicochemical properties as MBP within the myelin environment. However, due to the 
folding differences observed in SRCD with different lipid tails, correlated with amount of protein bound in SPR, 
one can speculate that the membrane-bound concentration of P0ct may influence its overall folding population. 
Already early studies in the 1930s and 1940s have shown that native myelin is an ordered structure diffracting 
X-rays43,44. P0ct stacks membranes at such a level of order that X-ray diffraction bands are observed, and a repeat 
distance of 75 Å can be deduced in the multilayers. Lipid-bound MBP, having a high content of PE and low 
Figure 6. Full-length P0 in a membrane environment. (a) Cryo-EM of full length P0 displays good 
monodispersity in 0.4% DM. (b) SCRD spectra of full length P0 in detergents and lipids. (c) Analysis of full-
length P0 monodispersity and oligomeric state using SEC-MALS. Shown are data measured in DPC. The 
Rayleigh ratio is shown (black) together with the total mass (gray dash), protein mass (red) and detergent 
mass for each peak (gray solid). (d) P0 reconstituted into DOPC and E. coli polar lipid extract vesicles 
result in membrane stacks that resemble myelin. (e) Cryo-EM micrographs of E. coli polar lipid extract 
with reconstituted P0. Both curved loosened and planar tight bilayer adhesions are present. In the latter, a 
significantly higher protein density between the membranes is evident. The loose and tight areas are marked 
with red arrows and white asterisks, respectively. (f) 2D class averages generated from the tight adhesions of P0 
in E. coli polar lipids sample cryo-EM micrographs display a zipper of apposing Ig-like domains that interact 
with each other and settle between the two lipid bilayers.
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content of bound cholesterol and SM, was shown to similarly generate stacked multilayers with repeat distances 
between 70–85 Å45. Our study provides evidence that P0ct may not harbour a similar role in the formation of 
the major dense line as MBP, although it is definitely able to bridge charged membranes together at high protein 
concentrations in vitro. In this respect, it is important to remember that in vivo, P0ct is an extension of the trans-
membrane domain of P0, and solidly anchored to the membrane surface, possibly allowing stronger effects on 
membrane stacking than observed with the P0ct in isolation.
Our cryo-EM experiments on full-length P0 reconstituted into bilayers answer an important question regard-
ing the arrangement of the intraperiod line: the Ig-like domains of P0 organize into apposed dimers, forming a 
zipper between the two membranes. This is apparently independent of lipid composition, and the interaction is 
mediated directly through the Ig-like domains. The data clearly indicate that the Ig-like domain of P0 from one 
membrane does not bind directly to the apposing membrane, but two rows of Ig-like domains are present in the 
extracellular compartment. This arrangement explains the double structure observed at the intraperiod line in 
high-resolution electron micrographs46. Full-length P0 from the raft fraction, purified with the protocol used in 
our experiments, contains lipids typical of raft microdomains, including cholesterol and sphingomyelin, as well as 
N-linked glycan structures belonging to hybrid types40. The glycan moieties present in P0 were in an earlier study 
suggested to play a role in the assembly of complex structures and different populations of P0 partitioning in and 
outside the raft microdomains of PNS myelin40. The latter suggestion stems from the varying glycan content of P0 
extracted from different myelin membrane subdomains.
From our data, it is not yet possible to observe atomic resolution details of dimerization. To understand P0 
assembly in myelin, the crystal structure of the P0 extracellular domain can be used. As discussed in the original 
publication12, the packing of the P0 Ig-like domain in the crystal state provides a potential dimerization scheme 
with one N-terminal β-strand of each apposing dimer forming an antiparallel β sheet (Fig. 7). In this assembly, the 
C terminus of each Ig domain monomer, near the start of the transmembrane helix, would directly face a mem-
brane surface. The single 26-residue transmembrane helix of P0 is predicted to be roughly 4.5 nm long, spanning 
a single lipid bilayer.
While P0 dimerizes through apposing Ig-like domain monomers, the adjacent dimers in the lateral dimension 
are separated from one another, forming a uniformly spaced, lattice-like structure. Therefore, the lateral archi-
tecture is likely to be achieved by other factors than the Ig-like domains alone, perhaps through contributions 
by P0ct on the cytoplasmic face. Our diffraction studies suggest that P0ct is capable of forming higher order 
structures with membranes, indicating stable molecular interactions (Fig. 7). One can speculate that the function 
of P0ct is twofold: Firstly, P0ct may affect the lateral organization of P0 molecules in a manner that spaces the Ig 
Figure 7. Model for the ultrastructure of the intraperiod line. Potential arrangement of P0 in the intraperiod 
line and lipid bilayers. Antiparallel apposing Ig-like domains interact weakly with each other through a β-strand 
stretch (red dotted circle; based on crystal contacts in PDB ID 1neu12) and form the basis of membrane stacking 
in the extracellular space. This arrangement results in the C-terminal end of the crystal structure to face the 
membrane, which logically would continue into the subsequent transmembrane helix. Additionally, the size of 
the antiparallel dimer is similar to the width of the intraperiod line. While the lateral Ig-like domain monomers 
are not necessarily in close contact with one another, P0ct anchors onto the cytoplasmic phospholipid 
headgroups through electrostatic interactions, gaining folding and potentially forming a stable, ordered protein 
lattice within the membrane, which forces P0 molecules to adjacency, including the extracellular domains. 
Additionally, P0ct changes the phase transition properties of the lipid bilayer, potentially influencing the 
stiffness and stability of PNS compact myelin, given that P0ct is capable of changing the mechanical properties 
of membranes in its bilayer-bound state. The given lengths in brackets match the measured dimensions from the 
crystal structure, cryo-EM micrographs, and SAXD.
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domains on the extracellular side in a manner productive for membrane stacking. The formation of organized 
P0-rich areas could provide a strong enough interaction surface to keep the apposing bilayers together. This 
apposition would be primarily mediated by the orientation and even spacing of the Ig-like domains to allow the 
subsequent ‘zipper structure’; this arrangement of P0 could be affected by attractive and/or repulsive interac-
tions between P0ct moieties on the cytoplasmic leaflet. The details of such interactions remain to be determined. 
Secondly, P0ct influences the phase behaviour of the membrane itself by destabilizing the gel phase by lowering 
the Tm, potentially by directly associating with certain lipid species, including saturated lipid tails, cholesterol, 
and SM, which influence lipid behaviour that favours productive stacking and the stability of myelin. This could 
also contribute to the lateral organization of P0 and its interaction partners, such as PMP2229,30. Similarly to P0, 
mutations in PMP22, many of which are located in transmembrane helices, are hallmark features of CMT and 
DSS47. Changes in the properties and conformation of proteins inside the myelin membrane can have a significant 
impact on myelin morphology and disease etiology.
Our studies involving the folding of P0ct and P0ctpept suggest a strong influence of lipid electrostatics. While 
both display folding in the presence of negatively charged lipids, P0ctpept appears to gain a tilted orientation in 
the membrane upon charge neutralization. This neuritogenic segment of P0ct can directly interact with lipid 
headgroups and fold into a rigid segment, and as the cytoplasmic side of the lipid bilayer is negatively charged, 
P0ct could adopt a defined orientation within the membrane. Other positively charged regions of P0ct might 
function in a similar manner. The adoption of a specific orientation in a membrane would aid in the formation of 
higher-order structures, which in turn could alter the behaviour, morphology, and rigidity of the membrane per se 
–as exemplified by our EM results at high protein concentrations. In general, membrane curving has been linked 
to phenomena highly relevant to P0 behaviour observed here at the molecular level; these include the asymmetric 
insertion of proteins to membrane leaflets, as well as the oligomerization of protein monomers into structures 
stabilizing a curved membrane shape48.
The current study sheds light on the role of P0 at both the major dense line and the intraperiod line. If P0ct 
stabilizes the arrangement of P0 within a membrane, its importance for the integrity of myelin becomes obvious, 
and hints of potential molecular disease mechanisms arising from mutations within P0ct, many of which are spe-
cifically located within the neuritogenic helical sequence. The impact of these mutations has not yet been studied 
at the molecular level. Once the molecular basis of the disease mutations in P0ct has been solved, more functional 
aspects of P0ct will unravel, contributing to a better understanding of PNS compact myelin and its relation to 
CMT disease etiology.
Experimental Procedures
Cloning, protein expression, and Purification. A synthetic gene encoding for the 69 C-terminal res-
idues (amino acids 151–219) of mature human myelin protein zero isoform 1 (UniProt ID: P25189) was trans-
ferred into the Gateway donor vector pDONR221 (Life Technologies). A tobacco etch virus (TEV) protease 
digestion site (ENLYFQG) was added before the gene, and the required attB1 and attB2 recombination sites 
before and after the gene, respectively. This entry clone was used to generate an expression clone in the pHMGWA 
vector49, which encodes for an N-terminal His6-tag, followed by a segment encoding for maltose-binding pro-
tein (MaBP), and finally followed by the inserted P0ct gene itself (His-MaBP-P0ct). A Cys153Leu mutation was 
included in the construct for two reasons: this cysteine is known to be palmitoylated in vivo, and free cysteines 
in small, disordered proteins are reactive and can easily result in unwanted intermolecular disulfides37. While 
the introduced Leu residue is not comparable to native palmitoylation, it does manifest as a bulky hydrophobic 
residue, whilst keeping the protein in a soluble state.
His-MaBP-P0ct was expressed in Escherichia coli BL21(DE3) using 0.4 mM IPTG induction for 3 hours in 
LB medium, at 37 °C. After expression, the cells were collected using centrifugation, broken by ultrasonication 
in Ni-NTA washing buffer (40 mM HEPES, 400 mM NaCl, 20 mM imidazole, pH 7.5) supplemented with an 
EDTA-free protease inhibitor cocktail (Roche). Purification was performed using Ni-NTA affinity chromatogra-
phy using standard procedures. Elution was performed using 32 mM HEPES, 320 mM NaCl, 500 mM imidazole, 
pH 7.5. The eluted protein was pre-dialyzed at 4 °C with constant stirring against 40 mM Tris-HCl, 400 mM NaCl, 
1 mM DTT, pH 8.5, before addition of recombinant TEV protease for His-MaBP tag removal50. Quantitative 
proteolysis was achieved by overnight dialysis, which resulted in cleaved P0ct with an additional N-terminal Gly 
residue. After this, sequential SEC using a HiLoad Superdex 75 pg 16/60 column (GE Healthcare) was used to 
separate the cleaved protein from any contaminants, TEV protease, and the cleaved tag, resulting in pure, mon-
odisperse P0ct. Depending on downstream application, either 20 mM HEPES, 300 mM NaCl, 1% (w/v) glycerol, 
pH 7.5 (SEC buffer) or 20 mM HEPES, 150 mM NaCl, pH 7.5 (HBS) was used as size-exclusion buffer.
Full length P0 was obtained from the raft fraction of bovine nerves as described40. The SDS extract was 
lyophilized until use. The protein was redissolved in water to regain the original buffer conditions and recon-
stituted into lipid membranes or other detergents through extensive dialysis. For EM imaging, control samples 
were taken from redissolved, non-reconsituted samples to control for the presence of putative membranes and 
multilayers from the original tissue source.
Mass spectrometry. The identity and accurate molecular weight of P0ct were verified by mass spectrometry. 
In short, the undigested mass of P0ct was determined using ultra-performance liquid chromatography (UPLC) 
coupled electrospray ionization (ESI) time-of-flight mass spectrometry in positive ion mode using a Waters 
Acquity UPLC-coupled Synapt G2 mass analyzer with a Z-Spray ESI source. The identity of P0ct was determined 
using peptide fingerprinting as described earlier for MBP16.
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Multi-angle light scattering. SEC-MALS was used to determine the monodispersity and molecular weight 
of P0ct in solution. Chromatography was performed using an Äkta Purifier (GE Healthcare) and a Superdex 75 pg 
10/300GL (GE Healthcare) column with 20 mM HEPES, 300 mM NaCl, pH 7.5 as mobile phase. A 250-µg P0ct 
sample was injected into the column at an isocratic flow of 0.4 ml/min, and light scattering recorded using a Wyatt 
miniDAWN TREOS instrument. The UV signal recorded at 280 nm was used as concentration source using the 
extinction coefficient of P0ct (Abs 0.1% = 1.061) calculated using ProtParam51. Data were analyzed using the 
ASTRA software (Wyatt).
Full length P0 was similarly run on SEC-MALS in the presence of different detergent micelles. The run-
ning buffer contained 250 mM sodium phosphate (pH 8.0), 1 mM EDTA, and 0.1% of either DPC or LDAO. A 
Superdex 200 column was used in the experiment. The protein conjugate analysis routine in the ASTRA software 
was used to obtain the molecular weight of P0 and the detergent in the separated peaks.
Small-angle X-ray scattering. SAXS data for P0ct were collected from samples at 1.1–4.2 mg ml−1 in SEC 
buffer on the EMBL P12 beamline, DESY (Hamburg, Germany). Monomeric bovine serum albumin was used as 
a molecular weight standard. See Supplementary Table 1 for further details. Data were processed and analyzed 
using the ATSAS package52. GNOM was used to calculate distance distribution functions53, and ab initio model-
ling was performed using GASBOR54. Ensemble optimization analysis was performed using EOM55.
Vesicle preparation. Cholesterol, DMPC, DMPG, DMPS, DOPC, DOPG and SM were purchased from 
Larodan Fine Chemicals AB (Malmö, Sweden). DMPE, DOPS and the deuterated d54-DMPC and d54-DMPG 
were purchased from Avanti Polar Lipids (Alabaster, Alabama, USA).
Lipid stocks were prepared by dissolving the dry lipids in chloroform or chloroform:methanol (1:1 v/v) at 
10 mg ml−1. All mixtures were prepared from the stocks at desired molar or mass ratios, followed by solvent evap-
oration under an N2 stream and freeze-drying for at least 4 h at −52 °C under vacuum. The dried lipids were either 
stored air-tight at −20 °C or used directly to prepare liposomes.
Liposomes were prepared by agitating dried lipids with either water or HBS at a concentration of 2–10 mg ml−1, 
followed by inverting at ambient temperature, to ensure that no unsuspended lipids remained in the vessel. MLVs 
were subjected to freeze-thawing using liquid N2 and a warm water bath, with vigorous vortexing afterwards. 
Such a cycle was performed 7 times. LUVs were prepared by passing fresh MLVs through a 0.1-µm membrane 11 
times on a 40 °C heat block. SUVs were prepared by sonicating fresh MLVs. Either probe tip sonicators (a Branson 
Model 450 and a Sonics & Materials Inc. Vibra-Cell VC-130) or a water bath sonicator with temperature control 
(UTR200, Hielscher, Germany) were used to clarify the liposome suspensions, while avoiding overheating. All 
lipid preparations were immediately used for the designated experiments.
Synchrotron radiation circular dichroism spectroscopy. The synthetic P0ctpept peptide (NH2- 
ASKRGRQTPVLYAMLDHSRS-COOH) was ordered from GenScript as 5 mg lyophilized aliquots, which were 
dissolved directly in water. Folding predictions of P0ctpept were generated using PEP-FOLD56.
Full-length P0 was studied with SDS, LDAO, and DOPC:DOPS. For preparing P0 in detergents, the sample 
from purification was dialyzed against 10 mM sodium phosphate buffer (pH 8.0) containing either 0.1% SDS or 
0.1% LDAO. For reconstitution into lipids, DOPC:DOPS (1:1) were added to 1 mg/ml, and dialysis was carried 
out against 10 mM sodium phosphate buffer (pH 8.0).
Isotropic SRCD data were collected from 0.2–0.5 mg ml−1 protein and peptide samples in water on the 
UV-CD12 beamline at KARA (KIT, Karlsruhe, Germany)39 and the AU-CD beamline at ASTRID2 (ISA, Aarhus, 
Denmark). We used unbuffered conditions to exclude any unwanted effects, like the electrostatic binding of inor-
ganic phosphate to P0ct, which could interfere with protein binding to detergents and phospholipids. Samples 
containing lipids were prepared right before measurement by mixing P0ct (P/L ratio 1:200) or P0ctpept (P/L ratio 
1:25) with freshly sonicated SUVs, followed by degassing in a water bath sonicator at ambient temperature for 
5–10 min. 100-µm pathlength closed cylindrical cells (Suprasil, Hellma Analytics) were used for the measure-
ments. Spectra were recorded from 170 to 280 nm at 30 °C and truncated based on detector voltage levels as well 
as noise. After baseline subtraction, CD units were converted to Δε (M−1 cm−1), using P0 and P0ct concentration 
determined from absorbance at 280 nm, or by calculating from the stock concentration of the peptide. SDS and 
TFE were purchased from Sigma-Aldrich and the detergents LDAO, OG, DM, and DPC from Affymetrix. P0ct 
and P0ctpept were measured several times in the absence of additives, as well as with DOPC:DOPS (1:1) and 
DMPC:DMPG (1:1) and the observed spectra were deemed reproducible – the observed trends were always the 
same and the spectral maxima and minima were accurately present at their typically observed wavelengths.
OCD spectra were measured at the UV-CD12 beamline at KARA (KIT, Karlsruhe, Germany)39. 10 µg of P0ct 
was mixed with 200 µg DMPC or DMPC:DMPG (1:1) SUVs to yield 1:50 P/L samples in water, which were care-
fully dispensed on quartz glass plates (Suprasil QS, Hellma Optik GmbH, Jena, Germany) within a circular (∅ 
1.2 cm) area and allowed to dry at ambient temperature. A background sample without peptide was also prepared. 
The samples were assembled into humidifier chambers containing a saturated K2SO4 solution, and allowed to 
swell for 16 hours at 30 °C and over 97% relative humidity. After the swelling-induced formation of oriented lipid 
bilayers, the sample chambers were mounted on the beamline (swelled sample perpendicular to the incident 
beam) and allowed to equilibrate to the original 30 °C temperature and >97% relative humidity. Single-scan spec-
tra were recorded from 170 to 280 nm in 0.5 nm steps at sample rotation angles 0, 45, 90, 135, 180, 225, 270, 315°. 
The eight spectra were averaged and the lipid background spectrum was subtracted from the sample spectrum.
Differential scanning calorimetry. P0ct was mixed with MLVs in HBS at several protein-to-lipid ratios 
(1:250–1:1000), always containing 160 µM of either DMPC, DMPC:DMPG (4:1), or DMPC:DMPG (1:1), in final 
volumes of 700 µl. Lipid samples without P0ct were prepared as controls. The samples were incubated at 37 °C for 
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10 min to ensure thorough protein association with the vesicles, and degassed for 10 min in vacuum with stirring 
at 10 °C before measurements.
DSC was performed using a MicroCal VP-DSC calorimeter with a cell volume of 527.4 µl. The reference 
cell was filled with HBS. Each sample was scanned from 10 to 50 °C and again back to 10 °C in 1 °C min−1 
increments. Baselines were subtracted from sample curves and zeroed between 15 and 20 °C to enable easier 
cross-comparison. All samples were prepared and measured twice, with the underlying trends being reproducible.
Surface plasmon resonance. SPR was performed on a Biacore T200 system (GE Healthcare). According 
to the manufacturer’s instructions, 100-nm LUVs of 1 mM DMPC:DMPG (1:1) and 1 mM DOPC:DOPS (1:1) 
were immobilized on separate channels on an L1 sensor chip (GE Healthcare) in HBS, followed by the injection 
of P0ct. Chip regeneration was performed using a 2:3 (v:v) mixture of 2-propanol and 50 mM NaOH. The used 
P0ct concentrations were 20–2000 nM in HBS, and a single concentration per each lipid capture was studied; all 
samples were prepared and measured in duplicate. In each run, a single sample was measured twice to rule out 













to gain information about association affinity. For kinetic analyses, all association phases (180 s after injection 
of P0ct) were individually fitted to a one-phase exponential association model using GraphPad Prism 7. The 
determined kobs values were plotted against P0ct concentration and fitted using linear regression to determine kon 
(slope of the curve) and koff (Y-intercept of the curve). The values were extracted from two individually fitted data-
sets: one containing all data (Fitting set 1) as well as one omitting all data points below 350 nM P0ct (Fitting set 2).
Vesicle turbidimetry and X-ray diffraction. For turbidimetric measurements, SUVs of 0.5 mM 
DOPC:DOPG (1:1) and DMPC:DMPG (1:1), both with and without supplemented 10% (w/w) cholesterol, were 
mixed with 0.5–10 µM P0ct in duplicate. Light scattering was recorded at 450 nm for 10 min at 25 °C using a Tecan 
M1000Pro plate reader. The results were analyzed after the observed optical density per time had stabilized.
SAXD experiments were performed to investigate any repetitive structures in turbid samples. 10 and 20 µM 
P0ct was mixed with SUVs of 1–3 mM DMPC:DMPG (1:1) in HBS at ambient temperature and exposed at 25 °C 
on the EMBL P12 BioSAXS beamline, DESY (Hamburg, Germany). A HBS buffer reference was subtracted from 
the data. Lipid samples without added P0ct were devoid of Bragg peaks. The peak positions of momentum trans-








2 , where s 4 sin
Atomic force microscopy. Fresh DOPC:DOPS (1:1) SUVs were unrolled on freshly cleaved mica (∅ 
1.2 cm) in HBS-Ca (10 mM HEPES, 150 mM NaCl, 2 mM CaCl2, pH 7.5), by covering the mica entirely with 
0.2 mg ml−1 SUVs, followed by a 20-min incubation at 30 °C, and washing twice with HBS-Ca.
The samples were imaged immediately in HBS at ambient temperature using an Asylum Research MFP-3D 
Bio instrument. TR800PSA cantilevers (Olympus; spring constant (k) range 0.59–0.68 N m−1, resonance fre-
quency 77 kHz) were used in alternative current (AC) mode. Square 256 × 256 pixel scans were acquired from 
areas between 5–20 µm, using a 90° scanning angle and a 0.6–0.8 Hz scan speed. The resulting scan images were 
processed in Igor Pro 6.37.
After confirming the presence of lipid bilayers, 1.8–10 µM P0ct was added onto the bilayer samples in HBS. 
After a 15-min incubation period at ambient temperature, the bilayers were washed twice with HBS, and imaged 
as above. For each protein concentration, 2 samples were prepared and scanned with identical results. At least 3 
different parts per sample were scanned to gain an insight into any sample heterogeneity.
Electron microscopy. For negative stain EM, 740 µM DMPC:DMPG (1:1) SUVs were mixed with P0ct using 
protein-to-lipid ratios of 1:25, 1:50, 1:100, 1:200 and 1:500 and incubated at 22 °C for 1 h. EM grids with P0ct or 
full-length P0 samples were then prepared, stained, and imaged as described7,16.
For cryo-EM, full-length P0 (0.9 mg/ml) was reconstituted into lipid membranes, after dissolving the 
lyophilized protein extract in 10 mM sodium phosphate (pH 8.0), 0.4% DM. P0 was mixed with E. coli polar lipids 
or DOPC (both at 5 mg/ml in 2% DM) at lipid-to-protein ratio of 0.5 (w/w) and dialyzed against 10 mM sodium 
phosphate (pH 8.0) for 5 days at 37 °C. The total ternary mixture volume was 65 µl.
Approximately 3 µl of the P0 reconstituted into E.coli polar lipids (~0.65 mg ml−1) were applied onto 
glow-discharged Quantifoil holey carbon grids (R 1.2/1.3, R 2/2, or R3.5/1, Cu 400 mesh, Quantifoil Micro 
Tools GmbH, Germany). After 2-s blotting, grids were flash frozen in liquid ethane, using an FEI Vitrobot IV 
(Vitrobot, Maastricht Instruments) with the environmental chamber set at 90% humidity and a temperature 
of 20 °C. Samples were imaged with FEI Titan Krios TEM operated at 300 keV, and images were recorded using 
a Gatan K2-Summit direct electron detector. Images were collected manually in electron-counting mode at a 
nominal magnification of ×22,500 and a calibrated pixel size of 1.3 Å. Each image was dose-fractionated to 40 
frames (8 s in total, 0.2-s frames, dose rate 6-7 e−/pixel/s). Movie frames were aligned with MotionCorr57 and pre-
processed on the fly with 2dx_automator58. For image processing were used 20 drift-corrected cryo-EM images. 
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Particles were boxed and segmented using e2boxer.py in EMAN259. From all images more than 9000 overlapping, 
CTF-corrected, segments with size of 160 × 160 pixels (208 Å × 208 Å) were selected. 2D class averages of P0 
between lipid bilayers were calculated with SPRING software60.
Data Availability
The datasets generated and analyzed during the current study are available from the corresponding author on 
reasonable request.
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Supplementary Fig. S1. The purity, monodispersity, and folding of P0ct. (a) SEC-MALS 
profile of P0ct displays a mostly monodisperse preparation, with a single major peak 
corresponding to P0ct when eluting from a Superdex 75 10/300GL column. The calculated 
mass (7.5 kDa) matches that of a P0ct monomer. SDS-PAGE analysis of the purity of P0ct 
fractionated with a Superdex 75 16/60 HiLoad SEC column is shown as inset. (b) P0ct gains 
significant secondary structure content in TFE, DPC and SDS, but not in LDAO or OG, as 
shown using CD spectroscopy. (c) The Kratky plot displays the highly elongated nature of 
P0ct. (d) The SRCD spectra of P0ct in DMPC:DMPG (1:1) display different degrees of 
folding at different P/L ratios, 1:200 producing the strongest signal. 
  
 
Supplementary Fig. S2. Kinetic analysis of SPR association data. The data (solid lines) of 
irreversible P0ct association with DOPC:DOPS (1:1) and DMPC:DMPG (1:1) (shown as 
panels a and b, respectively) vesicles fitted individually to an exponential one-phase binding 
model (dashed lines). (c) The derived kobs values plotted against P0ct concentration, with the 
DOPC:DOPS (1:1) and DMPC:DMPG (1:1) data fitted to linear functions (see 
Supplementary Table 2 for the extracted kon and koff values). (d) Same data but all data points 
below the critical binding concentration have been omitted, resulting in a better linear fit. 
  
 
Supplementary Fig. S3. SEC-MALS of P0 in LDAO. Analysis of full-length P0 
monodispersity and oligomeric state using SEC-MALS in LDAO. The Rayleigh ratio is 
shown (black) together with the total mass (gray dash), protein mass (red) and detergent mass 
for each peak (gray solid). 
  
Supplementary Table S1. SAXS parameters.  
 
Data collection parameters 
Instrument P12, PETRAIII, DESY 
Wavelength (nm) 0.124 
Angular range (nm-1) 0.027 - 4.801 
Exposure time (s) 0.045 
Concentration range (mg ml-1) 1.1 - 4.2 
Temperature (°C) 20 
Structural parameters 
I0 (relative) [from p(r)] 1882 
Rg (nm) [from p(r) ] 2.67 
I0 (relative) [from Guinier] 1892 
Rg (nm) [from Guinier] 2.46 
Rg (nm) [from EOM ensemble] 2.69 
Dmax (nm) [from GNOM] 11.06 
Dmax (nm) [from EOM ensemble] 8.03 
Molecular mass determination 
Molecular mass Mr (kDa) [from I0 using p(r)] 8.4 
Molecular mass Mr (kDa) [from I0 using Guinier] 8.4 
Theoretical Mr from sequence (kDa) 7.99 
 Software 
Primary data reduction PRIMUS 
Data processing PRIMUS 
Ab initio analysis GASBOR 
Conformational ensemble analysis EOM 
Validation and averaging PRIMUS 
Three-dimensional graphics representation PyMOL 
 EOM model parameters 
Conformer #1 
Rg (nm) 2.488 
Dmax (nm) 7.904 
Mass fraction 0.182 
Conformer #2 
Rg (nm) 2.867 
Dmax (nm) 8.264 
Mass fraction 0.182 
Conformer #3 
Rg (nm) 3.946 
Dmax (nm) 12.73 
Mass fraction 0.182 
Conformer #4 
Rg (nm) 2.068 
Dmax (nm) 6.14 
Mass fraction 0.364 
Conformer #5 
Rg (nm) 2.954 
Dmax (nm) 9.862 
Mass fraction 0.090 
Total mass fraction of main conformers 1.000 
  
Supplementary Table S2. Kinetic parameters derived from P0ct association phase with 
vesicles. 
Vesicle composition 
Fitting set 1a Fitting set 2a 
kon (nM-1 s-1)b × 105 koff (s-1)c × 102 R2 kon (nM-1 s-1)b × 105 koff (s-1)c × 102 R2 
DOPC:DOPS (1:1) 6.994 ± 0.1978 -0.4874 ± 0.1827 0.9812 7.873 ± 0.1629 -1.655 ± 0.1629 0.9940 
DMPC:DMPG (1:1) 5.657 ± 0.2326 -0.5059 ± 0.2148 0.9610 6.804 ± 0.1252 -2.042 ± 0.1468 0.9953 
a Fitting set 1 contains all data points from the linear fit, whereas all data points below 350 
nM were omitted from Fitting set 2. 
b Slope of the linear fit function to kobs(on) vs. [P0ct]. 









Ionic strength and calcium regulate the membrane interactions of myelin basic 
protein and the cytoplasmic domain of myelin protein zero. 
Raasakka A., Jones N.C., Hoffmann S.V. & Kursula P. 
bioRxiv 529586. DOI: 10.1101/529586. Preprint. (2019) 
 
Abstract 
The formation of a mature myelin sheath in the vertebrate nervous system requires specific 
protein membrane interactions. Several myelin-specific proteins are involved in the stacking 
of lipid membranes into multilayered structures around neuronal axons, and misregulation of 
these processes may contribute to chronic demyelinating diseases. Two key proteins 
functioning in myelin membrane binding and stacking are the myelin basic protein (MBP) 
and protein zero (P0). Other factors, including Ca2+, are important for the regulation of 
myelination. Here, we studied the effects of ionic strength and Ca2+ on the direct molecular 
membrane interactions of MBP and the cytoplasmic domain of P0 (P0ct). While both MBP 
and P0ct bound and aggregated negatively charged lipid vesicles, while simultaneously 
folding, both ionic strength and calcium had systematic effects on these interactions. 
Especially when decreasing membrane net negative charge, the level and kinetics of vesicle 
aggregation, which is a functional assay for myelin membrane stacking proteins, were 
affected by both salt and Ca2+. The results indicate that the effects on lipid membrane 
surfaces by ions can directly affect myelin protein-membrane interactions at the molecular 
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Abstract 1 
The formation of a mature myelin sheath in the vertebrate nervous system requires specific protein-2 
membrane interactions. Several myelin-specific proteins are involved in the stacking of lipid membranes into 3 
multilayered structures around neuronal axons, and misregulation of these processes may contribute to 4 
chronic demyelinating diseases. Two key proteins functioning in myelin membrane binding and stacking are 5 
the myelin basic protein (MBP) and protein zero (P0). Other factors, including Ca2+, are important for the 6 
regulation of myelination. Here, we studied the effects of ionic strength and Ca2+ on the direct molecular 7 
membrane interactions of MBP and the cytoplasmic domain of P0 (P0ct). While both MBP and P0ct bound 8 
and aggregated negatively charged lipid vesicles, while simultaneously folding, both ionic strength and 9 
calcium had systematic effects on these interactions. Especially when decreasing membrane net negative 10 
charge, the level and kinetics of vesicle aggregation, which is a functional assay for myelin membrane-11 
stacking proteins, were affected by both salt and Ca2+. The results indicate that the effects on lipid membrane 12 
surfaces by ions can directly affect myelin protein-membrane interactions at the molecular level, in addition 13 
to signalling effects in myelinating glia. 14 
15 
Keywords 16 
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Introduction 1 
Myelin contributes greatly to the efficiency of both the central and peripheral nervous system (CNS and PNS 2 
respectively) via axonal insulation and trophic support (1,2). Comprised of tightly stacked lipid membranes, 3 
held together by a specific assortment of proteins, compact myelin (CM) – a water-deficient structure – 4 
insulates selected axonal segments and enables fast saltatory nerve impulse conduction. While neuronal 5 
axons undergo frequent membrane depolarization, and [K+] and [Na+] vary upon action potential firing, the 6 
ionic conditions in myelinating glia remain fairly constant, with higher [K+] and [Na+] compared to neurons 7 
in general (3). 8 
In myelinating cells, [Ca2+] and [Zn2+] (1 mM and 50 µM, respectively) are relatively high compared to 9 
many other cell types (3,4). This signifies the importance of the underlying Ca2+ signalling (5–7); due to the 10 
narrow bilayer spacing and low water content in CM, intracellular divalent cations must be subjects of 11 
attractive and repulsive interactions. These involve negatively charged and zwitterionic phospholipid 12 
headgroups, as well as myelin proteins, which are often highly positively charged and directly participate in 13 
interactions with other proteins and lipids. Both Ca2+ and Zn2+ have been studied with respect to 14 
autoinflammatory diseases and pathogenesis (5,8–10), and intracellular Ca2+ levels and changes therein have 15 
been directly linked to the correct development of myelin (11–14). 16 
Myelin basic protein (MBP) plays a fundamental role in forming and maintaining stable myelin membrane 17 
stacks, defining the boundaries between CM and non-compact myelin (15–18). MBP is involved in multiple 18 
sclerosis (MS) (19–21), being an intrinsically disordered protein (IDP) that folds upon lipid binding-induced 19 
charge neutralization (16,22,23). MBP is highly positively charged and manifests as a pool of post-20 
translationally citrullinated variants with differing net charges (24). MBP requires negatively charged lipids 21 
for membrane adhesion, but correct myelin morphology is also dependent on the presence of other lipids and 22 
a controlled ionic content (14,16,25). MBP interacts with divalent cations (26–30), with the underlying 23 
mechanisms being very specific; one would expect electrostatic repulsion due to its unusually high positive 24 
net charge. MBP binds to calmodulin in a Ca2+-dependent manner (27,31–33), and the pool of different MBP 25 
isoforms has been shown to regulate oligodendroglial Ca2+ influx (34,35). Concentration-dependent binding 26 
of divalent cations to different MBP variants could, together with altered membrane compositions, influence 27 
their in vivo functions, having implications in MS etiology and the stability of CM (6,14,27,36). 28 
Myelin protein zero (P0) is a transmembrane protein in PNS myelin, with relevance in human peripheral 29 
neuropathies and animal models (37–39). It consists of an extracellular domain with an immunoglobulin-like 30 
fold (40), a single transmembrane helix, and a short cytoplasmic segment (P0ct) involved in the regulation of 31 
membrane fluidity (41). Similarly to MBP, P0ct is highly positively charged and directly interacts with 32 
phospholipids through electrostatics, gaining secondary structure in the process (41,42), which might make it 33 
susceptible to effects caused by cationic species. 34 
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In this study, the effects of ionic strength and Ca2+ on the structural and functional properties of recombinant 1 
MBP and P0ct binding to lipid membranes were studied using different biophysical techniques. The results 2 
shed new light on the interplay between ions and proteins in CM and support the proposed role of Ca2+ as a 3 
regulator of the bilayer-MBP interaction (14,36,43). 4 
5 
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Experimental procedures 1 
Protein expression and purification 2 
Mouse MBP and human P0ct were expressed and purified as described (16,41). The final size-exclusion 3 
chromatography after affinity purification and tag removal was performed using Superdex75 16/60 HiLoad 4 
and Superdex75 increase 10/300GL columns (GE Healthcare) with 20 mM HEPES, 150 mM NaCl, pH 7.5 5 
(HBS) as mobile phase. When required, the buffer was exchanged to water by sequential dialysis. The 6 
purified proteins were either used fresh or snap-frozen in liquid N2 and stored at -80 °C for later use. 7 
Vesicle preparation 8 
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-9 
glycerol) (Na-salt) (DMPG), and the deuterated d54-DMPC, d54-DMPG, and d7-cholesterol were from Avanti 10 
Polar Lipids (Alabaster, Alabama, USA). The detergent n-dodecylphosphocholine (DPC) was from 11 
Affymetrix. 12 
Lipid stocks were prepared by dissolving the dry lipids in chloroform or chloroform:methanol (9:1 v/v) at 10 13 
– 30 mM. All mixtures were prepared from the stocks at desired molar ratios, followed by solvent14 
evaporation under an N2 stream and freeze-drying overnight at -52 °C under vacuum. The dried lipids were 15 
either stored air-tight at -20 °C or used fresh for liposome preparation. 16 
Liposomes were prepared by agitating dried lipids with either water or HBS at a concentration 10 – 15 mM, 17 
followed by gentle mixing at ambient temperature, to ensure that no unsuspended lipids remained in the 18 
vessel. MLVs were prepared by freeze-thawing using liquid N2 and a warm water bath, with vigorous 19 
vortexing afterwards. Such a cycle was performed 7 times. SUVs were prepared by sonicating fresh MLVs 20 
using a probe tip sonicator (Materials Inc. Vibra-Cell VC-130) until clear, while avoiding overheating. All 21 
lipid preparations were immediately used for experiments. 22 
Vesicle turbidimetry 23 
For turbidimetric measurements, samples containing 0.5 mM DMPC:DMPG (1:1) SUVs were prepared with 24 
2.5 µM P0ct or MBP in duplicate at 150 µl final volume on a Greiner 655161 96-well plate. Optical density 25 
at 450 nm was recorded immediately after thorough mixing at 25 °C using a Tecan Spark 20M plate reader. 26 
Synchrotron radiation circular dichroism spectroscopy 27 
SRCD data were collected from 0.1–0.4 mg ml-1 protein samples in water or 0.5% SDS on the AU-CD 28 
beamline at ASTRID2 (ISA, Aarhus, Denmark). Samples containing lipids were prepared immediately 29 
before measurement by mixing P0ct (P/L ratio 1:200) or MBP (P/L ratio 1:300) with freshly sonicated 30 
SUVs. 100-µm and 1-mm pathlength closed circular cells (Suprasil, Hellma Analytics) were used for the 31 
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measurements, and SRCD spectra were recorded from 170 to 280 nm at 30 °C and truncated based on 1 
detector voltage levels as well as noise. Baseline spectra were subtracted from sample spectra, and CD units 2 
were converted to Δε (M-1 cm-1) using CDtoolX (44). 3 
Stopped-flow SRCD 4 
Rapid kinetic SRCD data were collected using an SX-20 stopped-flow instrument (Applied Photophysics) 5 
mounted on the AU-AMO beamline at ASTRID2 (ISA, Aarhus, Denmark) at 30 °C. Acquisition of kinetic 6 
data comprised of 6–10 shots (160-µl total volume per shot) per sample. The two 1-ml syringes were loaded 7 
as follows: syringe 1 contained 0.1 mg/ml protein and syringe 2 a lipid solution (final molar P/L ratios of 8 
1:200 and 1:300 for P0ct and MBP, respectively). The contents per each shot were rapidly mixed (2 ms dead 9 
time) before injection into the measurement cell (2-mm pathlength). Change in CD signal (mdeg) was 10 
monitored at 195 nm for 5 s per shot. The successful overlaying shots were averaged into a single curve for 11 
each sample. All sample sets were prepared and measured in duplicate. Water baselines were subtracted from 12 
sample curves, and data were analyzed in GraphPad Prism 7 using single- and two-phase exponential decay 13 
functions to obtain rate constants. 14 
15 
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Results 1 
In the current project, the folding and lipid membrane aggregation of MBP and P0ct were studied. Optical 2 
density measurements were used to observe the aggregation of lipid vesicles in the presence of proteins and 3 
different ionic species. The studies were expanded to different ratios of DMPC:DMPG, which affects the 4 
surface net charge of the SUVs. Using SRCD spectroscopy, the folding of the two proteins was probed, and 5 
time-resolved experiments provided data on membrane aggregation kinetics. 6 
The effect of ionic content on myelin protein-induced vesicle turbidity 7 
As a functional assay for MBP and P0ct, turbidimetric experiments on SUVs were carried out. In our earlier 8 
studies, we concluded that in the presence of MBP, net negatively charged lipid vesicles aggregate and 9 
subsequently form myelin-like bilayer stacks, resulting in sample turbidity (16). P0ct, on the other hand, can 10 
cause SUVs to undergo fusion events to produce large aggregated lipid bodies (41), which may cause 11 
additional sample turbidity. 12 
The turbidity induced by the proteins for 1:1, 4:1, and 9:1 DMPC:DMPG SUVs, at a 1:200 protein-to-lipid 13 
(P/L) ratio, was determined. The experiments were carried out at various concentrations of NaCl, NaF, and 14 
CaCl2. Since ionic species, especially multivalent cations, are known to induce lipid aggregation in the 15 
absence of proteins (45), control samples without proteins were included (Fig. 1). Protein-free sample 16 
turbidity was observed mostly in the presence of CaCl2, with more CaCl2 needed for induction, when the net 17 
charge of the lipids became more negative. The effect of monovalent ions as inducers of turbidity per se in 18 
protein-free samples was low. 19 
NaCl and NaF boosted the measured turbidity levels in all lipid mixtures at least to some extent. The 20 
turbidity induced by MBP was higher than that of P0ct, with the exception of DMPC:DMPG (9:1), in which 21 
P0ct was surprisingly more efficient than MBP. In the presence of either protein, the induced turbidity 22 
systematically increased with salt concentration DMPC:DMPG (1:1) (Fig. 1A). In DMPC:DMPG (4:1) and 23 
(9:1) the turbidity decreased above a certain ionic strength (Fig. 1B,C), indicating that the balance between 24 
ionic strength and the net charge of the lipids plays a role in protein-induced membrane aggregation. The 25 
turbidification of DMPC:DMPG (9:1) was completely abolished at ionic concentrations of 150 mM or 26 
above. In all three lipid mixtures, both proteins in the presence of NaCl and NaF produced roughly the same 27 
levels of turbidity, or at least the observed concentration-dependent trends were identical. This indicates that 28 
the choice of monovalent anion matters little in the level of induced turbidity. 29 
In order to follow the physiological concentration regime in myelinating glia, CaCl2 was included at much 30 
lower concentration than NaCl and NaF, but the increased turbidity was still observed. CaCl2 alone was able 31 
to induce lipid turbidity in the absence of protein; the levels varied as a function of concentration. Calcium-32 
induced turbidity showed differences between the three DMPC:DMPG ratios: the turbidification of 33 
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DMPC:DMPG (1:1) vesicles was more resistant to increased CaCl2 concentration than 4:1 and 9:1 mixtures 1 
(Fig. 1). 2 
CaCl2 changed the turbidity induced by MBP and P0ct, depending on the membrane composition. In 3 
DMPC:DMPG (1:1), turbidity was higher than in the other two lipid mixtures, being at a similar level to that 4 
induced by the presence of salt (Fig. 1A). DMPC:DMPG (9:1) showed the least turbidity, and high calcium 5 
concentrations brought OD to the baseline level (Fig. 1C). Interestingly, in DMPC:DMPG (4:1), the presence 6 
of 0.5 mM and 1 mM CaCl2 showed a great difference in turbidity in the absence of proteins, but when 7 
proteins were included the turbidity levels were almost identical, indicating that the proteins could override 8 
the aggregating effect of CaCl2 at moderate concentrations (Fig. 1B). Increasing CaCl2 to 1.5 mM diminished 9 
the turbidity induced by MBP or P0ct in all membrane compositions. Taking all these results together, it is 10 
evident that while salt can influence the interactions between proteins and lipids, and protein-decorated 11 
vesicles with each other, the effect of Ca2+ with phospholipid headgroups is rather specific. Even small 12 
changes in divalent cation levels, in the range 0.5-1.5 mM, can alter the protein-lipid interactions required for 13 
vesicle aggregation and fusion, given that negatively charged lipid species do not dominate in abundance 14 
over neutral/zwitterionic lipids. 15 
Folding of lipid-bound MBP and P0ct 16 
We observed lipid-induced increase in secondary structure content for both MBP and P0ct in our earlier 17 
studies, in the absence of salt (16,41). To investigate the effect of ionic strength and divalent cations on 18 
protein folding, SRCD was carried out with 150 mM NaF and 1 mM CaCl2. NaF was used due to the high 19 
UV absorbance of Cl-. NaF had a very similar concentration-dependent behavior to NaCl in turbidimetric 20 
studies (Fig. 1). 21 
NaF and CaCl2 had no effect on MBP or P0ct overall folding in water and 0.5% SDS (Supplementary Fig. 22 
S1). The SRCD spectra acquired for proteins in the presence lipids often suffer from turbidity-induced light 23 
scattering, here, especially at 1:1 and 4:1 DMPC:DMPG ratios in the presence of CaCl2 (Fig. 2A,B). Under 24 
such conditions, the positions of the spectral peaks can be used to detect the presence of secondary structure. 25 
The observed changes in conformation correspond well to the turbidimetry assays under the same conditions, 26 
whereby the negative peak in SRCD at 200 nm is indicative of unfolded structure and possibly lack of 27 
membrane binding. 28 
Without additives, MBP reached a similar secondary structure content in all lipid compositions (Fig. 2). In 29 
DMPC:DMPG (9:1), the presence of NaF or CaCl2 decreased MBP helical content, potentially indicating 30 
less binding to lipids (Fig. 2C). Also P0ct obtained secondary structure in lipid mixtures, and the decrease of 31 
membrane negative charge (DMPG) correlated with the loss of P0ct helical structure - as seen through the 32 
movement of the main spectral minimum towards 200 nm (Fig. 2). NaF had a small unfolding effect on the 33 
P0ct secondary structure with all lipid mixtures. 34 
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The kinetics of initial vesicle nucleation 1 
To visualize the underlying kinetics involved in MBP and P0ct binding to lipid vesicles, stopped flow 2 
measurements were carried out using an SRCD setup. The original goal was to study the folding kinetics of 3 
MBP and P0ct when encountering lipid membranes, but initial measurements and optimization attempts 4 
revealed that the proteins gained their folding completely within the dead time of the instrument (~2 ms), 5 
which made the underlying kinetics practically impossible to follow. 6 
Despite the setback with protein folding kinetics, a strong decay in SRCD signal was observed within a 5-10 7 
s measurement window (before the onset of induced photodegradation; data not shown), when proteins were 8 
mixed with lipids in the presence of 150 mM NaF or 1 mM CaCl2 (Fig. 3A). This resembled exponential 9 
decay and could be described with two potentially independent rate constants (Supplementary Table 1). 10 
Since we observed similar behaviour in the absence of proteins (Supplementary Fig. S2, Supplementary 11 
Table 1), the effect does not stem from changes in protein folding. Considering the wavelength of the used 12 
monochromatic beam (195 nm), which is in the size range of large vesicular lipid bodies, and the strength of 13 
the decay (spanning tens of mdeg), the effect is caused by light scattering from initial vesicle fusion and/or 14 
aggregation, especially since the lipid mixtures and ionic conditions correlate with the observed steady states 15 
in turbidimetry (Fig. 1). 16 
While lipids mixed with CaCl2 alone produced quite noisy data with individual shots and replicates not 17 
overlaying very well, all protein samples had excellent reproducibility both in terms of shot quality and 18 
between replicates, which is evident from the small standard deviations. The data could be fitted with 19 
confidence, and in most cases, two rate constants were obtained: k1, which describes a fast event (> 2 s-1), 20 
and k2, for a slower event (< 1 s-1). The obtained rate constants in the presence of proteins vary between the 21 
three different lipid compositions (Fig. 3B). The accuracy of k2 is rather low, given the limited time window 22 
used in the experiments. 23 
In the absence of proteins, the turbidity kinetics induced by Ca2+ were similar in DMPC:DMPG (4:1) and 24 
(9:1), and clearly slower in DMPC:DMPG (1:1) (Supplementary Fig. S2, Supplementary Table 1), 25 
suggesting that electrostatic repulsion plays a role in the observed effect. Considering the fact that the two 26 
less charged lipid compositions aggregate with roughly the same rate, the latter effect is more likely to occur 27 
due to saturation of the surface with Ca2+, although more experiments are required to fully understand the 28 
mechanism. It should be noted that the concentration of CaCl2 in these experiments was 1 mM, while the 29 
total concentration of negative headgroups in the lipid mixtures was either 0.25, 0.1, or 0.05 mM. It appears 30 
that the membranes with less charge are fully neutralized, while the neutralization might be partial for the 1:1 31 
mixture. 32 
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In protein-lipid samples, in the presence of NaF and CaCl2, DMPC:DMPG (1:1) presents a higher k1 value 1 
than the other two lipid compositions. The effects of the two salts on k1 on turbidity increase with the molar 2 
percentage of DMPG (Fig. 3B, Supplementary Table 1). 3 
Interestingly, in DMPC:DMPG (9:1), the aggregation effect was dominated by the 1 mM CaCl2 over proteins 4 
(Supplementary Table 1); this correlates with the steady-state turbidity under the same condition (Fig. 1C). 5 
The rate constants are similar regardless of the presence of protein, indicating that the aggregation behaviour 6 
under this condition is governed by the cation. On the other hand, 150 mM NaF inhibits aggregation of 7 
DMPC:DMPG (9:1) vesicles (Fig. 1C, Supplementary Table 1), and in salt-free conditions, the proteins 8 
display aggregation, which was not the case for the other two vesicle compositions (Fig. 3A). Taken 9 
together, the kinetics measurements correlate well with the results from turbidimetry, providing further 10 
insights into determinants of membrane binding and stacking. 11 
12 
13 
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Discussion 1 
Myelination requires a delicate balance between myelin protein expression, protein-membrane interactions, 2 
and additional regulatory factors, such as calcium (6,13). Both MBP and P0ct are IDPs in aqueous solution, 3 
but upon binding to lipid membranes, they fold into helical structures, at the same time altering the physical 4 
properties of the membrane (16,18,23,33,41). The salt sensitivity of the protein-membrane interactions 5 
supports the role of electrostatic interactions in these processes, and the effects of calcium on the molecular 6 
interactions are reflective of more specific mechanisms of regulation. 7 
Phospholipid vesicle aggregation was followed using optical density methods as well as SRCD to see how 8 
salt content and Ca2+ influence the activity and folding of MBP and P0ct. Our results show that while vesicle 9 
turbidity increases with ionic strength, both in the steady state and in initial kinetics, the effect of salt varies 10 
with membrane surface net charge. Considering the combination of ionic strength and membrane charge, it 11 
seems clear that high salt concentrations effectively screen the protein-membrane interactions, while lower 12 
concentrations, in fact, have an inducing effect. The results are in line with earlier data on extractability of 13 
MBP from myelin and myelin swelling under different conditions (46–48). 14 
The effects of calcium are likely to be more specific than the electrostatic competition caused by near-15 
physiological ionic strength per se. Ca2+ alone induces spontaneous vesicle turbidity, showing that it affects 16 
the surface properties of the membrane. Calcium influences both the steady-state levels and the kinetics of 17 
MBP- and P0ct-mediated vesicle aggregation. The binding of divalent cations by MBP has been observed in 18 
earlier studies (26,28,29), and calcium is known to affect both MBP solubility in purified myelin as well as 19 
myelin membrane spacing (48,49). It, thus, appears that calcium might be able to affect the surface of both 20 
the protein and the membrane in a manner that can regulate the direct molecular interaction. 21 
A new SRCD-based time-resolved technique was used to follow the kinetics of vesicle aggregation by MBP 22 
and P0ct, as well as by Ca2+ alone. While it is at the moment unclear what the rate constants actually 23 
represent, some conditions are physiologically relevant, and the observed differences in kinetics may be 24 
relevant to myelin membrane stacking. Considering the k1 values alone, P0ct is faster than MBP at inducing 25 
turbidity. The difference could arise from the smaller size of P0ct, which potentially both tumbles in solution 26 
faster than MBP and folds/neutralizes more easily upon membrane interaction. Due to its larger size, MBP 27 
will experience more steric and repulsive effects from protein molecules already bound to the membrane. 28 
The smaller P0ct may possess higher accessibility to the vesicle surface. 29 
Several studies have highlighted calcium as a major regulator of proper myelination (5,6,11,12,36,50), and in 30 
addition to being crucial for signalling and cellular homeostasis, it has been suggested to directly affect 31 
MBP-membrane interactions (14,36,48). Phosphoinositides are important constituents of the myelin 32 
membrane, involved in MBP-membrane interactions regulated by Ca2+(36). Various mechanisms have been 33 
proposed for the effects of calcium on myelin structure and formation; these include activation of calpains, 34 
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possibly degrading MBP, the involvement of calmodulin, signalling pathways, cytoskeletal events, as well as 1 
effects on protein-lipid interactions (6,11–14,36). 2 
It was proposed that a "sweet spot" concentration of calcium exists during myelination, which promotes 3 
normal myelin formation (13). Deviations from this range might be relevant for dys/demyelination. In fact, 4 
similar effects have been observed in early studies on MBP extraction from nerve tissue (43,48). Here, 5 
concentrations around the physiological [Ca2+] were used to follow myelin protein-membrane interactions, 6 
and indeed, concentration dependence around 1 mM [Ca2+] is evident. Together with the membrane surface 7 
charge, calcium may either promote or inhibit lipid membrane stacking induced by myelin proteins. The 8 
obvious next steps would involve studies on the effects of calcium on myelin protein-membrane interactions 9 
in more physiological lipid compositions corresponding to the myelin cytoplasmic leaflet; the experiments 10 
here using simplified lipid mixtures pave the way for these studies. 11 
MBP and P0 are not related by sequence; however, as shown by us and others, the physicochemical 12 
properties of MBP and the P0 cytoplasmic domain are very similar (16,18,23,33,41,42). Both bind to 13 
membrane surfaces through electrostatic interactions, get embedded and fold, and affect properties of the 14 
lipid bilayer. Functional similarity is also true considering the effects of ionic strength and calcium studied 15 
here. In addition, other myelin proteins, such as P2 in the PNS and PLP in the CNS (51–54), have likely 16 
roles in membrane stacking and will have to work in synergy with MBP and P0 during myelination. Our 17 
observations point towards common regulatory mechanisms for the function of different myelin proteins in 18 
membrane stacking during myelin maturation and maintenance. 19 
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Figure legends 1 
Fig. 1. Vesicle turbidimetry. MBP (red) and P0ct (blue)-induced turbidity was studied in (A) 1:1, (B) 4:1, 2 
and (C) 9:1 DMPC:DMPG vesicles under different salt conditions. Each condition in the absence of protein 3 
is shown for reference (gray). Error bars represent standard deviation. 4 
Fig. 2. Lipid-induced protein folding in the presence of salt and divalent cations. SRCD experiments reveal 5 
differences in the folding of MBP and P0ct in different lipid compositions. Trace explanations: no additive 6 
(green); 150 mM NaF (blue); 1 mM CaCl2 (red). Protein controls without additives or lipids in water (black) 7 
are plotted for reference in each panel. 8 
Fig. 3. Rapid kinetics of protein-induced lipid turbidity. A. The SRCD signal at 195 nm was monitored for 5 9 
s using stopped-flow measurements. Proteins were mixed with lipids in the absence (green) and presence of 10 
150 mM NaF (blue) and 1 mM CaCl2 (red). Error bars represent standard deviation. Fits (dashed black) are 11 
shown where data fitting was successful. B. Comparison of kinetic parameters. Evolution of the determined 12 
rate constants (k1, solid markers; k2, open markers) as a function of DMPC:DMPG molar ratio in 150 mM 13 
NaF (black) and 1 mM CaCl2 (red). The values for MBP and P0ct are shown as circles and squares, 14 
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Supplementary Fig. S1. SRCD control experiments. The folding of MBP and P0ct in the 
absence (top) and presence (bottom) of 0.5% SDS as determined by SRCD spectroscopy. No 
additive (green); 150 mM NaF (blue); 1 mM CaCl2 (red). Protein controls without additives 





Supplementary Fig. S2. Rapid kinetics of Ca2+-induced initial lipid turbidity. Evolution 
of the SRCD signal at 195 nm was monitored for 5 s using stopped flow measurements. For 
clarity, linear (top) and logarithmic (bottom) time scales are shown. Ca2+ was mixed at a final 
concentration of 1 mM with 2.5 mM DMPC:DMPG 1:1 (green), 4:1 (blue), and 9:1 (red) 
molar lipid ratios. Error bars represent standard deviation. Fits (dashed black) are shown; see 
Supplementary Table 1 for rate constants. 
 
  
Supplementary Table 1. Two-phase exponential decay rate order parameters from 
rapid kinetics SRCD experiments. Values marked with a dash could not be fitted, as the CD 
signal decayed very little, if at all, within the measurement time window. All errors represent 


































































































































a Data fit best into one-phase exponential decay function, but the change in SRCD signal 
overall is very small. 
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Abstract 
Schwann cells myelinate selected axons in the peripheral nervous system (PNS) and 
contribute to fast saltatory conduction via the formation of compact myelin, in which water 
is excluded from between tightly adhered lipid bilayers. Peripheral neuropathies, such as 
Charcot-Marie-Tooth disease (CMT) and Dejerine-Sottas syndrome (DSS), are incurable 
demyelinating conditions that result in pain, decrease in muscle mass, and functional 
impairment. Many Schwann cell proteins, which are directly involved in the stability of 
compact myelin or its development, are subject to mutations linked to these neuropathies. 
The most abundant PNS myelin protein is protein zero (P0); point mutations in this 
transmembrane protein cause CMT subtype 1B and DSS. P0 tethers apposing lipid bilayers 
together through its extracellular immunoglobulin-like domain. Additionally, P0 contains a 
cytoplasmic tail (P0ct), which is membrane-associated and contributes to the physical 
properties of the lipid membrane. Six CMT- and DSS-associated missense mutations have 
been reported in P0ct. We generated recombinant disease mutant variants of P0ct and 
characterized them using biophysical methods. Compared to wild-type P0ct, some mutants 
have negligible differences in function and folding, while others highlight functionally 
important amino acids within P0ct. For example, the D224Y variant of P0ct induced tight 
membrane multilayer stacking. Our results show a putative molecular basis for the 
hypermyelinating phenotype observed in patients with this particular mutation and provide 
overall information on the effects of disease-linked mutations in a flexible, membrane-
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Abstract  1 
Schwann cells myelinate selected axons in the peripheral nervous system (PNS) and contribute to fast 2 
saltatory conduction via the formation of compact myelin, in which water is excluded from between tightly 3 
adhered lipid bilayers. Peripheral neuropathies, such as Charcot-Marie-Tooth disease (CMT) and Dejerine-4 
Sottas syndrome (DSS), are incurable demyelinating conditions that result in pain, decrease in muscle mass, 5 
and functional impairment. Many Schwann cell proteins, which are directly involved in the stability of 6 
compact myelin or its development, are subject to mutations linked to these neuropathies. The most abundant 7 
PNS myelin protein is protein zero (P0); point mutations in this transmembrane protein cause CMT subtype 8 
1B and DSS. P0 tethers apposing lipid bilayers together through its extracellular immunoglobulin-like 9 
domain. Additionally, P0 contains a cytoplasmic tail (P0ct), which is membrane-associated and contributes 10 
to the physical properties of the lipid membrane. Six CMT- and DSS-associated missense mutations have 11 
been reported in P0ct. We generated recombinant disease mutant variants of P0ct and characterized them 12 
using biophysical methods. Compared to wild-type P0ct, some mutants have negligible differences in 13 
function and folding, while others highlight functionally important amino acids within P0ct. For example, the 14 
D224Y variant of P0ct induced tight membrane multilayer stacking. Our results show a putative molecular 15 
basis for the hypermyelinating phenotype observed in patients with this particular mutation and provide 16 
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Introduction 1 
Fast saltatory nerve impulse conduction requires myelin, a structure composed of tightly stacked lipid 2 
bilayers that wrap around selected axonal segments in the central and peripheral nervous systems (CNS and 3 
PNS, respectively). The insulative nature of myelin enables efficient nerve impulse propagation, and the 4 
destruction of myelin, demyelination, underlies a range of chronic diseases. In the PNS, peripheral 5 
neuropathies affect Schwann cell compact myelin. These include Charcot-Marie-Tooth disease (CMT) and 6 
its more severe, rapidly progressive form known as Dejerine-Sottas syndrome (DSS), which cause incurable 7 
chronic disability (Hartline 2008; Stassart et al. 2018). CMT and DSS manifest through both dominant and 8 
recessive inheritance, and they harbour a strong genetic component, typically caused by mutations in 9 
proteins relevant for the formation and stability of PNS myelin, while axonal forms also exist. 10 
Myelin protein zero (P0) is a type I transmembrane protein consisting of an extracellular immunoglobulin 11 
(Ig)-like domain (Shapiro et al. 1996), a single transmembrane helix, and a 69-residue C-terminal 12 
cytoplasmic tail (P0ct). P0ct is likely to be involved in the regulation of myelin membrane behaviour, 13 
supporting the arrangement of the P0 Ig-like domains in the extracellular space upon the formation of the 14 
myelin intraperiod line (Luo et al. 2007; Raasakka et al. 2019b; Wong and Filbin 1994). P0ct contains a 15 
neuritogenic segment, which can be used to induce experimental autoimmune neuritis (EAN) in animal 16 
models (de Sèze et al. 2016). In vitro, P0ct is disordered in aqueous solution, gaining secondary structure 17 
upon binding to negatively charged phospholipids (Luo et al. 2007; Raasakka et al. 2019b). In its lipid-18 
bound state, P0ct affects the phase behaviour of lipids and promotes the fusion of lipid vesicles. High-degree 19 
molecular order, most likely from stacked lipid bilayers, can be detected via X-ray diffraction of P0ct-bound 20 
membranes (Raasakka et al. 2019b). This suggests that P0ct harbours a structural role in mature myelin. 21 
Dozens of mutations have been identified in P0, most of which affect the Ig-like domain. These mutations 22 
affect myelin morphology and integrity, leading to the development of peripheral neuropathies (Mandich et 23 
al. 2009; Shy et al. 2004). Six known missense mutations are located within P0ct, of which four cause 24 
dominant demyelinating CMT type 1B (CMT1B). These include T216ER (Su et al. 1993), D224Y (also 25 
referred to as D195Y and D234Y) (Fabrizi et al. 2006; Miltenberger-Miltenyi et al. 2009; Schneider-Gold et 26 
al. 2010), R227S (Shy et al. 2004), and the deletion of Lys236 (K236del) (Street et al. 2002). In addition, 27 
K236E has been linked to dominant axonal CMT type 2I (CMT2I) (Choi et al. 2004), and A221T, which was 28 
discovered as a co-mutation together with the deletion of Val42 in the Ig-like domain, was identified in a 29 
patient with DSS (Planté-Bordeneuve et al. 2001). How these mutations relate to CMT/DSS etiology is not 30 
known, although P0 mutations have been linked to the unfolded protein response (UPR) (Bai et al. 2013; Bai 31 
et al. 2018; Wrabetz et al. 2006), indicating issues in either translation or folding that induce stress within the 32 
endoplasmic reticulum (ER).  33 
Considering the small size of P0ct and the nature of the disease mutations in it, many of which change its 34 
electrostatic charge, impairment in the function of P0ct as a membrane binding/stabilizing segment is a 35 
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possible functional mechanism. We used methodologies established earlier for myelin basic protein (MBP) 1 
(Raasakka et al. 2017) and wild-type P0ct (wt-P0ct) (Raasakka et al. 2019a; Raasakka et al. 2019b) to 2 
characterize structure-function relationships of the CMT- and DSS-related P0ct variants. Our results suggest 3 
that D224Y is a hypermyelinating gain-of-function mutation, which is in line with the clinically relevant 4 
phenotype of abnormally thickened myelin sheaths (Fabrizi et al. 2006). 5 
6 
7 
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Results 1 
We have earlier studied the binding of MBP and P0ct to model lipid membranes (Raasakka et al. 2017; 2 
Raasakka et al. 2019a; Raasakka et al. 2019b), using a biophysical workflow that allows the determination of 3 
binding affinity, gain in folding, alteration of lipid phase behaviour, quantification and visualization of 4 
vesicle aggregation and fusion, and supported lipid bilayer (SLB) stacking. In the current study, we 5 
examined whether and how CMT and DSS mutations within P0ct influence its structure and function. For 6 
this purpose, we expressed and purified the wild-type protein and six mutant variants, each harbouring one of 7 
the following amino acid changes: T216ER, A221T, D224Y, R227S, K236E, and K236del. 8 
9 
Characterization of P0ct CMT mutants 10 
wt-P0ct and the six CMT variants were purified to homogeneity. Most mutants were straightforward to 11 
purify, showing identical behaviour to wt-P0ct in size-exclusion chromatography (SEC) (Fig. 1b). D224Y, 12 
on the other hand, had to be gel filtrated at a higher pH and salt concentration than the others, and while 13 
yields were generally lower, minor amounts of degradation were present and the migration in SEC was 14 
altered, albeit not in denaturing gel electrophoresis (SDS-PAGE) (Fig. 1b. Supplementary Fig. S1). In 15 
dynamic light scattering (DLS), all variants displayed a similar hydrodynamic radius (Rh) and an absence of 16 
aggregation (Fig. 1c, Supplementary Table 1). All of the variants showed high apparent molecular weight in 17 
SDS-PAGE, which reflects the intrinsically disordered nature of P0ct (Raasakka et al. 2019b). The molecular 18 
weight and the presence of the mutations were confirmed using mass spectrometry (Table 1). The total yields 19 
of the purified mutant proteins were different from wt-P0ct (Supplementary Fig. S1, Table 1), most mutants 20 
giving larger yields, with the exception of D224Y. It should be noted that all mutants were expressed as 21 
maltose-binding protein fusions. Thus, mutations, which represent small changes in the overall sequence and 22 
size of the fusion protein, can affect the expression and purification behaviour.  23 
Small-angle X-ray scattering (SAXS) verified that for most variants, both the size and behaviour in solution 24 
were nearly identical, with radius of gyration (Rg) and maximum dimension (Dmax) at 2.4 - 2.7 nm and 9.0 – 25 
10.7 nm, respectively, and molecular masses matching monomeric protein based on I0 values (Fig. 2, 26 
Supplementary Table 2). D224Y presented a marginally larger Dmax (11.6 nm) compared to the other 27 
variants, but all variants were flexible and extended in solution, as evident from the Kratky plot (Fig. 2d). 28 
29 
The folding and lipid binding properties of P0ct CMT mutants 30 
To compare the conformation of the P0ct variants, we carried out a series of synchrotron radiation circular 31 
dichroism (SRCD) spectroscopic experiments in the absence and presence of different lipid compositions, 32 
detergents, and 2,2,2-trifluoroethanol (TFE), as previously described for wt-P0ct (Raasakka et al. 2019b). 33 
P0ct is disordered in solution and gains a significant amount of secondary structure upon binding to small 34 
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unilamellar vesicles (SUV) with a net negative surface charge (Luo et al. 2007; Raasakka et al. 2019b). In 1 
water, all mutants were disordered as expected, with D224Y having less secondary structure than the others 2 
(Fig. 3). This is in agreement with the longer Dmax determined using SAXS. All mutants closely resembled 3 
wt-P0ct in TFE and the detergents sodium dodecyl sulphate (SDS), n-dodecylphosphocholine (DPC), 4 
lauryldimethylamine N-oxide (LDAO), and n-octyl glucoside (OG), while K236del was more α-helical than 5 
the other variants in the presence of SDS (Fig. 3, Supplementary Fig. S2). 6 
Addition of DMPC retained the proteins in a disordered state, with D224Y deviating slightly (Supplementary 7 
Fig. S2). In the presence of net negatively charged SUVs composed of DMPC:DMPG ratios of 1:1, 4:1, and 8 
9:1, the variants presented some folding differences (Fig. 3, Supplementary Fig. S2). Overall, most folding 9 
was observed in 1:1 DMPC:DMPG, and the degree of folding decreased with decreasing fraction of DMPG, 10 
i.e. negative charge. In DMPC:DMPG (1:1), a small shift to the right of the maximum at 188 nm was evident11 
for D224Y and K236del, indicating slightly increased folding, although the two minima at 208 and 222 nm, 12 
typical for helical content, remained the same for all variants (Fig. 3d). In DMPC:DMPG (4:1), this effect 13 
was only observed for D224Y (Fig. 3e). In DMPC:DMPG (9:1), the differences in signal magnitude were 14 
large, reflecting different levels of turbidity (Supplementary Fig. S2). It can be assumed that the variants 15 
showing high turbidity under this condition are membrane-bound, while the ones giving strong CD signal of 16 
an unfolded protein do not bind to 9:1 DMPC:DMPG.  17 
The affinity of P0ct variants towards immobilized DMPC:DMPG (1:1) SUVs was investigated using surface 18 
plasmon resonance (SPR). All variants bound to lipids with similar kinetic parameters (Fig. 3f, Table 2), 19 
including the A1 value, which corresponds to the apparent Kd, of 0.35-0.4 µM. This value in the same range 20 
with those obtained earlier for wt-P0ct, MBP, and P2 (Raasakka et al. 2017; Raasakka et al. 2019b; 21 
Ruskamo et al. 2014; Wang et al. 2011). While the differences in Kd were minor, the behaviour of D224Y 22 
was unique: the observed maximal response level was higher compared to the other variants. This suggests 23 
that the D224Y variant can either accumulate onto immobilized vesicles in higher amounts, or it induces a 24 
change on the surface that affects the measurement, such as the fusion, swelling, or aggregation of lipid 25 
vesicles. 26 
27 
Effect of CMT mutations on lipid membrane properties 28 
To determine the effect of the mutations on lipid structure, experiments probing changes in the 29 
thermodynamic and structural properties of lipid membranes were carried out. As shown before (Raasakka et 30 
al. 2019b), the presence of P0ct changes the melting behaviour of dimyristoyl lipid tails, inducing a 31 
population that melts 0.9 °C below the major phase transition temperature of 23.8 °C. The presence of the 32 
mutations altered this effect mildly (Fig. 4a), with T216ER and R227S behaving similarly to wt-P0ct. The 33 
Lys236 mutations deviated from wt-P0ct, with a decreased temperature for the emerged population; K236E 34 
and K236del showed lipid phase transition temperatures of 22.7 and 22.8 °C, respectively. A221T presented 35 
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slightly higher temperature for phase transition compared to wt-P0ct, with the major peak at 23.0 °C. Based 1 
on the shape of the calorimetric landscape, D224Y was clearly different from the rest, as the new population 2 
did not appear as a single, symmetric peak, but was rather formed of several overlapping peaks.  3 
Similarly to MBP and P2 (Raasakka et al. 2017; Ruskamo et al. 2014), P0ct is capable of inducing 4 
concentration-dependent solution turbidification, when mixed with lipid vesicles of net negative charge 5 
(Raasakka et al. 2019b). The turbidity can arise from vesicle fusion and/or aggregation, and different 6 
processes may be dominant in different samples with respect to the measured signal. To determine the effect 7 
of P0ct CMT mutations on this function, turbidity experiments were carried out with the different variants. 8 
T216ER and A221T produced turbidity levels similar to wt-P0ct (Fig. 4b, Supplementary Fig. S3a). At 1:100 9 
P/L ratio, D224Y, R227S, K236E, and K236del all had decreased turbidity. At a P/L ratio of 1:50, however, 10 
only D224Y had a significant inhibitory effect on turbidity. This result highlights that the D224Y mutant 11 
protein may function differently from the other variants, when it binds to and aggregates vesicles.  12 
To shed further light on the protein-induced changes in membrane structure, small-angle X-ray diffraction 13 
(SAXD) experiments were performed on P0ct-membrane mixtures. In our earlier study, wt-P0ct mixed with 14 
lipids produced two strong Bragg peaks, and the corresponding repeat distance evolved as a function of the 15 
P/L ratio (Raasakka et al. 2019b). Here, we observed that in all cases, the repeat distance increased when 16 
protein concentration in the sample decreased (Fig. 4c, Supplementary Fig. S3b). Each variant presented a 17 
minimum repeat distance, which was reached at and above a P/L ratio of 1:100. The repeat distance for wt-18 
P0ct was ~7.5 nm, while D224Y produced a spacing of <7.0 nm. R224S, K236E, and K236del had looser 19 
packing than wt-P0ct. K236E had a minimum repeat distance of ~8.0 nm at the highest protein 20 
concentration.   21 
To understand the effect of the mutations on the function of P0ct, and the origin of the high molecular order 22 
reflected by X-ray diffraction, electron microscopy imaging was performed. Most mutants functioned in a 23 
manner similar to wt-P0ct, producing large vesicular structures with a spread-out morphology (Fig. 5), with 24 
occasional regions indicative of bilayer stacking. D224Y showed a clear difference to wt-P0ct, producing 25 
strongly stacked myelin-like membranes in a manner resembling MBP (Raasakka et al. 2017). This gain of 26 
function was reproducible over a wide range of P/L ratios (Supplementary Fig. S4) and a unique feature 27 
among the six mutant P0ct variants. The results confirm that the Bragg peaks seen in SAXD, indeed, 28 
originate from repeat distances in membrane multilayers, identically to two other PNS myelin peripheral 29 
membrane proteins, MBP and P2 (Raasakka et al. 2017; Ruskamo et al. 2014; Sedzik et al. 1985). The 30 
observed bilayer spacing for the D224Y mutant in EM was narrow and in general better defined than seen 31 
for MBP (Raasakka et al. 2017), suggesting that P0ct forms a tight structure within and/or between the 32 
membranes. Based on SAXD, the intermembrane spacing is ~3 nm, a value in close relation to the 33 
dimensions of the major dense line (MDL) in myelin.  34 
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To gain an insight into the kinetic aspects of P0ct-induced lipid fusion/aggregation, stopped-flow kinetics 1 
experiments were performed using SRCD (Fig. 6, Table 3) (Raasakka et al. 2019a). All variants followed a 2 
similar kinetic pattern as wt-P0ct and could be best fitted to a two-phase exponential decay with two rate 3 
constants (k1, fast and k2, slow). Rather minor differences were present: k2 values were very similar in all 4 
cases, and while D224Y presented 10% higher k1 and k1/k2 compared to wt-P0ct and most other variants, 5 
both K236E and K236del displayed k1 and k1/k2 20% lower than for wt-P0ct, indicating slower kinetics (Fig. 6 
6b). While all variants produced a similar end-level CD value around -100 mdeg, the starting level of 7 
K236del was higher than for any other variant, and remained so until ~0.3 s, before settling on a similar level 8 
to other variants. It is currently unclear whether this is due to an increased level of protein folding or less 9 
scattered light from fused or aggregated vesicles. 10 
11 
The membrane insertion mode of P0ct 12 
To understand the membrane insertion of P0ct, how it compares to MBP (Raasakka et al. 2017), and how it 13 
might be related to disease mutations, we performed neutron reflectometry (NR) experiments (Fig. 7, Table 14 
4). The insertion of P0ct to a DMPC:DMPG SLB was quite different to that of MBP. P0ct inserted 15 
completely into the membrane, thickening it by 2 nm and increasing its roughness, most likely due to 16 
increased bilayer mobility, as the hydration layer below the membrane became thicker (Fig. 7b,c). P0ct was 17 
present in the acyl tail fraction of the membrane, as well as the outer headgroup fraction. The data could not 18 
be fitted with only these parameters, but a very rough, narrow layer of protein had to be considered on top of 19 
the membrane. Unfortunately, the roughness and high solvation fraction of this layer did not allow for 20 
precise thickness determination: the layer was modelled to be between 5 – 15 Å thick within the fit to the 21 
data. To investigate the effect of the D224Y mutation on P0ct membrane association, NR data were collected 22 
for SLB-bound D224Y, which appeared identical to wt-P0ct (Supplementary Fig. S5). 23 
24 
25 
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Discussion 1 
The formation of compact myelin and the major dense line requires an interplay of myelin molecules, many 2 
of which have similar functional properties despite lack of sequence homology. Considering the MDL of 3 
PNS compact myelin, the major protein components according to current knowledge are MBP, P2, P0ct, and 4 
cytosolic loops of PMP-22. We characterized the potential functional anomalies of P0ct CMT mutants in 5 
membrane binding using earlier established biophysical strategies (Raasakka et al. 2017; Raasakka et al. 6 
2019a; Raasakka et al. 2019b).  7 
The six mutations reported in P0ct are clustered within or near the neuritogenic segment. Most of them 8 
reside in the vicinity of putatively phosphorylated Ser residues (Fig. 1a), which have been speculated to be 9 
affected by P0ct mutations (Su et al. 1993; Xu et al. 2001). Many P0 mutations have been suggested to lead 10 
to UPR activation (Bai et al. 2013; Bai et al. 2018; Wrabetz et al. 2006), indicating problems with translation 11 
rate, folding, and/or membrane insertion. Given the fact that P0ct is known to interact with lipid membrane 12 
surfaces (Luo et al. 2007; Raasakka et al. 2019b; Raasakka et al. 2019a), these mutations could also have 13 
direct effects on the formation of mature compact myelin at the molecular level.  14 
Mechanism of P0ct binding to membranes 15 
In order to fully understand the effects of P0ct mutations on its structure and function, detailed knowledge 16 
about P0ct binding to lipid membranes, and the effects thereof on multilayered membrane stacks, are 17 
required. NR allowed us to gain a picture of P0ct in a lipid bilayer. P0ct inserts deep into a membrane, with 18 
only a small fraction remaining solvent-exposed on the membrane surface. This is a clear difference to MBP, 19 
which forms a brush-like protein phase on top of the membrane surface, while being partially embedded into 20 
the bilayer (Raasakka et al. 2017). After undergoing charge neutralization and folding, P0ct seems to 21 
collapse into a tight conformation and remain stable. The compact, deep conformation of P0ct suggests that 22 
instead of directly embedding into two bilayers, which is the working model for e.g. MBP-induced stacking 23 
(Raasakka et al. 2017; Vassall et al. 2015), P0ct may change the surface properties of the membrane in a 24 
way that supports apposing bilayer surface adhesion. It could also regulate membrane curvature and the 25 
twining of lipid bilayers around the axon.  26 
At the level of full-length P0, P0ct is a direct extension of the transmembrane segment, and hence, anchored 27 
permanently to a membrane surface at its beginning. Membrane stacking could involve the insertion of P0ct 28 
across the MDL into an apposing membrane leaflet, which is only 3 nm away. Considering this scenario, P0 29 
is basally expressed in Schwann cells even before myelination occurs (Lee et al. 1997). Moreover, P0 is 30 
translated and inserted into the ER membrane and trafficked through the trans-Golgi network to the plasma 31 
membrane after the Ig-like domain has been post-translationally modified (Eichberg 2002; Lemke and Axel 32 
1985). If P0ct were to enter an apposing membrane during the formation of compact myelin, it would have to 33 
remain in a disordered state until another membrane is present. On the other hand, if P0ct is embedded in the 34 
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membrane after translation, it might afterwards be able to dissociate and enter the apposing leaflet within 1 
compact myelin. Considering the attractive phospholipid bilayer around the transmembrane helix, and the 2 
fact that P0ct binds negatively charged lipids essentially irreversibly in vitro 5, both mechanisms described 3 
above are unlikely to exist. Thus, the role of P0ct in membrane adhesion is likely to be based on altered lipid 4 
membrane properties, as opposed to MBP and P2, which directly interact with two membrane surfaces. 5 
While P2 and MBP were observed to synergistically stack lipid bilayers in vitro (Suresh et al. 2010), mice 6 
lacking both proteins formed apparently normal and functional myelin (Zenker et al. 2014). Hence, multiple 7 
factors must participate in the correct formation of compact myelin; these include both lipid components of 8 
the myelin membrane, different myelin proteins, as well as signalling molecules and inorganic ions. Hence, 9 
further experiments in more complex sample environments are required to decipher the details of the 10 
molecular interplay between these factors in PNS myelin MDL formation.   11 
P0ct mutations and membrane interactions 12 
Compared to wt-P0ct, we observed only subtle differences for two mutants: T216ER and A221T. While 13 
T216ER behaved very similarly to wt-P0ct, its role in CMT etiology could be of another origin than related 14 
to protein-membrane binding. A221T, on the other hand, resides in the YAML-motif, which directs the 15 
trafficking of P0 (Kidd et al. 2006) and might compromise the function of P0 even without inducing changes 16 
in membrane binding, especially when combined with a second mutation in the extracellular domain, such as 17 
the deletion of Val42 (Planté-Bordeneuve et al. 2001).  18 
Functionally the most interesting mutant studied here is D224Y, which now has been described in at least 3 19 
studies (Fabrizi et al. 2006; Miltenberger-Miltenyi et al. 2009; Schneider-Gold et al. 2010). It is a gain-of-20 
function mutant, inducing ordered lipid bilayer stacks in vitro, which are more tightly packed than those 21 
formed by wt-P0ct or the other variants. The results correlate well the hypermyelinating disease phenotype 22 
(Fabrizi et al. 2006). Neutron reflectometry produced a nearly identical result for D224Y compared to wt-23 
P0ct, which together with the SRCD experiments indicates that the conformation of wt-P0ct and D224Y is 24 
similar in the membrane. The change of an acidic to an aromatic residue near the lipid bilayer surface most 25 
likely enables a specific interaction between surfaces that results in the observed gain of function.  26 
P0 is the most abundant protein in PNS myelin (Greenfield et al. 1973; Patzig et al. 2011), contributing 27 
primarily to the formation of the intraperiod line (Filbin et al. 1990), and molecular mechanisms of D224Y-28 
induced tight stacking could be two-fold. Firstly, with its short repeat distance – 1-2 nm smaller compared to 29 
MBP and P2 based on SAXD (Raasakka et al. 2019b; Ruskamo et al. 2014; Sedzik et al. 1985) – and active 30 
membrane binding, as evident from SPR, the mutant might cause size exclusion of P2 and other factors out 31 
of the cytoplasmic stack, leading to defective compact myelin maintenance. In PNS compact myelin, P2 is 32 
even more abundant in the cytoplasmic compartment than MBP, can form membrane stacks, and harbours a 33 
maintenance role in myelin homeostasis as a lipid carrier (Ruskamo et al. 2014; Zenker et al. 2014). 34 
Secondly, the tendency of D224Y to form such ordered, tight systems might affect the Ig-like domains on the 35 
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extracellular side. In the hypermyelinating phenotype of D224Y patients, membrane stacking seems 1 
condensed and regular, without abnormally loosened myelin (Fabrizi et al. 2006). SPR indicates that more 2 
D224Y can accumulate on membranes, and full-length P0 D224Y could accumulate and tighten up within 3 
the membrane, causing also the intraperiod line to become more crowded and/or structured. The original 4 
discovery of the D224Y mutation (Fabrizi et al. 2006) suggested that it has a gene dosage effect, since 5 
heterozygous carriers presented little to no symptoms. Hence, the presence of wild-type P0 can rescue the 6 
effects of the mutation. Correct gene dosage of P0 is important for normal myelination in animal models as 7 
well as CMT patients (Fabrizi et al. 2006; Maeda et al. 2012; Martini et al. 1995; Quattrini et al. 1999; 8 
Speevak and Farrell 2013; Wrabetz et al. 2000). The molecular details of the involved mechanisms are 9 
currently lacking. Further studies on the D224Y mutation in vitro and in vivo could help in understanding 10 
molecular aspects of both normal and abnormal myelination.  11 
Lys236 appears to be a functionally important amino acid in P0ct. In its membrane-bound state, P0ct is likely 12 
to have Lys236 close to the lipid headgroups, and altering the charge in this environment might influence 13 
folding and the global positioning of P0ct on the membrane. Indeed, a gradual effect in membrane packing 14 
was observed in SAXD; the repeat structure loosens, as residue 236 neutralizes (K236del) and turns to 15 
negative (K236E). Turbidimetry also indicated a clear effect of charge reversal at residue 236. The Lys236 16 
mutants folded to a similar degree as wt-P0ct, which suggests that the role of Lys236 is in packing, rather 17 
than folding. This is supported by the slower kinetic parameters for Lys236 mutants in stopped-flow 18 
measurements.  19 
Similarly to Lys236, Arg227 could harbour a role in membrane packing. In our experiments, R227S is one of 20 
the mutants that appeared to induce weaker adhesion than the wild-type protein. The mutation results in a 21 
loosened repeat structure without a major impact on protein folding. Arg227 might be involved in 22 
electrostatic anchoring of the protein to the lipid headgroups – the R227S mutation likely has low impact on 23 
ER stress and UPR, as mutated P0 correctly localizes to the plasma membrane (Lee et al. 2010). 24 
Concluding remarks  25 
To a large extent, the P0ct CMT variants studied here perform similarly to wt-P0ct in controlled simple 26 
environments. This might differ in vivo, where other components are present and P0 is present in its full-27 
length form. Our characterization is focused on protein-lipid interactions and does not take into account 28 
possible protein-protein interactions with MBP, P2, or PMP22, which might be relevant for myelination and 29 
disease phenotypes. Nevertheless, we have uncovered critical amino acids in P0 that may contribute to the 30 
formation of healthy myelin and be involved in disease mechanisms. These include Arg227, Lys236, and 31 
Asp224. Our results shed light on the molecular fundamentals of myelination in the PNS, but more 32 
comprehensive studies in biological model systems, as well as on molecular structure and dynamics of 33 
native-like myelin, are needed for deciphering the mechanisms of the P0ct mutations causing human 34 
neuropathy.  35 
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Experimental procedures 1 
Bioinformatics, mutagenesis, protein expression & purification 2 
Secondary structure prediction for P0ct was performed using JPred (Drozdetskiy et al. 2015). Mutations 3 
were generated in the P0ct pHMGWA expression vector (Busso et al. 2005; Raasakka et al. 2019b) by PCR 4 
using Phusion High-Fidelity DNA polymerase (Thermo Fisher Scientific) with 5′-phosphorylated primers 5 
that introduced the desired point mutations. The samples were treated with DpnI (New England Biolabs) to 6 
digest template DNA and linear vectors circularized using T4 DNA ligase (New England Biolabs), followed 7 
by transformation and plasmid isolation. The presence of mutations and integrity of the constructs was 8 
verified using DNA sequencing. 9 
Protein expression and purification were carried out in E. coli BL21(DE3) as described for wt-P0ct 10 
(Raasakka et al. 2019b), with the exception of an added amylose-resin affinity step between Ni-NTA and 11 
size-exclusion chromatography. The step was introduced to remove any contaminating maltose-binding 12 
protein tags from the tobacco etch virus protease-digested recombinant proteins. Size exclusion 13 
chromatography was carried out using Superdex S75 16/60 HiLoad and Superdex 75 10/300GL columns 14 
(GE Healthcare) with 20 mM HEPES, 150 mM NaCl, pH 7.5 (HBS) as mobile phase, with the exception of 15 
D224Y, where a 20 mM Tris-HCl, 300 mM NaCl, pH 8.5 (TBS) solution was used. The monodispersity and 16 
Rh of all proteins were checked from filtered 1 mg/ml samples using a Malvern Zetasizer ZS DLS 17 
instrument. The D224Y mutant was then dialyzed into HBS. Additionally, all proteins were dialyzed into 18 
water prior to SRCD experiments. 19 
20 
Mass spectrometry 21 
The molecular weight and identity of the purified proteins were verified by mass spectrometry. In short, the 22 
proteins were subjected to ultra-performance liquid chromatography (UPLC) coupled electrospray ionization 23 
(ESI) time-of-flight mass spectrometry in positive ion mode, using a Waters Acquity UPLC-coupled Synapt 24 
G2 mass analyzer with a Z-Spray ESI source. This allowed us to determine the undigested masses of each 25 
purified P0ct variant. Protein identity and the presence of the desired mutations were confirmed from 26 
peptides extracted after in-gel tryptic proteolysis, using a Bruker Ultra fleXtreme matrix-assisted laser 27 
desorption/ionization time-of-flight (MALDI-TOF) mass analyzer. 28 
29 
Small-angle X-ray scattering 30 
SAXS data were collected from protein samples at 0.3 – 12.9 mg/ml in HBS and TBS on the EMBL P12 31 
beamline, PETRA III (Hamburg, Germany) (Blanchet et al. 2015). Monomeric bovine serum albumin (Mr = 32 
66.7 kDa; I0 = 499.0) was used as a molecular weight standard. Data were processed and analyzed using the 33 
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ATSAS package (Franke et al. 2017), and GNOM was used to calculate distance distribution functions 1 
(Svergun 1992). See Supplementary Table 2 for further details. 2 
3 
Vesicle preparation 4 
DMPC, DMPG, and DOPC were purchased from Larodan Fine Chemicals AB (Malmö, Sweden). DOPS and 5 
the deuterated d54-DMPC and d54-DMPG were purchased from Avanti Polar Lipids (Alabaster, Alabama, 6 
USA). 7 
Lipid stocks were prepared by dissolving dry lipids in chloroform or chloroform:methanol (9:1 v/v) at 10-30 8 
mM. Mixtures were prepared from stocks at the desired molar ratios, followed by solvent evaporation under 9 
a stream of nitrogen and lyophilizing overnight at -52 °C. The dried lipids were stored at -20 °C or used 10 
directly for liposome preparation. 11 
Liposomes were prepared by mixing dried lipids with water or HBS at 10-15 mM, followed by inverting at 12 
ambient temperature for at least 3 h. Multilamellar vesicles (MLV) were prepared by freeze-thaw cycles in 13 
liquid N2 and a warm water bath and vortexing. The cycle was performed 7 times in total. Large unilamellar 14 
vesicles (LUV) were prepared by passing fresh MLVs through a 0.1-µm membrane 11 times at 40 °C. SUVs 15 
were prepared by ultrasonication of fresh MLVs using a probe tip sonicator (Sonics & Materials Inc. Vibra-16 
Cell VC-130) until clarified. All lipid preparations were immediately used in experiments. 17 
18 
Synchrotron radiation circular dichroism spectroscopy 19 
SRCD spectra were collected from 0.1 – 0.5 mg/ml protein samples in water on the AU-CD beamline at 20 
ASTRID2 synchrotron (ISA, Aarhus, Denmark). Samples containing lipids were prepared right before 21 
measurement by mixing proteins (P/L ratio 1:200) with SUVs. 100-µm pathlength closed circular cells 22 
(Suprasil, Hellma Analytics) were used for the measurements. Spectra were recorded from 170 to 280 nm at 23 
30 °C. Baselines were subtracted and CD units converted to Δε (M-1 cm-1) in CDtoolX (Miles and Wallace 24 
2018). SDS and TFE were from Sigma-Aldrich and the detergents LDAO, OG, DM, and DPC from 25 
Affymetrix. 26 
Rapid kinetic SRCD data were collected as described (Raasakka et al. 2019a). In short, an SX-20 stopped-27 
flow instrument (Applied Photophysics) mounted on the AU-rSRCD branch line of the AU-AMO beamline 28 
at ASTRID2 (ISA, Aarhus, Denmark) at was used for data collection at 10 °C. 1-to-1 mixing of a 0.1 mg/ml 29 
protein solution and a DMPC:DMPG (1:1) SUV solution (at P/L ratios 1:200) was achieved using a mixer (2 30 
ms dead time) before injection into the measurement cell (160 µl total volume, 2-mm pathlength) per shot. 31 
The CD signal (mdeg) was monitored at a fixed wavelength of 195 nm for 5 s with a total of 5 – 10 repeat 32 
shots per sample, which were averaged into a single curve. Each sample was prepared and measured in 33 
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duplicate. Water baselines were subtracted from sample data. The data were fitted to different exponential 1 
functions using GraphPad Prism 7. 2 
3 
Surface plasmon resonance 4 
SPR was performed on a Biacore T200 system (GE Healthcare). According to the manufacturer’s 5 
instructions, 100-nm LUVs of 1 mM DMPC:DMPG (1:1) were immobilized on an L1 sensor chip (GE 6 
Healthcare) in HBS, followed by the injection of protein solutions. Chip regeneration was performed using a 7 
2:3 (v:v) mixture of 2-propanol and 50 mM NaOH. The protein concentration was 20 – 2000 nM in HBS, 8 
and a single concentration per lipid capture was studied; all samples were prepared and measured in 9 
duplicate. In each run, one sample was measured twice to rule out instrumental deviation. The binding 10 
response as a function of protein concentration was plotted and fitted to the 4-parameter model, 11 







 , 12 
to gain information about association affinity. 13 
14 
Differential scanning calorimetry 15 
Proteins were mixed with MLVs in HBS at a protein-to-lipid ratio of 1:100 or 1:250, always containing 350 16 
µM of DMPC:DMPG (1:1) in a final volume of 700 µl. Lipid samples without proteins were prepared as 17 
controls. The samples were degassed for 10 min under vacuum with stirring at 10 °C before measurements. 18 
DSC was performed using a MicroCal VP-DSC calorimeter with a cell volume of 527.4 µl. The reference 19 
cell was filled with HBS. Each sample was scanned from 10 to 40 °C and back to 10 °C in 1 °C/min 20 
increments. Baselines were subtracted from sample curves and zeroed between 15 & 20 °C to enable 21 
straightforward comparison between samples. All samples were prepared and measured twice, with the 22 
observed trends being reproducible. 23 
24 
Vesicle turbidimetry and X-ray diffraction experiments 25 
For turbidimetric measurements, SUVs of DMPC:DMPG (1:1) were mixed with 0.5 – 10 µM protein in 26 
duplicate and mixed thoroughly. Turbidity was recorded at 450 nm at 30 °C using a Tecan Spark 20M plate 27 
reader. Turbidity of protein-free SUVs was subtracted from the protein samples, and statistical analysis was 28 
performed using GraphPad Prism 7.  29 
SAXD experiments were performed to investigate repetitive structures in the turbid samples. 10 and 20 µM 30 
proteins were mixed with SUVs of 1 – 3 mM DMPC:DMPG (1:1) in HBS at ambient temperature and 31 
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exposed at 25 °C on the EMBL P12 BioSAXS beamline, DESY (Hamburg, Germany). A HBS buffer 1 
reference was subtracted from the data. Lipid samples without added protein did not produce Bragg peaks. 2 
The peak positions of momentum transfer, s, in all measured samples were used to calculate mean repeat 3 




 , where s   





























For negatively stained EM, 740 µM DMPC:DMPG (1:1) SUVs were mixed with proteins using protein-
to-lipid ratios of 1:58, 1:100, 1:200, and 1:500 and incubated at 2  for 1 h. EM grids were then 
prepared, stained and imaged as described before (Raasakka et al. 2017; Raasakka et al. 2019b; 
Ruskamo et al. 2017). 
Neutron reflectometry 
Supported lipid bilayers were prepared onto flat (5 Å RMS roughness tolerance) 80 mm × 50 mm ×15 mm 
Si-crystal blocks (Sil’tronix Silicon Technologies, Archamps, France). Samples were prepared from a 
chloroform-methanol stock of 1 mg/ml DMPC:DMPG (1:1). Using Langmuir-Blodgett and Langmuir-
Schaefer techniques, the two membrane leaflets of the bilayers were deposited sequentially. The surface 
pressure was kept at a constant 30 mN m-1 during the deposition, as described previously (Barker et al. 2016; 
Hubbard et al. 2017; Raasakka et al. 2017). All sample blocks were assembled into low-volume 
measurement flow cells, which were used for in situ exchange of solvent and injection of protein samples 
between reflectometric data collections (Junghans et al. 2015). 
Neutron reflectometric measurements for wt-P0ct were performed as described (Raasakka et al. 2017). In 
short, the D17 neutron reflectometer at the Institut Laue-Langevin (Grenoble, France) was used for data 
collection at two incident angles (0.8° and 3.2°) (Cubitt and Fragneto 2002). All samples were kept at 30 °C 
with HBS buffer as the liquid phase, prepared at a final concentration of 95% (v/v) deuterium oxide (D2O, 
Sigma-Aldrich) and in H2O. The deposited bilayers were characterized, before and after the injection of P0ct, 
at three different solvent contrasts, varying the volume ratio of D2O and H2O in to the sample cell: (1) 95% 
D2O, (2) Si-matched water (SMW; 38% (v/v) D2O, 62% (v/v) H2O), and (3) 100% H2O. A 0.5 µM P0ct 
solution was allowed to interact with the membrane for 3 h whilst monitoring reflectivity, until no further 
changes were observed. Any excess P0ct was washed out from the bulk solution by exchanging 20 cell 
volumes of solvent slowly through the sample cell. Fitting was performed using Motofit in Igor Pro 7 
(Nelson 2006). 32 
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The scattering length densities of the phospholipids were calculated from volume fractions of the lipid 1 
components obtained from molecular dynamics simulations (Armen et al. 1998), and for the proteins, they 2 
were calculated from the sequences and amino acid volumes (Zamyatnin 1972). The P0ct scattering length 3 
density, assuming 90% labile hydrogen exchange, was 3.227, 2.324, and 1.722 x 10-6 Å-2 in 95%, 38%, and 4 
0% D2O, respectively. The errors in the structural parameters for each sublayer were derived from the 5 
maximum acceptable variation in the fitted thickness and lipid volume fraction that allowed a fit to be 6 
maintained, subject to a constant molecular area constraint required to maintain a planar bilayer geometry. 7 
Details of the analysis of supported lipid membrane structure (Vacklin et al. 2005) and interaction with 8 
soluble proteins (Wacklin et al. 2016) using time-of-flight neutron reflection have been described previously.  9 
The fraction of P0 in the lipid bilayers was determined by a simultaneous fit to all contrasts, taking into 10 
account the change in protein scattering length density with solvent contrast due to H/D exchange of protons 11 
on polar residues with the solvent. 12 
For mutant comparison to wt-P0ct, NR data for wt-P0ct and D224Y were collected on the INTER neutron 13 
reflectometer at ISIS Neutron and Muon Source (Didcot, United Kingdom) at two incident angles  (0.7° and 14 
2.3°) (Webster et al. 2006) covering a total q-range from 0.01 to 0.34 Å-1, with a resolution of Δq/q=0.03. 15 
The samples were prepared and handled as above. 16 
17 
18 
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Figure legends 1 
Fig. 1. Overview of P0ct mutations. (a) The primary sequence of the wt-P0ct construct, corresponding to 2 
amino acids 180 – 248 of the human P0 precursor, with an extra N-terminal Gly residue (gray) left behind 3 
from affinity tag cleavage. The Cys182 palmitoylation site was mutated into a Leu (green) in all constructs. 4 
Putative serine phosphorylation sites are indicated with asterisks. Residues affected by disease mutations are 5 
in bold. CMT1B, CMT2I, and DSS point mutations are shown in blue, red, and orange, respectively. The 6 
sequence highlighted in yellow corresponds to the neuritogenic segment used in EAN models (de Sèze et al. 7 
2016). Secondary structure prediction is shown below. (b) SEC traces of wt-P0ct and mutants as determined 8 
using a Superdex 75 10/300GL column. Note the slightly earlier retention volume of D224Y, for which the 9 
chromatography had to be performed with a different running buffer than for the other variants. The 10 
degradation products (red asterisk) present with D224Y could be completely removed using SEC. The final 11 
purity of each P0ct variant (4 µg per lane) as determined using SDS-PAGE is shown as inset. (c) DLS data 12 
of P0ct variants display good monodispersity with minimal variation in Rh.  13 
14 
Fig. 2. SAXS analysis of P0ct in solution. (a) SAXS data for P0ct variants. The scattering curves have been 15 
offset for clarity. (b) Guinier fits based on SAXS data. Data range is shown within each graph. (c) Distance 16 
distributions. (d) Kratky plots. P0ct variant data point coloring is consistent throughout the figure. GNOM 17 
fits to the data are shown as black lines in panels (a) and (c). 18 
19 
Fig. 3. Folding and lipid binding analysis of P0ct variants. The folding of wt-P0ct and mutants was 20 
studied using SRCD spectropolarimetry in (a) water, (b) 30% TFE, (c) 0.5% SDS, (d) DMPC:DMPG (1:1), 21 
and  (e) DMPC:DMPG (4:1) at 1:200 P/L ratio in each lipid condition. Additional spectra are presented in 22 
Supplementary Fig. S2. (f) SPR measurements were used to determine the affinity of each P0ct variant to 23 
immobilized DMPC:DMPG (1:1) vesicles. The colour coding legend in panel (a) for each mutant trace also 24 
corresponds to all other traces in subsequent panels. 25 
26 
Fig. 4. Analysis of protein-induced lipid structure behavior. (a) DSC analysis of lipid tail transition 27 
behaviour. (b) Turbidimetric analysis of 0.5 mM DMPC:DMPG (1:1) at 5 µM (gray) and 10 µM protein 28 
concentration (dark red). These proteins concentrations translate to 1:100 and 1:50 P/L ratios, respectively. 29 
Error bars represent standard deviation. Statistical analysis was performed using one-way analysis of 30 
variance (ANOVA) followed by Dunnett’s multiple comparisons test to wt-P0ct turbidity within the same 31 
protein concentration series (* : P < 0.05; *** : P < 0.001). (c) SAXD analysis reveals that D224Y displays a 32 
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significantly tighter mean repeat distances compared to wt-P0ct, whereas K236E is most loose. The traces 1 
have identical colouring to (a).  2 
3 
Fig. 5. EM analysis of P0ct mutants. Negatively stained samples of DMPC:DMPG (1:1) vesicles (a) alone, 4 
and with (b) wt-P0ct, (c) T216ER, (d) A221T, (e) D224Y, (f) R227S, (g) K236E, and (h) K236del were 5 
imaged at 1:200 P/L ratio. D224Y forms multilayered lipid structures that are absent for wt-P0ct. 6 
7 
Fig. 6. SRCD stopped-flow kinetics of protein-induced initial lipid turbidification. (a) The SRCD signal 8 
evolution was monitored using rapid kinetics at 195 nm for 5 sec. wt-P0ct and mutants were mixed with 9 
DMPC:DMPG (1:1) lipids at 1:200 P/L ratio in the presence of 150 mM NaF. Fits (dashed lines) are plotted 10 
over the measurement points. Error bars represent standard deviation. See Table 4 for fitting results. (b) 11 
Graphical comparison of the obtained k1 values.  12 
13 
Fig. 7. NR data and fitting. (a) NR data of a supported DMPC:DMPG (1:1) bilayer before (open markers) 14 
and after incubation with wt-P0ct (closed markers). The used solvent contrasts were 95% D2O (red), Si-15 
matched water (SMW, 38% D2O; green) and 100% H2O (blue). Fits are shown as dashed and solid lines for 16 
the bilayer before and after addition of wt-P0ct, respectively. (b) Scattering length density (ρ) profiles 17 
obtained from the fitting. The error bars denote standard deviation. (c) Model for the P0ct-bound membrane. 18 
The protein-free membrane is shown in light gray on the background.  19 
20 
21 
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Table 1. Recombinant protein characterization. 3 
Purification Molecular weight determination Peptide fingerprinting 
Variant* Condition pI** Yield*** Solubility Measured Theoretical** Difference Mutation confirmed 
wt-P0ct - 11.11 2.1 ± 0.4 ++ 7989.0 7990.35 -1.35 - 
T216ER CMT1 11.08 4.2 ± 0.4 +++ 8173.0 8174.54 -1.54 yes 
A221T DSS 11.11 5.0 ± 0.7 +++ 8018.0 8020.37 -2.37 yes 
D224Y CMT1 11.12 0.8 ± 0.3 + 8037.0 8038.43 -1.43 yes
R227S CMT1 10.89 6.1 ± 2.0 +++ 7919.0 7921.24 -2.24 yes 
K236E CMT2 10.85 5.1 ± 1.8 +++ 7989.0 7991.29 -2.29 yes 
K236del CMT1 11.09 5.2 ± 1.0 +++ 7860.0 7862.17 -2.17 yes 
*All proteins, including wt-P0ct, contain the C182L mutation.4 
**Values determined from protein sequences using ProtParam5 
***Expressed as mg protein obtained on average per liter culture. See Supplementary Fig. 1 for graphical6 
representation.7 
8 
Table 2. SPR fitting parameters. 9 
Variant Rhi Rlo A1 A2 R
2 
wt-P0ct 2975 ± 79 -69.10 ± 61.54 363.2 ± 15.1 3.237 ± 0.411 0.9858 
T216ER 3123 ± 86 -44.63 ± 64.19 375.1 ± 15.6 3.173 ± 0.409 0.9854 
A221T 3061 ± 82 -44.81 ± 62.30 357.0 ± 15.5 2.973 ± 0.363 0.9863 
D224Y 3811 ± 81 11.30 ± 66.26 385.2 ± 11.3 4.416 ± 0.540 0.9886 
R227S 2798 ± 78 -39.52 ± 55.20 384.9 ± 16.0 2.936 ± 0.361 0.9864 
K236E 2671 ± 92 -49.48 ± 60.00 380.8 ± 20.0 2.526 ± 0.340 0.9831 




Table 3. Kinetic constants for protein-induced vesicle turbidity. The kinetic constants were obtained by 13 






wt-P0ct 20.14 ± 0.25 1.12 ± 0.01 17.96 ± 0.22 0.9934 
T216ER 19.54 ± 0.28 1.18 ± 0.02 16.63 ± 0.25 0.9908 
A221T 19.15 ± 0.21 1.14 ± 0.01 16.76 ± 0.20 0.9943 
D224Y 22.11 ± 0.28 1.19 ± 0.02 18.53 ± 0.25 0.9923 
R227S 19.35 ± 0.27 1.08 ± 0.02 17.95 ± 0.26 0.9916 
K236E 14.98 ± 0.12 1.02 ± 0.01 14.64 ± 0.13 0.9969 
K236del 14.25 ± 0.12 1.05 ± 0.01 13.54 ± 0.13 0.9967 
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Table 4. NR parameters. 3 
Bilayer alone Bilayer with 0.5 µM wt-P0ct 
Substrate Oxide thickness (Å) 10.6 11 
Oxide solvation (%) 0 0 
Oxide roughness (Å) 4 4 
Hydration layer between oxide and bilayer (Å) 4.6 12 
Hydration layer roughness (Å) 3 6 
Bilayer Bilayer area-per-molecule (Å2/molecule) 60 70
Inner headgroups thickness (Å) 8.3 8 
Inner headgroups roughness (Å) 3.6 8.1 
Inner headgroups solvation (%) 35 45 
Acyl tails thickness (Å) 28.8 32 
Acyl tails roughness (Å) 3.8 13.3 
Acyl tails hydration (%) 0 17 
Outer headgroups thickness (Å) 8.8 8 
Outer headgroups roughness (Å) 4.9 9.5 
Outer headgroups solvation (%) 35 53.5 
wt-P0ct Protein in inner headgroups (%) 0 
Protein in acyl tails (%) 10 
Protein in outer headgroups (%) 20 
Protein layer thickness (Å) 7 
Protein layer roughness (Å) 15 
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Supplementary information 1 
2 
Supplementary Fig. S1. Protein yield. The purified protein amount from E. coli expression, shown as mg 3 
of protein obtained per 1 l of culture. 4 
5 
Supplementary Fig. S2. The folding of P0ct variants in TFE, detergents, and poorly binding 6 
membrane compositions. The folding of wt-P0ct and mutants was studied using SRCD spectropolarimetry 7 
in (a) 10% TFE, (b) 50% TFE, (c) 70% TFE, (d) 0.1% DPC, (e) 1% LDAO, (f) 1% OG, (g) DMPC, and (h) 8 
9:1 DMPC:DMPG. The colour coding legend in panel (a) for each mutant trace also corresponds to all other 9 
traces in subsequent panels. 10 
11 
Supplementary Fig. S3. P0ct variant-induced turbidimetry and diffraction. (a) Turbidimetric analysis of 12 
0.5 mM DMPC:DMPG (1:1) vesicles in the presence of 0 – 10 µM wt-P0ct and mutants. BSA was included 13 
as negative control. Error bars represent standard deviation. (b) Examples of Bragg peaks from the P0ct 14 
samples mixed with DMPC:DMPG (1:1) vesicles. 15 
16 
Supplementary Fig. S4. EM analysis of P0ct D224Y. Negatively stained samples of DMPC:DMPG (1:1) 17 
vesicles mixed with P0ct D224Y at (a) 1:100, (b) 1:200, and (c) 1:500 P/L ratios all display multilayered 18 
lipid structures. 19 
20 
Supplementary Fig. S5. NR data of wt-P0ct and D224Y. NR data for DMPC:DMPG (1:1)-bound wt-P0ct 21 
and D224Y. The data have been offset for clarity. Solvent contrasts are indicated for each trace on their right 22 
hand side. The D224Y H2O data is incomplete as reflectivity was collected at only one measurement angle 23 
(0.7°). The error bars denote standard deviation. 24 
25 
26 
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Supplementary Table 1. DLS parameters. 1 
Protein variant wt-P0ct T216ER A221T D224Y R227S K236E K236del 
Sample buffer* HBS HBS HBS TBS HBS HBS HBS
Rh (nm) 2.96 2.87 2.72 2.26 2.93 2.88 2.80
*HBS, 20 mM HEPES, 150 mM NaCl, pH 7.5; TBS, 20 mM Tris-HCl, 300 mM NaCl, pH 8.5. 2 
3 
Supplementary Table 2. SAXS parameters.  4 
Data collection parameters 
Instrument P12, PETRAIII, DESY 
Wavelength (nm) 0.124 
Angular range (nm-1) 0.0403 - 7.3195 
Exposure time (s) 0.045 
Measurement temperature (°C) 10 
Protein variant wt-P0ct T216ER A221T D224Y R227S K236E K236del 
Concentration range (mg ml-1) 0.3 - 1.2 1.0 - 3.8 2.0 - 8.0 0.5 - 2.1 1.7 - 6.8 3.5 - 12.9 2.3 - 9.3 
Sample buffer* HBS HBS HBS TBS HBS HBS HBS 
Structural parameters 
I0 (relative) [from p(r)] 58.90 64.72 59.06 58.27 56.14 62.73 58.17 
Rg (nm) [from p(r) ] 2.57 2.50 2.40 2.73 2.42 2.41 2.41 
I0 (relative) [from Guinier] 58.25 63.87 58.35 57.38 55.21 61.61 57.30 
Rg (nm) [from Guinier] 2.39 2.33 2.26 2.43 2.25 2.23 2.23 
Dmax (nm) [from GNOM] 9.59 9.21 9.59 11.57 8.96 10.34 10.69 
Molecular mass determination 
Molecular mass Mr (kDa) [from I0 using p(r)] 7.87 8.65 7.89 7.79 7.50 8.38 7.78
Molecular mass Mr (kDa) [from I0 using Guinier] 7.79 8.54 7.80 7.67 7.38 8.24 7.66 
Theoretical Mr from sequence (kDa) 7.99 8.17 8.02 8.04 7.92 7.99 7.86
Software 
Primary data reduction & processing PRIMUS 
*HBS, 20 mM HEPES, 150 mM NaCl, pH 7.5; TBS, 20 mM Tris-HCl, 300 mM NaCl, pH 8.5. 5 
6 
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